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Summary 
Proteins of the ferlin family mediate calcium-dependent vesicular fusion. Although present 
throughout eukaryotic evolution, their function in unicellular organisms including apicomplexan 
parasites is unknown.  
This study defined for the first time a crucial role for a ferlin-like protein (FLP) in host-to-vector 
transmission of the rodent malaria parasite Plasmodium berghei. Analysis of flp expression profile 
revealed a peak in the gametocyte stage. Endogenous tagging of the protein confirmed high 
abundance of FLP in this stage. In agreement with the reported vesicular localization of ferlins, 
HA-tagged FLP labelled intracellular speckles in asexual and sexual blood stages. The FLP-labelled 
vesicles relocalized to the cell periphery during gamete maturation, suggesting that they might 
act in the process of the gamete egress from the red blood cell.  
Infection of the mosquito vectors requires the formation of free gametes and their fertilization in 
the mosquito midgut. Mature gametes will only emerge upon secretion of factors that stimulate 
the disruption of the red blood cell membrane and the parasitophorous vacuole membrane. Lysis 
of the surrounding membranes is a critical step in host-to-vector transmission and its failure 
prevents infection of the mosquito.  
Genetic depletion of FLP in sexual stages led to a complete life cycle arrest in the mosquito. 
Although mature gametes formed normally, mutants lacking FLP remained trapped in the red 
blood cell. FLP function was restricted to egress as the observed phenotype was rescued by 
detergent-mediated in vitro membrane lysis facilitating escape from the host cell and allowing 
normal life cycle progression of the FLP-depleted gametocytes. The data of this work define FLP 
as a novel critical factor for Plasmodium fertilization and transmission and suggest an 
evolutionarily conserved example of ferlin-mediated exocytosis. 
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Zusammenfassung 
Proteine aus der Familie der Ferline vermitteln die Calcium-abhängige Fusion zellulärer Vesikel. 
Obwohl Ferline in der eukaryotischen Evolution konserviert sind, ist ihre Funktion in einzelligen 
Organismen, die Parasiten der Apicomplexa inbegriffen, bislang unbekannt. 
In dieser Studie wird erstmals die entscheidende Rolle eines Ferlin-ähnlichen Proteins (FLP, Ferlin-
like protein) für die Übertragung des Nagetiermalariaerregers Plasmodium berghei vom Wirt auf 
den Moskitovektor beschrieben. Die Analyse des FLP-Expressionsprofils zeigte ein Maximum im 
Gametozytenstadium. Die endogene Markierung (tagging) des Proteins bestätigte die starke 
Anreicherung in diesem Parasitenstadium. In Übereinstimmung mit der bekannten vesikulären 
Lokalisation von Ferlinen, konnte Hämagglutinin (HA)-markiertes FLP in punktförmigen Bereichen 
innerhalb asexueller und sexueller Blutstadien visualisiert werden. Während der Gametogenese 
kam es zu einer Relokalisierung der Vesikel an der Zellperipherie, was einen Hinweis darauf 
lieferte, dass diese am Prozess des Austritts der Gameten aus dem Erythrozyten beteiligt sein 
könnten. 
Die Infektion des Moskitovektors ist abhängig von der Bildung freier Gameten und deren 
Fertilisation im Mitteldarm der Stechmücke. Nur durch die Sekretion von Faktoren, die zur 
Auflösung der parasitophoren Vakuolen- und Erythrozytenmembran führen, können reife 
Gameten entstehen. Die Lyse dieser umhüllenden Membranen stellt einen essentiellen Schritt bei 
der Übertragung vom Wirt auf den Vektor dar. Ein Ausbleiben dieser Membranlyse verhindert die 
erfolgreiche Infektion der Stechmücke. 
Die genetische Depletion von FLP in Sexualstadien führte zu einer vollständigen Unterbrechung 
des Lebenszyklus in der Stechmücke. Obwohl sich reife Gametozyten normal ausbildeten, blieben  
mutierte Parasiten ohne FLP im Erythrozyten eingeschlossen. Die Funktion von FLP konnte auf den 
Austritt der Gameten eingegrenzt werden, da der beobachtete Phänotyp durch eine in vitro 
Membranlyse unter Verwendung eines Detergenz rückgängig gemacht werden konnte. Dies 
ermöglichte den Austritt aus der Wirtszelle und resultierte folglich in einer normalen 
Weiterentwicklung FLP-depletierter Gametozyten. Die Ergebnisse dieser Arbeit definieren FLP als 
einen neuen und entscheidenden Faktor bei der Fertilisation und Übertragung von Plasmodium 
und weisen auf ein evolutionär konserviertes Beispiel Ferlin-vermittelter Exozytose hin. 
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1 Introduction 
1.1 The life cycle of Plasmodium 
Plasmodium, the pathogenic single-celled protist causing malaria, alternates between the 
mammalian host and the mosquito vector in a complex life cycle with a number of intra- and 
extracellular stages (Fig. 1.1). The Plasmodium parasite was first reported as a live organism linked 
to the malaria fever in 1881. Interestingly, it was the process of exflagellation, the clearly 
distinguishable and unique event of rapid motility in the blood, that led to the discovery [1]. This 
drew attention to the causative agent of malaria and the whole life cycle was described in 1897 
[2]. Both these contributions were awarded a Noble Prize in Physiology or Medicine in 1907. 
1.1.1 Vector development 
The mosquito vector is infected by ookinetes, tetraploid and motile invasive stages that develop 
in the mosquito midgut from a zygote several hours after infectious blood meal (Fig. 1.1). 
Ookinetes are extracellular stages, which leaves them vulnerable in the hostile environment of 
the mosquito midgut [3]. This, together with the fact that ookinete formation (unlike other 
invasive stages) is not preceded by a replicative stage, leads to significant reduction of the parasite 
numbers in this stage [4]. Ookinetes penetrate the mosquito wall using the perforin MAOP 
(membrane attack ookinete protein). In the membrane epithelium, ookinetes transmigrate 
several cells with the help of CelTOS (cell traversal protein for ookinetes and sporozoites) [5]. 
Eventually, ookinetes leave the epithelium and form an oocyst on its outer side, a perfectly round 
stage that can be observed already several days after the infectious blood meal (Fig. 1.1). Oocyst 
formation seems to be mainly dependent on laminin as ookinete-to-oocyst transformation 
proceeds in a laminin-supplemented Matrigel [6]. Inside the oocyst, syncytium with intense DNA 
replication is established. Subsequently, haploid sporozoites bud from sporoblast (syncytial lobes 
marked by the protein CSP (circumsporozoite protein)) in a complex process called sporogony [7]. 
Sporogony (a type of schizogony, discussed in chapter 1.1.3) is dependent on the organization of 
MTOC (microtubule organizing center) and the assembly of attached microtubules [8]. Mature 
sporozoites are curved with uneven microtubule distribution underneath their plasma membrane 
[9]. Motility of sporozoites precedes their release from the oocyst around day 14 post infection 
[10], but also proteins play a role in the release – SERA protease ECP1 [11], CSP [12] and others. 
After the release, sporozoites are passively carried through the mosquito body by the hemolymph 
and only recognition of salivary gland-specific molecules leads to their attachment [13]. The 
migration through the hemolymph leads to severe loss in parasite numbers, representing a second 
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bottleneck in the mosquito development [14]. Sporozoites migrate through acinar cells into the 
salivary gland duct [15], where they reside until the next blood meal.  
 
 
Figure 1.1 Life cycle of Plasmodium. The life cycle alternates between mammalian host (right side) 
and mosquito vector (left side) and includes a number of intracellular (liver stages, asexual blood 
stages – except merozoites, gametocytes) and extracellular (merozoites, gametes, zygotes, 
ookinetes, sporozoites) stages. Salivary gland sporozoites are injected into the human host during 
infectious blood meal. They use blood circulation to travel to the liver, where they establish the 
first replicative stage. After several days, thousands of merozoites are released into the blood 
stream, where they start the pathological asexual blood stage cycle (merozoites, rings, 
trophozoites and schizonts). Some parasites develop into gametocytes inside red blood cells and 
are transmitted to the mosquito vector during blood meal. Inside the mosquito midgut, 
gametocytes mature into fertilization-competent gametes and fuse to produce a zygote. Zygote 
differentiates into motile ookinete that penetrates the midgut wall and establishes an oocyst, in 
which replication followed by sporozoite budding takes place. Mature sporozoites travel through 
the mosquito haemocoel to the salivary glands, where they await the next blood meal. 
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1.1.2 Vector-to-host transmission 
Sporozoites (Fig. 1.1) are passively transmitted to the host during blood meal. Experiments 
showed that despite general belief, sporozoites are not deposited directly into blood vessels, but 
instead into the host skin [16]. Interestingly, about half of the deposited sporozoites are left in the 
skin, about 20 % are taken up to local lymph nodes and only the rest glides in a corkscrew manner 
in search of a blood vessel [17]. 
1.1.3 Mammalian development 
The first parasite destination is the liver, to which sporozoites are passively carried by the blood 
stream. Although the process is largely unclear, sporozoites recognize and cross the sinusoidal 
barrier, possibly via Kupfer cells, and enter hepatocytes [18]. After transmigrating through and 
killing several hepatocytes, the parasite finally establishes a protective parasitophorous vacuole 
(PV) [19] and settles in one cell [20]. Hidden from the immune system, the parasite develops for 
several days (around 2 days in a mouse, around a week in a human), eventually releasing large 
membranous assemblies of thousands of merozoites, called merosomes, into the blood stream 
[21–23]. Merosomes eventually rupture in small lung capillaries [22,23] and release the first 
generation of infectious merozoites. This stadium infects red blood cells (RBC) within minutes and 
extensively rearranges the cell to fit its needs. Blood asexual cycle is repeated every 48 hours with 
sequential development of ring stage, trophozoite stage, schizont stage and release of mature 
merozoites (Fig. 1.1). In some species, like the human P. falciparum, the blood cycle is 
synchronized, leading to massive synchronous releases of merozoites and causing periodical 
fevers to the host. P. berghei develops asynchronously in the blood stage. The asexual blood stage 
cycle is currently the only permissive stage for transgenesis [24], which excludes genes essential 
for this stage from the possibility of knock-out studies.  
A typical feature of Plasmodium common to mosquito, liver and blood stages is the schizogony. 
Schizogony is a process of several DNA replications and mitoses without nuclear envelope 
breakage and cytokinesis [25]. This allows the parasite to produce tens (in the blood stage) or 
thousands (in the oocyst and liver stage) of new merozoites (merogony) or sporozoites 
(sporogony) with a single cytokinesis and to achieve extremely short doubling time.  
The disease-causing blood stage is referred to as asexual stage to distinguish it from the 
subsequent sexual transmission stage, represented by gametocytes (Fig. 1.1). Male and female 
gametocytes form inside RBCs from sexually committed parasites. Although the process of sexual 
commitment is not completely clarified, recent findings shed light on the main switches. The 
decision to leave the asexual cycle and become sexually committed is triggered by external stimuli 
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[26] and mediated by epigenetic and transcriptional changes. In the first step, chromatin 
rearrangement leads to expression of Ap2-G [27–29], a gametocyte-specific plant-like 
transcription factor. This triggers a cascade that involves epigenetic rearrangements mediated by 
HDA2 (histone deacetylase 2) and HP1 (heterochromatin protein 1) [30,31]. Interestingly, the 
commitment to gametogenesis takes place in the schizont stage [32], leading to production of 
gametocytes from all the daughter merozoites. Already very early on, male- and female- specific 
markers can be detected, indicating that the sex determination takes place shortly after or at the 
time of commitment [33,34]. While male gametocytes are three times less abundant than females 
[35], their specialization is more pronounced as 36 % of their proteins are specific to the 
gametocyte stage (only 19 % in females) [36]. After formation, gametocytes remain 
developmentally silent in the mammalian host [37].   
1.1.4 Host-to-vector transmission 
Gametocytes are taken up by the mosquito during blood meal. In response to defined external 
stimuli in the mosquito midgut (drop in temperature of about five degrees [38], presence of 
xanthurenic acid (XA) [39]), calcium ions are released from the parasite’s intracellular stores and 
trigger gametogenesis (calcium signalling in this process is further discussed in chapter 1.3.1). This 
developmental program yields fertile gametes, female (macro-) and motile male (micro-) gametes, 
which are capable of fertilization (Fig. 1.1).  
Each female gametocyte develops into a single macrogamete. The macrogamete specifically 
represses translation of a large amount of proteins by mRNA-binding proteins DOZI and CITH 
[40,41]. Male gametocytes synthetize flagella and undergo mitosis in response to the calcium 
trigger [42], yielding eight flagellated microgametes. The flagella are supported by microtubules, 
assembly of which is regulated by PF16 and SAS6, followed by MAP2-mediated cytokinesis [43–
46]. After mature microgametes are formed, they become motile and egress from the residual 
body with the help of actin II [47], MAP2 [44,46], PF16 [43] and many other factors discussed in 
chapter 1.1.4.1.  
After fertile gametes are formed, microgametes actively move in search for their mating partners. 
Although no chemotaxis was reported in the process [48], in the restricted area of mosquito 
midgut microgametes and macrogametes encounter each other and fuse. Cellular fusion is 
followed by nuclear fusion and the formation of a zygote, the only diploid stage of the life cycle 
(Fig. 1.1). In the zygote stage, translational de-repression of mRNAs is mediated by CDPK1 [49]. 
Zygote undergoes DNA replication, differentiation and elongation, giving rise to the tetraploid, 
motile and invasive ookinete [50] (Fig. 1.1). Given the tetraploidy, it is not surprising that ookinetes 
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extensively regulate their transcription and, except for de novo transcribed genes, all genes are 
expressed from the maternal set [51]. 
1.1.4.1 Gametocyte egress 
Gametogenesis of both sexes involves egress from the two membranes surrounding the 
gametocyte [26]; i.e. RBC membrane (RBCM) and PV membrane (PVM, delineating the 
intraerythrocytic niche of the parasite [19]) (Fig. 1.2). The sequence of RBCM and PVM disruption 
remained unclear for a long time with several models tested. It was first established for the egress 
of P. falciparum asexual blood stage that PVM rupture precedes RBCM rupture in so called inside-
out model [52]. The same model was shown to hold true for P. falciparum gametocytes [53]. Only 
recently, a complete sequence of events confirming the inside-out model was reported for egress 
of P. berghei gametocytes [54]. While PVM rupture initiates in several sites, RBCM ruptures from 
one site only [53]. The egress of both P. falciparum and P. berghei gametocytes consists of similar 
sequence of events, namely swelling of the host cell followed by rupture and vacuolisation of the 
PVM and afterwards rupture of the RBCM and its vacuolisation take place (Fig. 1.2) [53,54]. 
Interestingly, similar events were identified in the egress of P. falciparum asexual blood stages 
[55]. The sequence of events  in gametocyte egress seems to be more tightly regulated in P. 
falciparum [53] than in P. berghei, in which both male and female gametocytes show highly 
variable delays in between individual events [54].  
Disruptions of both PVM and RBCM are dependent on proteases and exocytosis of secretory 
vesicles (Fig. 1.2), although different subsets are linked to each process [53]. The first reported 
vesicles that undergo exocytosis during egress were named osmiophilic bodies (OBs) due to their 
prominent staining in electron microscopy [56]. Although egress needs to be completed by male 
and female gametocytes alike, OBs defined by the marker protein G377 are only present in 
females [36,57,58]. Other gamete egress factors (MDV1/PEG3, GEST, PAT and MTRAP) were 
reported to localize to OBs but at the same time, both male and female gametocytes express these 
factors [59–61]. Additionally, perforin PPLP2 was reported to play a role in egress but to occupy 
egress vesicles distinct from OBs [62]. PPLP2 is the only molecule involved specifically in the lysis 
of RBCM reported to date [62,63]. Interestingly, in P. berghei its expression is restricted to male 
gametocytes, while in P. falciparum both sexes express the protein [62,63]. More proteins 
participating in egress were reported sex-specific in one Plasmodium species and sex-independent 
in another [57,58,62], suggesting that egress molecules have evolved to fulfil slightly different 
functions in different Plasmodium species. 
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Female OBs (Fig. 1.3. A and C) are defined by the protein G377, which plays a major role in their 
biogenesis in both P. falciparum [58] and P. berghei [57]. While in P. falciparum G377 also plays a 
role in egress and female gametocytes lacking the protein transmit less efficiently, this effect is 
much less prominent in P. berghei, where egress of macrogametes is only delayed in the absence 
of G377 with no impact on transmission [57]. While in both P. falciparum and P. berghei, G377 
plays a role in biogenesis of female OBs, these roles differ. In P. falciparum, G377 absence leads 
to reduction of OB number, which explains the observed egress impairment [58]. In P. berghei, 
female OBs are formed in the absence of G377, however their shape and size is significantly 
reduced. MDV1/PEG3 (an egress molecule defining egress vesicles in both males and females) 
localizes to these reduced OBs, and they still react to induction of gametogenesis by relocalization 
to the cell periphery and exocytosis [57]. This differential role in OBs biogenesis between the two 
parasites explains why in the absence of G377, P. falciparum macrogametes egress less efficiently 
while P. berghei macrogametocytes egress is only delayed. Interestingly, no other molecule 
implicated in biogenesis of OBs was reported so far.  
 
 
0.3 
Red blood cell membrane (RBCM) 
Parasitophorous vacuole membrane (PVM) 
Parasite plasma membrane 
Egress vesicles including osmiophilic bodies 
or 8 ♀ ♂ 
Figure 1.2 Gametocyte egress. Sequence of events (from left to right) leads from a mammal-
resident gametocyte to a fully differentiated fertile gamete. In the mammalian host, gametocyte 
resides inside the RBC surrounded by PVM and RBCM and contains cytoplasmic egress vesicles. In 
reaction to the change of environment after transmission, the cell undergoes swelling, exocytosis 
of egress vesicles followed by permeabilization and rupture of PVM and RBCM. Remnants of 
membranes remain in the proximity of the egressed gametocyte. Female gametocyte only 
produces one gamete. Male gametocytes produce eight flagellated sperm-like gametes. Figure was 
kindly provided by Gunnar R. Mair and was adapted from Smith and Barillas-Mury, 2016 [197]. 
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Male gametocytes do not express G377 in either P. falciparum, nor in P. berghei [57,58]. However, 
their egress is dependent on discharge of secretory vesicles as well. Several egress molecules 
(including MDV1/PEG3) define egress vesicles in both male and female gametocytes [57,59–
61,64]. An electron microscopic study suggested that male gametocytes harbour so-called male 
OBs, vesicles different from female OBs in size, shape and exocytosis [57]. The comparison of 
MDV1/PEG3-positive vesicles showed that female OBs were oval, while male OBs were club 
shaped and three times smaller in volume compared to female OBs (Fig. 1.3). Gametocyte 
activation led to exocytosis of both male and female OBs, but their trafficking differed. While 
female OBs relocalized individually to the cell periphery and formed several foci underneath the 
Figure 1.3 Male and female gametocytes harbour different OBs. Sections of female (A) and 
male (B) gametocytes from electron microscopy (5 nm thick, scale bar 100 nm) show difference 
in shape, size and localization pattern of male and female OBs. Electron tomograms visualizing 
OBs (C) show that female OBs (magenta, upper row) are bigger and different in shape 
compared to male OBs (cyan, lower row). Measurement of male and female OB volume from 
electron tomograms (D) confirms three-fold difference. Figure was published by Olivieri et al., 
2014 [57]. 
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PVM, male OBs first formed clusters in the cytoplasm [57,65], but each vesicle remained intact. 
These clusters of individual vesicles were later transported to the cell periphery for exocytosis. 
While clustering of male OBs was induced by temperature drop, their exocytosis required 
additional stimuli [57]. Interestingly, all relocalization events were strongly dependent on calcium 
signalling as chelation of calcium prevented both the clustering of male OBs and relocalization of 
both male and female OBs to the cell periphery [57]. 
An additional difference between male and female OBs is the number of PVM lysis points. While 
female OBs fused with PVM in several foci [53,57], male OB clusters relocalized to the PVM and 
fused in one or very few spots [57] similarly to RBCM lysis [53]. This difference might be explained 
by the different nature of male and female gametes. While male gametes are defined by the 
formation of eight highly motile and vigorously beating flagella, which can easily emerge from the 
PVM through a single pore, female gametes do not exert any forces and lysis of PVM in several 
points might be necessary for the efficient disruption and removal of the membrane.  
Male OBs were first defined by the presence of protein MDV1/PEG3, which colocalizes with G377 
in females [57]. The absence of MDV1/PEG3 leads to severe impairment of egress of both sexes 
[61]. Similarly, a P. berghei specific protein GEST colocalizes with MDV1/PEG3 in both female and 
male OBs and its absence leads to impairment of egress from the PVM and RBCM [59].  MTRAP is 
another egress molecule that localizes to vesicles and is essential for gametocyte egress in both 
P. berghei and P. falciparum [64,66]. Interestingly, vesicles occupied by MTRAP, despite their clear 
secretory nature and role in egress, are not colocalizing with G377 nor with MDV1/PEG3 [64]. 
PPLP2 secretion is not impaired in parasites lacking MTRAP, indicating that the RBCM lysis is 
regulated independently of MTRAP [64]. PAT, a recently described essential egress factor, localizes 
to membranes of egress vesicles and partially colocalizes with both (male-specific) PPLP2 and 
(female-specific) G377, which indicates that PAT localizes to more than one subset of OBs.  
Although MTRAP is indispensable for the egress to proceed, it occupies vesicles distinct from the 
originally defined OBs [64]. Similarly, PAT is necessary for egress but localizes to vesicles previously 
shown to localize to different cells (males and females) [60]. These studies together show that 
egress vesicles contain a range of different cargo combinations with yet unclear roles. Some 
proteins seem to occupy more subsets of these vesicles, e.g. MDV1/PEG3 or PAT [57,59–61]. This 
notion was supported by two high-throughput screenings analysing the proteome of gametocyte 
egress vesicles [66]. In this screening, proteins released to supernatant after gametocyte 
activation (when egress took place) were compared to a list of MDV1/PEG3 interaction partners 
(analysed using a BioID). The list of exocytosed proteins contained over eighty proteins, of which 
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about one fourth matched the list of MDV1/PEG3-interaction partners. This further confirms that 
MDV1/PEG3 likely localizes to several subsets of vesicles, as its interaction partners included 
proteins previously shown not to colocalize [62,64,66]. Previously reported gametocyte egress 
molecules as well as proteases SUB1 and the SERA family were found in the lists [66]. The 
drawback of the egressome approach is the absence of transmembrane proteins, which remain 
associated with the parasite membrane after discharge of egress vesicles and cannot be detected 
in the supernatant. This is the reason why PAT colocalization with PPLP2 and G377 could not be 
verified [66].  
1.2 Egress of Apicomplexans 
Apicomplexan parasites spend most of their life cycle hidden inside host cells, with the need to 
periodically egress. Apicomplexan egress is underlined by host cell lysis with severe effect on the 
host organism [67] as shown by periodical fevers caused by synchronized egress of P. falciparum 
merozoites. Egress is mediated by apical complex, a cytoskeletal structure bound to secretory 
vesicles typical for apicomplexans [67]. Plasmodium, Toxoplasma and other organisms from the 
phylum contain a number of secretory vesicles, discharge of which is typically calcium-dependent 
(Fig. 1.4). Calcium signalling either triggers vesicular trafficking or directly induces exocytosis [67]. 
While some vesicles play a role in both invasion and egress (micronemes), others are specific for 
one step only (rhoptries and dense granules for invasion and exonemes for egress) [68]. Exonemes 
are the critical secretory organelles for Plasmodium asexual blood stage egress since they carry 
the necessary protease SUB1. Calcium-dependent discharge of SUB1 into the PV and its activation 
by calcium ions leads to activation of SERA proteases, which cleave a number of substrates and 
trigger the egress cascade [69]. 
Egress from the host cell is taking place in three stages within the Plasmodium life cycle, namely 
the asexual blood stage, sexual blood stage and liver stage (Fig. 1.5). The three processes are 
generally considered different as involved players were often identified in just one life-cycle stage. 
On the other hand, several common features can be found, among others the involvement of 
secretory vesicles, proteases and calcium signalling. One feature common to all three egressing 
stages is the inside-out model discussed in chapter 1.1.4.1. In all stages, PVM rupture precedes 
the host cell membrane rupture (Fig. 1.5) [21,53,70]. Only the liver stage resides in a metabolically 
active cell, PVM rupture is followed by the death of the host hepatocyte and its detachment from 
the tissue (Fig. 1.5) [23,71]. This cell death is different from apoptosis or necrosis as the cell 
membrane remains intact and DNA is not processed [23]. All three stages that egress are 
furthermore characterized by a sharp increase of calcium levels [72–74] and some common 
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players such as proteases from the SERA family, SUB1, falcipain-1/berghepain-1, plasmepsins IX 
and X [52,53,66,69,74–81]).  
 
The evolutionary conservation of molecular processes in egress can be demonstrated on the 
comparison of Plasmodium and Toxoplasma, related apicomplexan parasites, with very distinct 
life cycles but some common molecular processes. Screening of egress-deficient mutants of 
Toxoplasma led to a discovery of DOC2, a C2 domain containing protein. The egress defect caused 
by DOC2 mutation was further characterized as micronemal secretion impairment, a process 
critically dependent on calcium signalling [82]. In Plasmodium, the link between calcium signalling 
and exocytosis of micronemes and exonemes and subsequent egress is not known. Based on the 
example of C2 domain-regulated egress in Toxoplasma, it was suggested that calcium trigger could 
be sensed by a C2 domain containing protein [67]. Although Plasmodium encodes the DOC2 
protein, its depletion did not result in egress impairment, but instead inhibited invasion [82]. This 
phenotype can be explained by the differences in micronemal populations between Plasmodium 
and Toxoplasma. While Toxoplasma contains just one type of micronemes, necessary for both 
invasion and egress [83], Plasmodium uses for both events a separate type of micronemes [84]. 
This leaves the possibility that another C2-domain containing protein is involved in egress of 
Plasmodium asexual blood stages still open. 
 
Figure 1.4 Secretory organelles of Plasmodium. The asexual blood stage cycle includes release of 
mature merozoites from the RBC (egress) and their invasion into new ones. These processes 
depend on parasite organelles that discharge their content calcium-dependently with a precise 
timing. Organelles necessary for merozoite egress are micronemes and exonemes (that contain 
SUB1). Organelles necessary for merozoite invasion include rhoptries, micronemes and dense 
granules (that contain the protein RESA). Figure was published by Janse and Waters, 2007 [198]. 
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Figure 1.5 Egress of Plasmodium liver, asexual blood and sexual blood stages. Despite clear 
differences, egress of liver stages (A), asexual blood stages (B) and gametocytes (C) share common 
features. For example: parasitophorous vacuole membrane (PVM) always ruptures before the host 
cell membrane (HCM), egress vesicles are discharged, calcium ions and proteases are involved in 
the process, cells swell before the egress. PPM = parasite plasma membrane.  Figure was published 
by Wirth and Pradel, 2010 [199]. 
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1.3 Calcium signalling in Plasmodium 
Signalling via the second messenger Ca2+ is in molecular terms a conserved pathway in eukaryotes 
[85]. Plasmodium heavily relies on calcium signalling, with some typical eukaryotic pathways 
missing and some additional unique pathways involved. A large number of pathways is regulated 
by calcium during the complex Plasmodium life cycle – e.g. invasion, egress, secretion, motility or 
cell cycle (Fig. 1.6) [42]. 
Calcium regulation is challenging for the Plasmodium parasite due to very different calcium levels 
in its host environments – invasive stages in the mammalian host (i.e. sporozoites and merozoites) 
are transiently present in blood, an environment very rich in calcium. On the other hand, cell-
resident stages (liver trophozoites and schizonts and blood rings, trophozoites and schizonts) are 
exposed to a very low concentration of calcium. The parasite stores calcium ions in the 
endoplasmic reticulum [86], mitochondria [87,88], acidocalcisomes [89] and partially in the food 
vacuole [86]. Two types of calcium-binding domains can be found in Plasmodial proteins: EF hands 
that are present in calcium-dependent protein kinases (CDPKs) [90] and other proteins, and less 
abundant C2 domains [91], present for example in PI-PLC or in ferlin proteins. The complexity of 
calcium signalling and homeostasis in the parasite is far from being fully understood. One of the 
reasons for that is the small size of the parasite, hindering detailed analysis of calcium sources. 
Another challenge is the fact that analysis of calcium homeostasis and signalling typically relies on 
the use of inhibitors. Plasmodium with a large number of unknown proteins and evolutionary 
quite distinct targets represents a huge risk of off-targeting of inhibitors needed for the calcium 
study [42].  
Upstream of the calcium release into the parasite cytosol is the cGMP-dependent protein kinase 
(PKG) pathway activated by cGMP and triggered by various and usually unknown stimuli (Fig. 1.6). 
PKG can trigger calcium release directly or by phosphoinositide-specific phospholipase C (PI-PLC)-
induced production of inositol-triphosphate (IP3) [92,93], which opens calcium channels on 
endoplasmic reticulum. A typical feature of calcium signalling in Plasmodium are the plant-specific 
CDPKs [94]. Plasmodium encodes seven CDPKs with functions in different stages of the life cycle. 
CDPKs represent promising potential drug targets due to their critical roles in several stages and 
a complete absence of similar genes from the mammalian genome.  
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Extracellular source of calcium is necessary only for the invasion of merozoites (Fig. 1.6) [95] and 
subsequent development of the asexual stages [96,97]. Other pathways depend on intracellular 
Figure 1.6 Selected calcium-regulated pathways in Plasmodium life cycle. In response to 
different stimuli, cGMP is produced and activates PKG. This pathway induces calcium release 
from internal stores. The Ca2+ second messenger acts in merozoite invasion (attachment and 
micronemal secretion), merozoite egress (micronemal and exonemal secretion, activation of 
SUB1), gametocyte activation (assembly of flagella, egress), ookinete motility and others. GC = 
guanylyl cyclase, PDE = phosphodiesterase. Figure was published by Brochet and Billker, 2016 
[42]. 
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stores of calcium as shown by chelation experiments with membrane-permeable and -
impermeable chelators [42]. During invasion, calcium signalling induces the discharge of rhoptries 
[95], which induces calcium peak inside the erythrocyte to be invaded. Interestingly, melatonin 
induces a calcium peak in the parasite cytosol [98], which initiated speculations on involvement 
of this pathway in parasite synchronization during the asexual blood cycle observed in some 
Plasmodium species. 
Another pathway critically dependent on calcium is the merozoite egress (Fig. 1.6) [97]. Unknown 
trigger leads to the universal pathway of PKG-mediated release of calcium ions [99] and 
subsequently to microneme release, exoneme release and CDPK5 activation [100,101]. Calcium is 
also necessary for SUB1 activation after its release from exonemes into the PV [102]. Interestingly, 
CDPK5 is also necessary for merozoite egress, but its function is independent on exonemal 
secretion [101]. 
Ookinete gliding requires high concentration of intracellular calcium (Fig. 1.6) [99], which triggers 
CDPK3 and calcineurin [99,103]. CDPK3 acts in attachment to the midgut epithelium and motility 
of the ookinete [104,105]. Sporozoite activation by serum leads to sharp peak of calcium, which 
transforms into oscillating peaks later on [106] and mediates motility. Hepatocyte invasion 
depends on calcium, which activates calcineurin [103]. During the liver development [107], 
similarly to blood stage development [97], calcium concentration in the parasite cytoplasm 
gradually rises, with the need for calcium-activated SUB1 for merozoite egress from the liver cells 
[80,108]. 
1.3.1 Calcium signalling in host-to-vector transmission 
Gametogenesis, taking place after host-to-vector transmission, is critically dependent on calcium 
(Fig. 1.6). The trigger is represented by the environmental changes between mammalian host and 
the mosquito vector. The environment is sensed by the parasite by two particular features, drop 
in temperature by at least five degrees [38]  and the presence of a mosquito specific molecule, XA 
[39]. XA induces GC that produces cGMP [109,110], which in turn activates PKG [109]. Afterwards 
PI-PLC produces IP3 [92,93], which mediates opening of calcium channels on endoplasmic 
reticulum and leads to a sharp increase of intracellular calcium after a lag phase of about 30 
seconds after the initial trigger [73]. This triggers several pathways, including the male-specific 
CDPK4 pathway inducing the synthesis of flagella and cell cycle regulation [73], the CDPK1 
pathway involved in changes in gene expression [49] and the discharge of egress vesicles [49] (Fig. 
1.6).  
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Despite the clear calcium-dependent nature of gamete maturation [73,111], the known and 
putative gamete egress molecules lack calcium binding domains and the calcium-dependent 
factor linking these two events remains unclear. CDPK1 has been the only calcium-dependent 
egress factor suggested to date (Fig. 1.6) [42,49]. However, its depletion leads only to a delay of 
egress and after few minutes of active flagellar beating within the host RBC, free microgametes 
lacking CDPK1 eventually emerge [49]. This suggests that egress can be mediated in the absence 
of CDKP1 function.  
1.4 The Ferlin protein family 
Calcium ions regulate, among many others, the function of ferlins, proteins that contain the 
largest number of C2 domains. The ferlin protein family is conserved in most eukaryotes with the 
exception of plants or fungi [112]. Their important role in secretory pathways remained elusive 
for a long time, likely due to their absence in the yeast genome [113], which served as the main 
model organism for secretory pathways.  
1.4.1 Topology and common features 
The typical feature of ferlins is their domain composition (Fig 1.7 C). These proteins contain the 
largest number of C2 domain (four two seven) of all protein families, typically labelled with letters 
(C2A – C2F). C2 domain is a well described structural unit formed by beta sheets with negatively 
charged calcium binding pockets (Fig. 1.7 A and B) [91]. It remains unclear why proteins encode 
more than one C2 domain, but a tandem role of the domains is anticipated. Some C2 domains 
have lost their ability to bind calcium, indicating that their role is probably extended beyond this 
basic function. Although the main structural features are common between C2 domains, the 
sequence variability is significant and details like exact localization of the calcium binding pockets 
cannot be predicted from comparisons of individual sequences (Fig. 1.7 A and B) [114]. 
 Ferlins additionally harbor a C-terminal transmembrane domain, which localizes them to 
membranes, often vesicles (Fig. 1.7C, 1.8). In many cases, ferlins contain a Fer domain – a ferlin 
specific motif of unknown function [115]. Several Fer domains (FerA, FerB and FerI) can be 
distinguished in ferlins and they are typically placed between the first and second C2 domains 
(C2A and C2B), forming a tandem structure (Fig 1.7 C and 1.10 A) [113]. Ferlin proteins can be 
divided into type I and II based on the presence or absence of dysferlin domain (DysF) of unknown 
function. In general, invertebrates encode two ferlins, one type I and one type II. In vertebrates 
the family expanded to three type I and three type II members, indicating the conservation of two 
functional clusters of ferlins [113]. Interestingly, the C2 domains in ferlins show more evolutionary 
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conservation between ferlin homologues than between the individual domains in one protein. In 
general, the C-terminal (C2E and C2F) domains are highly conserved, while N-terminal domains 
show more variability [113]. N-terminal C2A domain plays the major functional role in many 
ferlins, explaining its evolutionary variability underlined by adjusting to specific functions. 
  
 
Calcium dependency of ferlin function has been shown for all proteins analysed [112,116–120]. 
Mutations hindering ferlin function localize mostly to their C2 domains and lead to insensitivity to 
Figure 1.7 Schematic of C2 domains and ferlin insertion into membranes. C2 domain is an 
independent structural unit formed by beta sheets and connecting loops. Ribbon diagram of 
synaptotagmin I C2A domain (A) shows the typical structure of the C2 domain with calcium binding 
pocket located in one of the top loops. Ribbon diagram of myoferlin C2A domain (B) shows that 
main features are conserved and calcium is coordinated in the top loop, but overall the structure 
differs from (A). Ferlins are typically embedded in membranes (often vesicular) via their single C-
terminal transmembrane domain. The short C-terminal part is facing the lumen of vesicle, while 
the major N-terminal portion (with C2 domains, DysF and Fer domains) faces the cytosol (C). 
Figures in (A) and (B) were published by Nalefski and Falke, 1996 [91] and Lek et al., 2012 [151], 
respectively. 
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calcium [116,118]. Manipulation of calcium levels helped establish the dependency on calcium in 
many ferlins, although the exact mechanism by which calcium coordination into negatively 
charged pockets in the C2 domains (Fig. 1.7 A and B) mediates ferlin function is not clear. Two 
lines of evidence can be found in the literature, originating from in vitro biochemical studies with 
recombinant proteins. Some ferlin C2 domains were shown to bind phospholipids more efficiently 
in the presence of calcium [118]. This could explain why ferlin-mediated exocytosis only happens 
in the presence of calcium signaling. Another set of biochemical experiments with otoferlin C2 
domains showed that these domains show high affinity for each other in the absence of calcium, 
while this affinity is lost in the presence of calcium [119]. This observation led the authors to 
propose a model, in which otoferlin (and perhaps other ferlins) resides in a closed conformation 
in the absence of calcium and only upon calcium signaling, its conformation opens (as C2 domains 
lose affinity for each other) and triggers vesicle exocytosis. 
1.4.2 Mammalian ferlins 
Mammalian ferlins are in the focus of active research as mutations in these genes lead to deafness 
(mutation of otoferlin, [121]) or muscular dystrophy (mutation of dysferlin [122]) in humans. 
Humans encode six ferlin genes distinguished by tissue-specific expression and by functions.  
Inner ear hair cells, the whole vestibular system and cochlea and the brain express otoferlin [123]. 
Otoferlin binds syntaxin-1 and SNAP-25 in a calcium-dependent manner [124], this pathway is 
activated by synaptotagmins in other synapses and leads to neurotransmitter release. The inner 
hair cells lack expression of synaptotagmins and it seems that otoferlin has taken over the calcium-
dependent regulation of neurotransmitter vesicle fusion [121]. Indeed, mice lacking otoferlin 
show profound deafness and impairment of synaptic vesicle exocytosis, despite their normal 
biogenesis and docking [125]. Although the deletion of otoferlin, unlike other genes involved in 
the neurostimulation in hearing, is not lethal, its absence leads to impaired neurotransmitter 
signaling and deafness. Instead of amplitudinal release copying the peaks of calcium 
concentration, in the absence of otoferlin, neurotransmitter is released slowly and regardless of 
stimulation [126]. In agreement with that, most otoferlin C2 domains bind lipids calcium-
dependently and can induce membrane aggregation in vitro. Also, parts of the protein can 
accelerate SNARE-dependent membrane fusion in vitro but only in the presence of high calcium 
levels [127]. Interestingly, otoferlin seems to play an additional role in the recycling of synaptic 
vesicles [126]. A point mutation in the C2F domain, unlike the absence of otoferlin, leads to no 
impairment in synaptic exocytosis amplitudes. However, the mice bearing this mutation are still 
profoundly deaf. Closer examination revealed that synaptic vesicles are not efficiently 
18 
 
replenished, leaving the synapse unable to sustain signaling with high frequency amplitude [126]. 
This finding is further supported by otoferlin interaction with myosin VI [125,128] and Rab8a [129], 
which could mediate recycling of vesicles after exocytosis. The question remains, why the 
synaptotagmin regulation mediating neurotransmitter release in most synapses is replaced by 
otoferlin in the inner hair cells. One explanation might be the need for extremely high frequency 
of neurotransmitter release needed for the hearing. An estimate calculated that given the 
frequency of stimulation, in each synapse the synaptic vesicles need to be replenished up to 70 
times per second. Such high frequency is beyond the rates reported for synapses without otoferlin 
[124]. 
 
 
Two ferlin genes, dysferlin and myoferlin, are expressed ubiquitously [123]. However, their 
expression is highly enhanced in muscle tissue, heart tissue and placenta [122,130]. Although both 
proteins play a role in muscle membrane trafficking, their functions are strictly separated. 
Figure 1.8 Mode of action of dysferlin. Membrane damage induces calcium ions transport from 
the extracellular environment into cytosol (A). This induces dysferlin-decorated vesicles to interact 
with annexins and SNARE proteins (B, not shown). Vesicles subsequently fuse with each other and 
the plasma membrane (C). The formed membrane patch reseals the membrane rupture. Figure 
was published by Kobayashi et al., 2012 [187]. 
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Myoferlin is important for myoblast fusion to myotubes with enriched abundance at the site of 
fusion [131] and hence is expressed mainly during muscle development [130,131] and partially 
after muscle injury and during regeneration [132]. Dysferlin is expressed after the development is 
finished, it localizes to plasma membrane and after membrane injuries, it relozalizes to 
cytoplasmic vesicles and reseals membrane ruptures (Fig. 1.8) [132,133]. Similarly overlapping but 
specialized roles are played by the two proteins in the placenta, with dysferlin expression peaking 
at fusion of placental syncytium [134]. Dysferlin was shown to interact with caveolin 3 [135] and 
calpain-3 [136]. Its absence leads to increased damage in skeletal muscles, similar to the one 
caused by absence of calcium, in mice. This further links dysferlin to calcium-mediated membrane 
repair in the muscle tissue (Fig. 1.8) [122,132,137–139]. Interestingly, in the dysferlin-deficient 
muscle, myoferlin is not upregulated, indicating no mutual redundancy between individual human 
ferlins [140]. Myoferlin, expressed mainly during the development of muscle tissue, is necessary 
for vesicular trafficking with highly reduced clathrin- and caveolin-dependent endocytosis, 
transferrin recycling [141] and impaired VEGF signaling in myoferlin-deficient cells. Trafficking of 
several growth factors (VEGF [142,143], IGFR [144] and others [145]) were linked to myoferlin and 
dysferlin, which along with their upregulation in several cancerous tissues [146–148] led to an 
increasing attention to their role in cancer.  
However, very little was reported so far about the three remaining mammalian ferlins, Fer1L4, 
Fer1L5 and Fer1L6. Fer1L4 transcripts were detected predominantly in the stomach, but 
annotated as non-protein coding RNA (NCBI gene 80307) [123]. Fer1L5 is expressed in pancreas 
[123] and the developing muscle tissue with some indications for roles in myotube fusion, 
temporally preceding the role of myoferlin [113]. Fer1L6 expression was detected in the heart, 
kidney and stomach [123]. While Fer1L5 is quite similar to myoferlin, Fer1L4 and Fer1L6 are more 
similar to otoferlin [149]. Electronic databases of cDNA suggest alternative splicing for Fer1L4, 
Fer1L5 and Fer1L6 [149]. 
Some ferlins were reported to interact with SNARE proteins [119] and in general their function is 
considered similar to synaptotagmin function, replacing them in tissues where synaptotagmins 
are not expressed. However, in knock-out studies, otoferlin deficiency could not be rescued by 
synaptotagmin presence and vice versa [150]. Similarly to that, individual mammalian ferlins 
cannot compensate for each other’s absence [151], which indicates high degree of specialization 
of individual proteins. Unlike synaptotagmins, ferlins serve as protein scaffold [120]. For example, 
dysferlin, additionally to vesicular fusion, mediates protein trafficking by recruitment of large 
protein complexes [152]. Interestingly, while this is not the case in C. elegans (discussed in chapter 
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1.4.3) [153], mammalian ferlins are implicated in vesicle docking and priming prior to fusion 
[124,154], a feature distinct from synaptotagmins.  
 
 
The presence of DysF domain divides ferlins into type I and II. Type I (with dysferlin domain) in 
mammals is represented by dysferlin, myoferlin and Fer1L5, while otoferlin, Fer1L4 and Fer1L6 
belong to the type II (without dysferlin domain). A complex study analysed several cell lines 
transfected with five human ferlins (leaving out the Fer1L4 pseudogene) tagged with small C-
terminal tags [123]. Localization of individual tagged proteins along with their dynamics gave rise 
to a complex model of human ferlin pathways (Fig. 1.9). Interestingly, ferlins clustered into two 
groups distinguished by the presence of DysF domain – type I ferlins (myoferlin, dysferlin and 
Fer1L5) localized predominantly to plasma membrane and endosomes, while type II ferlins 
(otoferlin and Fer1L6) were found in trans-Golgi and recycling pathways. Myoferlin and dysferlin 
Figure 1.9 Model of human ferlins trafficking. Dysferlin (yellow) and myoferlin (green) are 
detected on the plasma membrane and in endosomal pathways, accumulating in Rab7-positive 
late endosomes. Otoferlin (orange) is detected in trans Golgi and very transiently on the 
plasma membrane. Fer1L6 is detected in trans Golgi, from where it recycles via Rab11-positive 
vesicles and it accumulates in the recycling endosome. Fer1L5 (magenta) is detected inside of 
the cell near the endoplasmic reticulum but the precise localization is not clear. Figure was 
published by Redpath et al., 2016 [123].  
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colocalized with Rab7 in late endosomes, which together with evidence from other studies 
[145,155] indicates their role in transit of cargo through endosomes to lysosomes. Otoferlin and 
Fer1L6 localize to trans-Golgi and recycling networks, colocalizing with Rab11 and other markers 
of this compartment. Otoferlin additionally showed weak plasma membrane staining, which might 
suggest its transient residence in the membrane in between closely coupled exocytosis-
endocytosis cycles. Fer1L5 appeared to localize to the endoplasmic reticulum but did not 
colocalize with ER markers calreticulin or calnexin [123].  
1.4.3 Invertebrate ferlins 
The first protein of the ferlin family was identified in the invertebrate Caenorhabditis elegans and 
named fertility factor 1 (Fer-1) as it acts in the process of spermatogenesis [153]. The protein was 
found in the testis tissue and is therefore male specific. When Fer-1 is mutated, sperm cells arrest 
in their development. In particular, membranous organelles (MO), vesicles filled with 
glycoproteins that need to fuse within the process of sperm development, do not fuse with the 
membrane and the worm is not fertile. As was shown later, MO are indeed decorated by Fer-1 
with most of the protein facing the cytosol of the cell, a feature similar to SNARE proteins 
[112,153]. Also, Fer-1 function is calcium-dependent as shown by calcium chelation experiments 
[112]. Interestingly, most mutations interfering with Fer-1 function localize to C2 domains, further 
emphasizing their critical role in ferlin function [112]. Fer-1, apart from its role in fertility, is weakly 
expressed in the worm muscle. Mutation in Fer-1 additionally causes a mild impairment in total 
muscle power in the worm [156]. This is partially reminiscent of the roles of myoferlin and 
dysferlin in mammals (chapter 1.4.2).  
Another invertebrate ferlin, the misfire protein from Drosophila melanogaster, also plays an 
essential role in fertility [157]. In the case of misfire, expression was detected both in testis and 
ovaries, with different splicing variants expressed in each tissue. However, only the longest 
transcript expressed in the testis was shown to be essential for D. melanogaster fertility, depletion 
in ovaries did not result in a phenotype. Misfire protein was linked to plasma membrane 
breakdown during the process of insemination [157]. This sterility is, similarly to the case of C. 
elegans [153], linked to a calcium-mediated fusion of membranous structures with the sperm 
membrane, as acrosome discharge necessary for plasma membrane breakdown is dependent on 
calcium signalling [158].  
Not many non-mammalian ferlins were studied so far. One more example is a sea urchin ferlin, 
which is needed for exocytosis in wound repair. Interestingly, this ferlin is highly similar to 
dysferlin, as human dysferlin could compensate for the function in sea urchin [117,159]. This is an 
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unusual aspect, as human ferlins cannot complement each other [151]. Schistosoma japonicum 
expresses a ferlin gene similar to dysferlin, named S. japonicum dysferlin (SjDF). The protein 
localizes to tegument, a partially liquid host-parasite interface layer. After knock-down of SjDF by 
siRNA, worms showed reduced capacity to recover the tegument after injury. This suggests that 
the dysferlin role in membrane repair after injury is conserved in very ancient eukaryotes. The 
authors further considered SjDF as an immune target for potential intervention strategies based 
on its high immunogenicity in mice [160].  
 
Ferlins are present in most unicellular organisms, including apicomplexan parasites. Plasmodium 
harbors two ferlins - ferlin and ferlin-like protein (FLP) - with yet unknown functions (Fig. 1.10A). 
Figure 1.10 Apicomplexan ferlins. Protein domain analysis of selected ferlins (A) reveals highly 
conserved topology with multiple (2-6) C2 domains and a C-terminal transmembrane domain. 
Amino acid (aa) sequence identity in comparison to FLP (PBANKA_1224400) is shown in 
percent as calculated by Clustal. Phylogenetic tree of apicomplexan and selected invertebrate 
ferlins (B) FLP = ferlin-like protein, fer = ferlin, d.mela = Drosophila melanogaster, TGME49 = 
Toxoplasma gondii ME49, Cgd = Cryptosporidium parvum Iowa II, PF3D7 = Plasmodium 
falciparum 3D7, PBANKA = Plasmodium berghei ANKA, c.eleg = Caenorhabditis elegans. The 
tree was generated using amino acid sequence from eupathdb.org and uniprot.org and 
analysed in Phylogeny.fr. 
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T. gondii, the related apicomplexan parasite, encodes three ferlins. Two of them are very different 
and the third one is very similar to Plasmodium FLP (Fig. 1.10). Apicomplexan ferlins contain two 
to six C2 domains and a C-terminal transmembrane domain. Additionally, FLP and TGME_309420 
harbor a Fer domain. Lower eukaryotes typically encode two ferlin genes, one of which usually 
harbors a DysF domain [113]. No typical DysF domain was assigned to apicomplexan ferlins. 
However, a typical feature of a DysF domain is the presence of repeats [113], FLP contains a 
repetitive region between C2D and C2E domains, which might be considered a pseudo-DysF 
domain. 
1.5 The aim of the study 
The ferlin protein family is conserved throughout the Plasmodium phylum and also in Toxoplasma 
gondii and other related apicomplexan parasites, suggesting an evolutionarily conserved function. 
Plasmodium falciparum ferlins were previously identified in our laboratory as potential immune 
targets [161]. Plasmodium berghei, a murine malaria parasite, represents a powerful tool to study 
the entire life cycle of this parasite in detail. The P. berghei life cycle alternating between 
laboratory mice and Anopheles mosquitoes is established in our laboratory. This model system 
allows for studying the life cycle as a whole, including the bottleneck transmission stages and other 
features, which are very difficult or impossible to tackle using the human parasite P. falciparum.  
This study aimed at investigating the function of P. berghei ferlin-like protein (FLP). Deciphering 
FLP function should help its establishment as a novel immune target. Given the high degree of 
ferlin conservation throughout evolution, the role of FLP might additionally bring hints for roles of 
other ferlins in related organisms.  
We set three aims in order to functionally characterize FLP. First aim was to analyse flp expression 
during the parasite life cycle. The protein abundance in each stage and especially the comparison 
between stages is critical for identifying the stages, in which it acts. The second aim was to analyse 
subcellular localization of FLP. Colocalization with known structures indicates in which processes 
might a given protein participate. To minimize risk of artefacts and maximize our chances for 
success, we set two independent aims for FLP visualization, namely preparation of polyclonal 
antibody and endogenous tagging. The third aim was to analyse FLP depletion phenotype. The 
comparison of wildtype and target-deficient parasites is the classical approach to study protein 
function. We attempted to generate a knock-out parasite. However, previous dat a from our 
laboratory indicated that P. berghei might be refractory to FLP deletion. We therefore investigated 
other ways to deplete FLP in parallel – namely inducible knock-down using small molecules, 
truncation of the protein and promoter swapping. 
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2 Materials and Methods 
2.1 Material 
2.1.1 Laboratory equipment 
ABI 7500 Real-Time PCR System   Life Technologies, CA, USA 
AMAXA Nucleofector II electroporator  Lonza, Cologne 
Autoclave 5075 ELV    Systec, Wettenberg 
Balances 
Analytical balance Pioneer  Ohaus, Nanikon, Switzerland 
 Precision balance   Mettler Toledo, Switzerland 
BioPhotometer     Eppendorf, Hamburg 
Camera (gel documentation)   INTAS Science Imaging Instruments, Goettingen 
Centrifuges 
 Megafuge 1.0R    Heraeus Instruments, Hanau 
 Megafuge 2.0R    Heraeus Instruments, Hanau 
 Microcentrifuge 5415 D   Eppendorf, Hamburg 
 Microcentrifuge 5415 R   Eppendorf, Hamburg 
 Centrifuge 5804   Eppendorf, Hamburg 
 Ultracentrifuge J2-MC   Beckman Coulter, Krefeld 
 Ultracentrifuge RCB5 Plus  Sorvall, Thermo Fisher Scientific, USA 
Cold light source KL1500 LCD   Carl Zeiss, Oberkochen 
Computer hardware 
Dell Inspiron 11    Dell Inc., TX, USA 
Printer CX510de   Lexmark, KY, USA 
Printer MS510dn   Lexmark, KY, USA 
Scanner EPSON Perfection 2400 Photo EPSON, Japan 
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Computer software 
Adobe Photoshop elements 14  Adobe Systems Inc., CA, USA 
AutoQuant X3    Media Cybernetics, Inc., MD, USA 
Fiji (Image J) Version 1.51w  Wayne Rasband, NIH, USA 
Image Studio Version 5.0.21  Li-Cor Biosciences, NE, USA  
Prism 5     GraphPad Software Inc., CA, USA 
Serial Cloner 2.6.1   Franck Perez, SerialBasics 
Qiqqa Version v.79s   Quantisle Ltd. 
Diaphragm vacuum pump laboport  KNG Neuberger, NJ, USA 
Digital timer   NeoLab Migge, Heidelberg 
  Carl Roth, Karlsruhe 
  Oregon Scientific, CA, USA 
EasyjecT Prima electroporator   EquiBio, TX USA 
Electrophoresis Power Supply EPS 301  Amersham Pharmacia Biotech, Freiburg 
Gel electrophoresis System Horizon 11.14 Biometra, Goettingen 
Freezers -20⁰C     Liebherr, Bulle, Switzerland 
Freezer -80⁰C     Thermo Fisher Scientific, MA, USA 
Fridges      Liebherr, Bulle, Switzerland 
Gas Burner Soudagaz X2000 PZ   Campingaz, Hungen-Inheiden 
Haemocytometer chamber   Labotec Labor-Technik, Goettingen 
Heating block thermomixer comfort  Eppendorf, Hamburg 
Ice machine     Ziegra Eismachinen, Isernhagen 
Incubators 
 Mosquito incubators   Mytron, Heilbad Heiligenstadt 
 Hera cell incubator   Heraeus Instruments, Hanau 
 Hera cell 150 incubator   Heraeus Instruments, Hanau 
 Heraeus function line incubator  Thermo Fisher Scientific, MA, USA 
 Shaking Incubator Innova 4300  New Brunswick Scientific, Nijmegen, 
Netherlands 
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Lab pH meter inoLab pH 7110   WTW, Weilheim 
Li-Cor C-DiGit Blot Scanner   Li-Cor Biosciences, NE, USA 
Liquid nitrogen tank Cryosystem 4000 series Panasonic, Kadoma, Japan 
Liquid nitrogen tank MVE XC 34/18  MTG, Bruckberg 
Magnetic stirrer Heidolph MR3001  NeoLab Migge, Heidelberg 
Micropistill for 1.5 ml tubes, conical  NeoLab Migge, Heidelberg 
Microscopes 
Confocal spinning disc microscope Nikon Eclipse TI-E Nikon, Japan; Perkin Elmer, 
MA,USA   
Fluorescence microscope    Carl Zeiss, Oberkochen 
Stereomicroscope Stemi 2000-C    Carl Zeiss, Oberkochen 
Widefield fluorescent microscope Axiovert 200M Carl Zeiss, Oberkochen 
Widefield light microscope Axioskop 40   Carl Zeiss, Oberkochen 
Widefield light microscope Axiostar Plus  Carl Zeiss, Oberkochen 
Widefield light microscope Axiovert 25   Carl Zeiss, Oberkochen 
Microwave oven     Sharp electronics, Hamburg 
Mosquito cages      BioQuip Products, CA, USA 
PCR cycler GeneAmp System 9700   Life Technologies, CA, USA 
PCR Mastercycler gradient    Eppendorf, Hamburg 
Pipettes 
 Pipetman NEO     Gilson, WI, USA 
 Pipetman G     Gilson, WI, USA 
 Pipetman L     Gilson, WI, USA 
 Eppendorf Research    Eppendorf, Hamburg 
Pipetus       Hirschman Laborgeraete, Eberstadt 
PURIST Ultrapure Lab water systems   RephiLe Bioscience Ltd., China  
Roller mixer CAT RM 5     NeoLab Migge, Heidelberg 
Roller mixer SU 1400     NeoLab Migge, Heidelberg 
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Rotator SB3      Stuart, Staffordshire, UK 
SDS PAGE XCell SureLock Mini-Cell   Thermo Fisher Scientific, MA, USA 
Sterile workbench HeraSafe    Thermo Fisher Scientific, MA, USA 
UV transilluminator     Vilber, Eberhardzell 
Vortex Genie 2      Scientific Industries Roth, Karlsruhe 
Water bath 1003     GFL, Burgwedel 
Western blot XCell II Blot module   Thermo Fisher Scientific, MA, USA 
2.1.2 Consumables 
0.1 ml strip tubes and caps    Qiagen, Hilden 
14 ml polystyrene round bottom tubes with lid  Greiner bio-one, Frickenhausen 
24-well assay plate, clear bottom with lid, cell culture Sigma-Aldrich, MO, USA 
Aluminium foil      Carl Roth, Karlsruhe 
BD Discardit II 20 ml syringes    Becton Dickinson, NJ, USA 
BD Micro-Fine U-100, insulin syringes, 29G  Becton Dickinson, NJ, USA 
BD Microlance 3 20G, 23G, 27G needles   Becton Dickinson, NJ, USA 
BD Plastipak U-100, 1ml syringes   Becton Dickinson, NJ, USA 
Biopur safelock tubes 1.5 ml    Eppendorf, Hamburg 
Cell culture flasks Cell Star 25cm2, 75 cm2  Greiner bio-one, Frickenhausen 
Cryotubes      Sigma-Aldrich, MO, USA 
Disposable autoclave bags    Sarstedt, Nuembrecht 
Disposable powder free gloves Semperguard  Sempermed, Austria  
Electroporation cuvettes    Bio-Rad Laboratories, CA, USA 
Falcon tubes 15 ml, 50 ml    Sarstedt, Nuembrecht 
Filter tip Biosphere 20µl, 100µl, 200µl, 1000µl  Sarstedt, Nuembrecht 
Filter tip FT 10 E 1 µl     Greiner bio-one, Frickenhausen 
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Folded filter paper     NeoLab Migge, Heidelberg 
Glass pasteur pipettes     Brand GmbH, Heidelberg 
Glass slides with marked circles    Medco, Munich 
Immobilion-P transfer membrane, PVDF   Merck Millipore, MA, USA 
Kimtech Science precision wipes   Kimberly-Clark, Ontario, Canada 
Lab-Tek chamber slides, 8 well    Thermo Fisher Scientific, MA, USA 
Membrane filters 0.1 µm    Merck Millipore, MA, USA 
Micro tubes 1.5 ml, 2ml     Sarstedt, Nuembrecht 
Micro-cuvettes 10 x 4 mm    Sarstedt, Nuembrecht 
MicroAmp Optical 96-well reaction plate  Applied Biosystems, CA, USA 
Microscopic cover glasses 18 x 18 mm, 24 x 50 mm Marienfeld, Lauda-Koenigshofen 
Microscopic slides, frosted ends, 76 x 25 x 1 mm Marienfeld, Lauda-Koenigshofen 
Parafilm M      Bemis, WI, USA 
PCR tubes, RNase free, flat cap, 0.2 ml   Kisker Biotech, Steinfurt 
Petri dishes 94/16 mm, 145/20 mm   Greiner bio-one, Frickenhausen 
Pipette tips 0.1 – 10 µl     Kisker Biotech, Steinfurt 
Pipette tips 200 µl, 1000 µl    Sarstedt, Nuembrecht 
Polystyren cuvettes 10 x 4 x 45 mm   Sarstedt, Nuembrecht 
qPCR seals, optical clear    Peqlab technology, Erlangen 
Quali PCR-tube stripes with lid 0.2 ml   Kisker Biotech, Steinfurt 
Self-adhesive labels 33 x 13 mm    NeoLab Migge, Heidelberg 
Serological pipettes 1 ml, 5 ml, 10 ml, 25 ml  Sarstedt, Nuembrecht 
Stericup express PLUS 0.22 µm filtration system  Merck Millipore, MA, USA 
Syringe filter unit 0.22 µm    GE Healthcare, Little Chalfont, UK 
TouchNTuff nitril gloves     Ansell, Brussels, Belgium 
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Tubee’s self-adhesive dots    NeoLab Migge, Heidelberg 
WesternSure Pen     Li-Cor Biosciences, NE, USA 
Whatman paper     GE Healthcare, Little Chalfont, UK 
2.1.3 Chemicals and Reagents 
Acetic acid      Carl Roth, Karlsruhe 
Agarose      Sigma-Aldrich, MO, USA 
Albumin fraction V     Carl Roth, Karlsruhe 
Alsever’s solution     Sigma-Aldrich, MO, USA 
Ampicillin      Carl Roth, Karlsruhe 
100x Antibiotic-Antimycotic    Life Technologies, CA, USA 
BactoTM-Agar      Becton Dickinson, NJ, USA 
BactoTM-Tryptone     Becton Dickinson, NJ, USA 
BAPTA-AM      Sigma-Aldrich, MO, USA 
Bepanthen eye cream     Bayer AG, Leverkusen 
Bis Tris       Carl Roth, Karlsruhe 
Bromphenol blue     Serva Electrophoresis, Heidelberg 
β-Mercaptoethanol     Carl Roth, Karlsruhe 
Calcium chloride     AppliChem, Darmstadt 
Cat food Cachet classic     Saturn petfood, Bremen 
CF-11 Cellulose powder     Thermo Fisher Scientific, MA, USA 
4-chloro-DL-phenylalanine    Sigma-Aldrich, MO, USA 
Diethylether      Sigma-Aldrich, MO, USA 
Dipotassium hydrogen phosphate   AppliChem, Darmstadt 
Digitonin      Sigma-Aldrich, MO, USA 
DMEM medium      Life technologies, CA, USA 
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DMSO       Gruessing, Filsum 
Dry ice       Zentrallager UniKlinikum Heidelberg 
DTT       AppliChem, Darmstadt 
EDTA       AppliChem, Darmstadt 
Ethanol       Sigma-Aldrich, MO, USA 
Ethidium bromide     Carl Roth, Karlsruhe 
FCS (South American or US origin)   Life technologies, CA, USA 
5-Fluorocytosine     Sigma-Aldrich, MO, USA 
Gentamicin      Life technologies, CA, USA 
Giemsa staining solution    Carl Roth, Karlsruhe 
Glass beads unwashed     Sigma-Aldrich, MO, USA 
Glucose      Carl Roth, Karlsruhe 
Glutaraldehyde      Merck Millipore, MA, USA 
Glycerol      Carl Roth, Karlsruhe 
Glycine       AppliChem, Darmstadt 
Guanidine hydrochloride    Sigma-Aldrich, MO, USA 
HBSS medium      Life technologies, CA, USA 
Heparin      Ratiopharm, Ulm 
Hoechst 33342      Life technologies, CA, USA 
Hydrochloric acid     VWR International, PA, USA 
Hypoxanthine      Sigma-Aldrich, MO, USA 
Immersion oil      Waldeck, Muenster 
IPTG       Adipogen life science, Switzerland 
Kanamycin      Carl Roth, Karlsruhe 
Ketamine      Bremen Pharma GmbH, Warburg 
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Lithium acetate      Sigma-Aldrich, MO, USA 
Manganese chloride     Gruessing, Filsum 
Magnesium sulphate     Merck Millipore, MA, USA 
Methanol      AppliChem, Darmstadt 
N-lauroylsarcosinate     Sigma-Aldrich, MO, USA 
Nycodenz      Axis-Shield, Dundee, Scotland 
Para-aminobenzoic acid     Sigma-Aldrich, MO, USA 
Paraformaldehyde 4% in PBS    Carl Roth, Karlsruhe 
PBS tablets      Sigma-Aldrich, MO, USA 
Penicillin/Streptomycin     Life technologies, CA, USA 
Potassium acetate     Sigma-Aldrich, MO, USA 
Potassium dihydrogen phosphate   AppliChem, Darmstadt 
Power SYBR Green PCR Master mix   Applied Biosystems, CA, USA 
Propanol      Sigma-Aldrich, MO, USA 
Protease inhibitor     Roche, Basel, Switzerland 
Pyrimethamine      Sigma-Aldrich, MO, USA 
Riboflavin      Sigma-Aldrich, MO, USA 
RPMI       Life technologies, CA, USA 
Rubidium chloride     Carl Roth, Karlsruhe 
Saponin      Sigma-Aldrich, MO, USA 
SDS       Carl Roth, Karlsruhe 
Sea salt       Alnatura, Bickenbach 
Sodium acetate      Gruessing, Filsum 
Sodium deoxycholate     Sigma-Aldrich, MO, USA 
Sodium dihydrogen phosphate    Sigma-Aldrich, MO, USA 
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Sodium fluoride     Sigma-Aldrich, MO, USA 
Sodium hydrogen carbonate    AppliChem, Darmstadt 
Sodium hydroxide     J. T. Baker, NJ, USA 
Sulfadiazine      Sigma-Aldrich, MO, USA 
Sucrose       AppliChem, Darmstadt 
Tetracyclin      Carl Roth, Karlsruhe 
TRIS       Carl Roth, Karlsruhe 
Triton X-100      Sigma-Aldrich, MO, USA 
Trypan Blue      Sigma-Aldrich, MO, USA 
0.25% Trypsin/EDTA     Life technologies, CA, USA 
Tween 20      Carl Roth, Karlsruhe 
X-gal       NeoLab Migge, Heidelberg 
Xanthurenic acid     Sigma-Aldrich, MO, USA 
Xylazine      Ecuphar GmbH, Greifswald 
Yeast extract      Carl Roth, Kalrsruhe 
Western Lightning Plus-ECL    Perkin Elmer, MA, USA 
2.1.4 Commercial kits 
AMAXA Human T Cell Nucleofector Kit   Lonza, Cologne 
First strand cDNA synthesis kit    Thermo Fisher Scientific, MA, USA 
Gibson assembly cloning kit    New England Biolabs, MA, USA 
NuPAGE MOPS Kit     Thermo Fisher Scientific, MA, USA 
pGEM-T Easy Vector Systems    Promega, Mannheim 
QIAamp DNA Blood Kit     Qiagen, Hilden 
QIAprep Spin Plasmid Miniprep Kit   Qiagen, Hilden 
QIAquick PCR Purification Kit    Qiagen, Hilden 
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QIAquick Gel Extraction Kit    Qiagen, Hilden 
Qubit Protein Assay Kit     Thermo Fisher Scientific, MA, USA 
3‘RACE System for Rapid Amplification of cDNA Ends Thermo Fisher Scientific, MA, USA 
RNeasy Mini Kit      Qiagen, Hilden 
Turbo DNA free kit     Life technologies, CA, USA 
2.1.5 Strains 
2.1.5.1 Bacteria strains 
BigEasy-TSA Electrocompetent bacteria   Lucigen, WI, USA  
Chemocompetent E. Coli XL1 Blue   Agilent Technologies, CA, USA 
Electrocompetent E. Coli PMC103   provided by Prof. Jude M. Przyborski,  
Heidellberg Universit Hospital 
Competent E. Coli BL21(DE3)    provided by Dr. Julia Sattler, Heidelberg 
University Hospital 
Competent E. Coli JM109    Promega, Mannheim 
2.1.5.2 Cell lines 
Human hepatoma cell line HuH7   provided by Prof. Bartenschlager,  
Heidelberg University Hospital 
2.1.5.3 Parasite strains 
Plasmodium berghei ANKA cl15cy1   [162] 
Plasmodium berghei ANKA GFPcon   [163] 
Plasmodium berghei ANKA 820cl1m1cl1   [61] 
2.1.5.5 Mosquito strain 
Anopheles stephensi Max Planck Institute for Infection 
Biology, Berlin 
2.1.5.6 Mice strains 
Naval Medical Research Institute (NMRI), outbred Charles River, MA, USA 
C57BL/6      Janvier, France 
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2.1.6 Oligonucleotides 
Primers were purchased form Life Technologies at concentration 0.1 nmol/µl. 
2.1.6.1 Primers used for plasmid construction 
Number Purpose Restriction site Sequence (restriction site) 
#1 Cloning of pET28a_Ab1 and 
pET28a_Ab4 
BamHI GGGGATCCAGTATAGGAAAAA
AAACAC 
#2 Cloning of pET28a_Ab1 (triple stop 
codon) 
XhoI GTCTCGAGTTAATTAATTACTG
GGAATAAATAC 
#3 Cloning of pET28a_Ab2 BamHI GGGGATCCAATTTATATAAAAA
AAGACCAAAAAGG 
#4 Cloning of pET28a_Ab2 (triple stop 
codon) 
XhoI CTCTCGAGTTAATTAATTACTC
TTCCAATAGATG 
#5 Cloning of pET28a_Ab4 (triple stop 
codon) 
XhoI GACTCGAGTTAATTAATTAATA
TACCCCAACA 
#6 Cloning of flp_gfp SpeI CCCGACTAGTATTATGCCAATA
GAAT 
#7 Cloning of flp_gfp (ORF shift) PshAI CGGACTCCTGTCCTTTTAACAA
AAAC 
#8 Cloning of flp_gfp and dflp_TM   ACGTGGTCGACGAAGTACTTC
GTTTAAACGCTGATTTAATAAT
GGCAAAT 
#9 Cloning of flp_gfp and dflp_TM   ACGCGTGGGCCCCCTAGGTAC
GTATCTCGAGCCCGGGAAGAC
AGAAGTAATGAATTGTATCT 
#10 Cloning of dflp_C2A   TATAGGGGACGATCGGTCGTG
CACTGCCCCTAGAGCTTTTGAT
ATAG 
#11 Cloning of dflp_C2A   GTTGTACTTTTGAATATACATA
ATTTAAACTCATTTTATGGACG
CATAAAT 
#12 Cloning of dflp_C2A   TAAGAAATAAACTGATTTATGC
GTCCATAAAATGAGTTTAAATT
ATGTATA 
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#13 Cloning of dflp_C2A   GCATGGCGCGCCCGTCTCGTA
CATCATATGGATATTTGATTTA
TTGAAC 
#14 Cloning of dflp_TM SacII CTACCGCGGCAAATGAACCCAT
TGGTGA 
#15 Cloning of dflp_TM (triple stop 
codon) 
XbaI GTCGCTCTAGATTAATTAATTA
TTTCAATCCTTGCATTATAGAT
G 
#16 Cloning of flp_AID PstI GGGGCTGCAGAGACAGAAGTA
ATGAATTGTATC 
#17 Cloning of flp_AID (extra bp) SapI TAGCTCTTCCAGCACTGTATTC
CTAACAACCGA 
#18 Cloning of flp_AID AscI CTAGGCGCGCCCAAATGAACC
CATTGGTGA 
#19 Cloning of flp_AID XhoI GTCTCGAGTTTTAACAAAAACA
TTATAAAT 
#20 Cloning of dflp_ook NotI GGAACTGCGGCCGCAAAATGA
GTATAGGAAAAA 
#21 Cloning of dflp_ook SpeI ATAATCACTAGTAGGCCCAGG
GGCATGAGTTTT 
#22 Cloning of dflp_spz and dflp_gam KpnI AAGGTACCCCTAGAGCTTTTGA
TATAG 
#23 Cloning of dflp_spz and dflp_gam HindIII GGAAGCTTTTTATGGACGCATA
AATCAG 
#24 Cloning of dflp_spz BsmI GGGGGAATGCTATGAGTATAG
GAAAAAAAACAC 
#25 Cloning of dflp_spz SacII AACCGCGGGCCAATACCGGCA
ACAGAC 
#26 Cloning of dflp_liver   GGTCGACGAAGTACTTCGTTTA
AACGGTACCCTAGAGCTTTTGA
TATAG 
#27 Cloning of dflp_liver   CCTAGGTACGTATCTCGAGCCC
GGGAAGCTTTTATGGACGCAT
AAATCA 
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#28 Cloning of dflp_liver   TGTTTTTTCCTTCAATTTCGAGC
TCCGGATCGATTATTAATTTTA
GAGG 
#29 Cloning of dflp_liver   ATTATATTGTGTTTTTTTTCCTA
TACTCATTTTATCACATCCCCTT
TTC 
#30 Cloning of dflp_liver   AAGTGAAAATAGGAAAAGGG
GATGTGATAAAATGAGTATAG
GAAAAAAA 
#31 Cloning of dflp_liver   CGACGAAGTACTTCTCGCGAG
CGCGCCCGCGGGCCAATACCG
GCAACAG 
#32 Cloning of dflp_gam EcoRV GAGATATCATGAGTATAGGAA
AAAAAACAC 
#33 Cloning of dflp_gam AatII GAGACGTCACCTCTAAATATAT
TTATAC 
 
2.1.6.2 Primers used for genotyping and other assays  
Numb
er 
Purpose Chapter
s 
Sequence 
#1 genotyping of flp::gfp, 
ΔflpTM and flp::AID 
parasites 
3.1.3.1, 
3.2.2.2, 
3.2.3.1 
GGAATTCCATATGGATGAATTGCAAAGAGAA
GAAATG 
#2 genotyping of flp::gfp and 
ΔflpTM parasites 
3.1.3.1, 
3.2.2.2 
TGAATGCAACCATAACCCATACTC 
#3 genotyping of flp::gfp and 
ΔflpTM parasites 
3.1.3.1, 
3.2.2.2 
TAATACGACTCACTATAGGGCGA 
#4 genotyping of flp::gfp and 
ΔflpTM parasites 
3.1.3.1, 
3.2.2.2 
AATCCTTAAACGGGCTTGC 
#5 genotyping of flp::gfp and 
ΔflpTM parasites 
3.1.3.1, 
3.2.2.2 
GTTTACCTTCTACTGAAGAGGTTGTGG 
#6 genotyping of flp::gfp, 
flp::iLOV and flp::AID 
parasites 
3.1.3.1, 
3.1.3.3, 
3.2.3.1 
GCCTCTTTTGTGTGTCATTTCATC 
#7 genotyping of gfp::flp, 
Δflpook, Δflpspz, Δflpliver and 
Δflpgam parasites 
3.1.3.2, 
3.2.4.1, 
3.2.4.2, 
3.2.4.3, 
3.2.4.4 
TCCCCGCGGGTCTGTTTGAATGTCAAACTGCT
ATG 
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#8 genotyping of gfp::flp, 
Δflpook, Δflpspz, Δflpliver and 
Δflpgam parasites 
3.1.3.2, 
3.2.4.1, 
3.2.4.2, 
3.2.4.3, 
3.2.4.4 
TGTTGGGTGGGTCATGTTCT 
#9 genotyping of 
gfp::flpparasites 
3.1.3.2 ATGAGTAAAGGAGAAGAACTTTTCA 
#10 genotyping of 
gfp::flpparasites 
3.1.3.2 TTATTTGTATAGTTCATCCATGCC 
#11 gfp::flp transcript 
detectionm genotyping of 
Δflp parasites 
3.1.3.2, 
3.2.1.1 
CGACGCCATTTGTTTCTCCA 
#12 genotyping of flp::iLOV 
parasites 
3.1.3.3 GCAGAATTCGTGAATCATCTCTTGATTTATCT
GCTC 
#13 genotyping of flp::iLOV 
parasites 
3.1.3.3 TTGCGGCCGCGGACATGTTTTAAATGAGTTAT
GTGAGC 
#14 genotyping of flp::iLOV, 
Δflp and ΔflpC2A parasites 
3.1.3.3, 
3.2.1.1, 
3.2.2.1 
CCGATTTAAGATTCGTGATTGTATG 
#15 genotyping of flp::iLOV and 
flp::HA parasites 
3.1.3.3, 
3.1.3.4 
TTAGAATTAGCGGCTGTACTCGGTCAGCTCCA
GGAA 
#16 genotyping of flp::iLOV,  
flp::HA and Δflp parasites 
3.1.3.3, 
3.1.3.4, 
3.2.1.1 
GACTTTGGTGACAGATACTACTGTG 
#17 flp::iLOV transcript 
detection, 3'RACE 
3.1.3.3, 
3.1.5 
AACTGGGAGATGCAACTGCAT 
#18 genotyping of flp::HA 
parasites, 3'RACE, qPCR of 
flp 
3.1.3.4, 
3.1.5, 
3.1, 
3.2.4.1, 
3.2.4.4, 
3.3.4 
CATCAAATGAACCCATTGGTGAATC 
#19 genotyping of flp::HA 
parasites 
3.1.3.4 CAATTCATTACTTCTGTCT 
#20 genotyping of flp::HA and 
Δflp parasites 
3.1.3.4, 
3.2.1.1 
GGCTATTCATACTAGCCATTTTATGTG 
#21 genotyping of 
Δflpparasites 
3.2.1.1 TCGGATCCCCTTATTTAAGAGCAACGATATTT
AG 
#22 genotyping of 
Δflpparasites 
3.2.1.1 CGGGTACCGCTGACATTTCATATTTTAT 
#23 genotyping of 
Δflpparasites 
3.2.1.1 GGGGATGTACAAAGACATTG 
#24 genotyping of 
Δflpparasites 
3.2.1.1 GAAAAGATGATAATATAATTAAC 
#25 genotyping of ΔflpC2A 
parasites 
3.2.2.1 CGGGATCCATCTGGTTCTTCTACATCTTC 
#26 genotyping of ΔflpC2A and 
flp::AID parasites 
3.2.2.1, 
3.2.3.1 
CACATAAAATGGCTAGTATGAATAGCC 
#27 genotyping of ΔflpC2A and 
flp::HA parasites 
3.2.2.1, 
3.2.3.1 
TAATACGACTCACTATAGGG 
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#28 gentoyping of flp::AID 
parasites 
3.2.3.1 CCCTATGTTTTATAAAATTTTTTATTTATTTATA
AGC 
#29 gentoyping of Δflpook 
parasites 
3.2.4.1 TCCCCGCGGCATACCCACATACATGGATATAC
ATATGG 
#30 gentoyping of Δflpook 
parasites 
3.2.4.1 CCCGCACGGACGAATCCAGATGG 
#31 gentoyping of Δflpspz 
parasites 
3.2.4.2 CCGTGTGAATATGCTCATTTTGTATAC 
#32 gentoyping of Δflpspz 
parasites 
3.2.4.2 CCCGCACGGACGAATCCAGATGG 
#33 gentoyping of Δflpliver 
parasites 
3.2.4.3 CCGCATGTTTATTAACATT 
#34 gentoyping of Δflpgam 
parasites 
3.2.4.4 CCCCGCGGCATTTAGGGCATAAAAATAG 
#35 gentoyping of Δflpgam 
parasites 
3.2.4.4 CAAATTTTGAAGTATATGAGAAGAATGAT 
#36 gentoyping of Δflpgam 
parasites 
3.2.4.4 GGAACTGCGGCCGCAAAATGAGTATAGGAAA
AA 
#37 gentoyping of Δflpgam 
parasites 
3.2.4.4 CTCCGGTTCCCAACGATCAAG 
#38 genotyping of 
flp::HA;g377::mCherry 
parasites 
3.3.5 TATGATAATTTTGATGAG 
#39 genotyping of 
flp::HA;g377::mCherry 
parasites 
3.3.5 TTATTTTTAGATCAAAGC 
#40 genotyping of 
flp::HA;g377::mCherry and 
flp::HA;pplp2::mCherry 
parasites 
3.3.5 GCATGAACTCCTTGATGATGGC 
#41 genotyping of 
flp::HA;g377::mCherry and 
flp::HA;pplp2::mCherry 
parasites 
3.3.5 GGTGTTCTCTCTGATGTCCAGGAGGAGAAA 
#42 genotyping of 
flp::HA;pplp2::mCherry 
parasites 
3.3.5 GCTTCTGCGGGATATAAAAATGC 
#43 genotyping of 
flp::HA;pplp2::mCherry 
parasites 
3.3.5 ACGCATATCCATTCG 
#44 qPCR of flp 3.1, 
3.2.4.1, 
3.2.4.4, 
3.3.4 
TGCTGGGTGTTTACAAGAAATGG 
#45 qPCR of ferlin 3.1 GGTAATAGTTTTTCATCATGCGG 
#46 qPCR of ferlin 3.1 ATAGGGATTTTTGCTGCCTCT 
#47 qPCR of hop 3.1, 
3.2.4.1, 
3.2.4.3, 
GGTGCCTATTCAAGTTTAGGA 
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3.2.4.4, 
3.3.4 
#48 qPCR of hop 3.1, 
3.2.4.1, 
3.2.4.3, 
3.2.4.4, 
3.3.4 
CTAGTTGTCTTAAACCATGCTC 
#49 RT-PCR of aldolase 3.2.4.3 TGTATTTAAAGCTTTACATGATAATGG 
#50 RT-PCR of aldolase 3.2.4.3 TTTTCCATATGTTGCCAATGAATTTGC 
#51 qPCR of clag 3.2.4.4, 
3.3.4 
ACAGGCGTAATGACTCGACG 
#52 qPCR of clag 3.2.4.4, 
3.3.4 
CGGAGTATAGCGTCTTCGCC 
#53 qPCR of ama1 3.2.4.1 ATTTGGGTTGATGGTTATTG 
#54 qPCR of ama1 3.2.4.1 TCCTTGTCGAAATTTGGTAG 
#55 RT-PCR and qPCR of 
PBANKA_111780 
3.2.4.3 GCAAACTGCAATGAAGCCCA 
#56 RT-PCR and qPCR of 
PBANKA_111780 
3.2.4.3 TCCATTATGTGGGAACATGGCT 
#57 RT-PCR and qPCR of 
PBANKA_062260 
3.2.4.3 GTATCTTATTTATCTGAG 
#58 RT-PCR and qPCR of 
PBANKA_062260 
3.2.4.3 GATATTCTCAATAATCCC 
#59 RT-PCR and qPCR of 
PBANKA_121680 
3.2.4.3 TGGAGTTACACAAATTACTGGAAAA 
#60 RT-PCR and qPCR of 
PBANKA_121680 
3.2.4.3 TTTCCACAAGAGGAGTTAGGTAAA 
#61 RT-PCR and qPCR of 
PBANKA_121100 
3.2.4.3 CCATTCCCTGGACCTGGTTT 
#62 RT-PCR and qPCR of 
PBANKA_121100 
3.2.4.3 ACGGCAAATGCTTGCCCTA 
2.1.7 Antibodies 
2.1.7.1 Primary antibodies 
2.1.7.1.1 Immunofluorescence assay 
mouse anti-CSP, hybridoma supernatant (1:300)   [164] 
mouse anti-GFP, monoclonal (1:100)    Roche Diagnostics, IN, USA 
mouse anti-HSP70, hybridoma supernatant (1:100)  [165]   
mouse anti-βtubulin, monoclonal (1:400)   Sigma-Aldrich, MO, USA  
rat anti-HA tag, monoclonal, clone 3F10 (1:100)   Roche Diagnostics, IN, USA 
rat anti-TER-119, monoclonal (1:200)    Santa Cruz Biotechnology, TX, 
USA 
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rabbit anti-SEP-1, polyclonal serum (1:200) provided by Prof. Ponzi, 
Instituto Superiore di Sanita, 
Italy [166] 
2.1.7.1.2 Western blot 
mouse anti-GFP, monoclonal (1:500)    Roche Diagnostics, IN, USA 
mouse anti-His tag, monoclonal (1:1000)   Novagen, Merck Millipore, MA, 
USA 
mouse anti-Hsp70, hybridoma supernatant (1:100)  [165]   
rabbit anti-iLOV, polyclonal serum (1:2000) provided by Prof. Christie, 
University of Glasgow, UK [167] 
rat anti-HA tag, monoclonal, clone 3F10 (1:1000)  Roche Diagnostics, IN, USA 
2.1.7.2 Secondary antibodies 
2.1.7.2.1 Immunofluorescence assay 
goat anti-mouse Alexa 488 (1:300)    Life technologies, CA, USA 
goat anti-mouse Alexa 546 (1:300)    Life technologies, CA, USA 
goat anti-rat Alexa 488 (1:300)     Life technologies, CA, USA 
goat anti-rat Alexa 546 (1:300)     Life technologies, CA, USA 
goat anti-rabbit Alexa 488 (1:300)    Life technologies, CA, USA 
2.1.7.2.2 Western blot 
goat anti-mouse IgG-Peroxidase (1:10000)   Sigma-Aldrich, MO, USA 
goat anti-rabbit IgG-Peroxidase (1:5000)   Jackson ImmunoResearch, PA, 
USA 
goat anti-rat IgG-Peroxidase (1:5000)    Jackson ImmunoResearch, PA, 
USA 
2.1.8 Enzymes 
Alkaline Phosphatase      New England Biolabs, MA, USA 
DNase I        Sigma-Aldrich, MO, USA 
Fast Digest enzymes      Life technologies, MA, USA 
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Gateway LR Clonase      Thermo Fisher Scientific, MA, 
USA  
Lysozyme       Sigma-Aldrich, MO, USA 
Phusion DNA Polymerase     New England Biolabs, MA, USA 
Proteinase K       Life technologies, MA, USA 
Restriction endonucleases     New England Biolabs, MA, USA 
T4 DNA ligase       New England Biolabs, MA, USA 
Taq DNA Polymerase      Thermo Fisher Scientific, MA, 
USA 
2.1.9 Buffers, media and solutions 
2.1.9.1 Antibiotic stock solutions 
Ampicilin     100 mg/ml in 50% EtOH 
Kanamycin     50 mg/ml in H2O 
Tetracycline     5 mg/ml in 100% EtOH 
2.1.9.2 Buffers for molecular biology 
Fixing buffer IFA PBS 
4% paraformaldehyde 
0.0075% glutaraldehyde 
2x Laemmli buffer  250mM Tris pH 6.8  
10mM EDTA 
6.6% SDS 
24% glycerol 
6% mercaptoethanol 
bromphenol blue 
Permeabilization buffer IFA   PBS 
  125mM glycine 
  0.1% Triton X-100  
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RIPA buffer   50mM Tris pH 7.5 
  150mM sodium chloride 
  5mM EDTA 
  50mM sodium fluoride 
  0.5% sodium deoxycholate 
  0.1% SDS 
  1% Triton X-100    
TAE buffer   400M Tris 
  1mM EDTA 
  200mM acetic acid 
TBS(T) buffer   2mM Tris 
  137mM sodium chloride 
  (0.1% Tween 20) 
Transfer buffer   25mM Tris 
  250mM glycine 
  20% Methanol 
2.1.9.3 Buffers and media for microbiology 
Chemocompetent cells Tfb I buffer  30mM potassium acetate 
      100mM rubidium chloride 
      10mM calcium chloride 
      50mM manganese chloride 
      15% glycerol 
      -> pH 5.8, autoclave + store at 4⁰C 
Chemocompetent cells Tfb II buffer  10mM MOPS 
      10mM rubidium chloride 
      75mM calcium chloride 
      15% glycerol 
      -> pH 6.5, autoclave + store at 4⁰C 
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LB medium (agar)    10 g/l BactoTryptone 
      5 g/l Yeast Extract 
      10 g/l sodium chloride 
      (15 g/l BactoAgar) 
      -> autoclave + add antibiotic (1:1000) 
      -> for pGEM blunt cloning IPTG and X-gal added 
Lysis buffer     PBS  
      20 U/ml DNase I 
      10 µg/ml lysozyme 
      100mM β-mercaptoethanol 
      inhibitors of proteases 
Lysis buffer basic pH (with detergent) 50 mM Tris 
2 mM EDTA 
1 M sodium chloride 
100 µM β-mercaptoethanol 
inhibitors of proteases 
(0.1 % N-lauroylsarcosinate) 
-> pH adjusted to 8.3 
Lysis buffer acidic pH (with detergent) 50 mM Bis-Tris 
2 mM EDTA 
1 M sodium chloride 
100 µM β-mercaptoethanol 
inhibitors of proteases 
(0.1 % N-lauroylsarcosinate) 
-> pH adjusted to 6 
Solubilization buffer 6 M guanidine hydrochloride 
2 mM EDTA 
50 mM sodium dihydrogen phosphate 
50 mM DTT      
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SB medium      35 g/l BactoTryptone 
      20 g/l Yeast Extract 
      5 g/l sodium chloride 
      7 mM sodium hydroxide 
      -> autoclave  
TB medium  10.8 g/l BactoTryptone 
9.6 g/l Yeast Extract 
9.4 g/l dipotassium hydrogen phosphate 
2.29 g/l potassium dihydrogen phosphate 
-> autoclave + add 4 ml glycerol and antibiotic 
(1:1000) 
SOC medium      20 g/l BactoTryptone 
      5 g/l Yeast Extract 
      0.5 g/l sodium chloride 
      5 g/l magnesium sulphate 
      -> autoclave + add 20 ml of sterile 1M glucose 
YEG-Cl agar 5 g/l Yeast Extract 
5 g/l sodium chloride 
2 g/l 4-Chloro-DL-phenylalanine 
15 g/l BactoAgar 
-> autoclave + add 0.4% glucose and kanamycin 
(1:1000) 
2.1.9.4 Buffers and media for HuH7 cell culture 
Culture medium    DMEM 
      10% FCS 
      antibiotic-antimycotic 
      -> kept sterile, stored at 4⁰C 
2.1.9.5 Buffers and media for parasitology 
5-FLuorocytosine drinking water  1 g/l in tap water 
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Nycodenz stock     5mM Tris pH 7.5 
      3mM potassium chloride 
      0.3mM EDTA 
      276 g/l Nycodenz 
      -> autoclave + store in dark at 4⁰C 
Ookinete medium RPMI 
20% FCS  
50 mg/l hypoxanthine 
Pen/Strep 
2 g/l sodium hydrogen carbonate 
100µm xanthurenic acid 
Overnight blood culture medium  RPMI 
      20% FCS 
      2 mg/l gentamicin 
      -> sterile filtered, heparin added 
Pyrimethamine drinking water   70 mg/l in tap water with sucrose, pH 3.5-5 
Riboflavin drinking water   5 mg/l in tap water 
Sulfadiazine in drinking water   10 mg/l in tap water with sucrose 
2.1.9.6 Anaesthetics for mice 
Ketamine-Xylazine (K/X)   PBS 
      25% Ketamine 
      4% Xylazine 
2.1.9.7 Anopheles breeding 
Salt solution     1 g/l sea salt in dH2O 
Sugar solution 100 g/l sucrose in dH2O supplemented with 
para-aminobenzoic acid 
2.1.9.8 Protein/DNA ladder and loading dye 
Gene ruler 1 kb     Thermo Fisher Scientific, MA, USA 
6x Loading dye     Thermo Fisher Scientific, MA, USA 
Low MW ladder     New England Biolabs, MA, USA 
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PageRuler prestained    Thermo Fisher Scientific, MA, USA 
2.1.10 Plasmids 
2.1.10.1 Circular vectors 
The pET28a vector (Fig. 2.1A) was used as a backbone for recombinant production of parts of the 
FLP protein. The vector carries kanamycin resistance and a machinery for recombinant protein 
expression inducible with IPTG in BL21DE5 E. coli bacteria. The pET28a vector offers the possibility 
of both N-terminal (cleavable by thrombin) and C-terminal fusion of the recombinant protein to a 
His-tag. Parts for recombinant expression were selected based on structural analysis of FLP. We 
cloned parts of flp gene (PCR amplified from genomic DNA) into the vector using the XhoI and 
BamHI restriction sites, fusing the sequence to the N-terminal His-tag and omitting the C-terminal 
one (Fig. 2.1B-D). Fragments corresponding to the 5’end of flp (Ab1 and Ab4) were amplified 
without the start codon, all fragments were terminated by a triple stop codon. Sizes of the 
fragments were as follows, Ab1 – 903 bp (primers #1 and #2), Ab2 – 936 bp (primers #3 and #4) 
and Ab4 – 429 bp (primers #1 and #5). All primer sequences are listed in chapter 2.1.6.1. 
The pBAT-SIL6 vector (Fig. 2.2A, [168]) was used to generate the flp_gfp vector (for generation of 
flp::gfp parasite line). The vector carries an ampicillin resistance cassette and a recyclable 
hDHFR/yFcu resistance cassette,  which can be used to select for parasites that carry the cassette 
by Pyrimethamine selection and afterwards for parasites that recycled the cassette (via 3’UTR 
homology regions) by 5’ fluorocytosine selection [169]. Fragment corresponding to the 3’end of 
flp sequence without the stop codon (1035 bp, primers #6 and #7) was PCR amplified from 
genomic DNA and cloned into the backbone using the SpeI and PshAI restriction sites. Fragment 
corresponding to the 3’UTR of flp (693 bp, primers #8 and #9) was PCR amplified from genomic 
DNA and cloned into the KpnI/HindIII-opened backbone using Gibson assembly. The final vector 
(Fig. 2.2B) was linearized using the SpeI and KpnI restriction sites and used for transfection. All 
primer sequences are listed in chapter 2.1.6.1.  
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Figure 2.1 Plasmids used for recombinant expression of FLP fragments in E. coli. A) The 
backbone plasmid pET28a carries the kanamycin resistance cassette (orange), the E. coli origin 
of replication (ORI, light blue), LacL (dark blue), a cleavable (thrombin site, green) His-tag for 
N-terminal fusion (green) and a non-cleavable His-tag for C-terminal fusion. B)-D) Fragments 
corresponding to different parts of flp (purple) were cloned into the backbone using BamHI 
and XhoI restriction sites. 
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The gfp_flp vector (used for generation of gfp::flp parasite line) was generated and transfected by 
Gunnar R. Mair. In brief, fragments corresponding to 5’UTR of flp (1498 bp) and 5’end of flp 
without the start codon (1197 bp) were cloned upstream and downstream of gfp and triple HA 
tags, respectively (Fig. 2.3). Vector was linearized using the EcoRV restriction site and used for 
transfection. All primer sequences are listed in chapter 2.1.6.1. 
The pBAT-SIL6-MCS vector (Fig. 2.4A), generated by Franziska Hentzschel from the pBAT-SIL6 
backbone (Fig. 2.2A, [168]), was used to generate the dflp_C2A vector (for generation of ΔflpC2A 
parasite line). Similarly to pBAT-SIL6, the vector carries an ampicillin resistance cassette and a 
recyclable hDHFR/yFcu resistance cassette,  which can be used to select for parasites that carry 
the cassette by Pyrimethamine selection and afterwards for parasites that recycled the cassette 
(via 3’UTR homology regions) by 5’ fluorocytosine selection [169]. Fragment corresponding to the 
5’UTR of flp (1019 bp, primers #10 and #11) and the flp sequence starting after C2A domain and 
with a newly introduced start codon (1402 bp, primers #12 and #13) were PCR amplified from 
genomic DNA and cloned into the NaeI/NdeI-open backbone using Gibson assembly. The final 
Figure 2.2 Backbone and final plasmids used for generation of flp::gfp parasite line. A) The 
backbone plasmid pBAT-SIL6 carries the ampicillin resistance cassette (ampR, dark blue), the E. coli 
origin of replication (ORI, dark blue), homology arms for integration into a silent locus on 
chromosome 6 (SIL6, yellow), a recyclable selection cassette (hDHFR, ScFcy, salmon), mCherry 
(orange), triple c-myc tag (red) and gfp (green). B) Fragments corresponding to 3’end and 3’UTR of 
flp (pink) were cloned into the backbone using SpeI, PshAI, KpnI and HindIII restriction sites. 
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vector (Fig. 2.4B) was linearized using the BstBI restriction site and used for transfection. All primer 
sequences are listed in chapter 2.1.6.1. 
 
 
The pBAT-SIL6-MCS vector (Fig. 2.5A, introduced above) was used to generate the dflp_TM vector 
(for generation of ΔflpTM parasite line). Fragment corresponding to the 3’UTR of flp (1003 bp, 
primers #8 and #9) and the 3’end of flp ending before the transmembrane domain and with a 
newly introduced stop codon (1035 bp, primers #14 and #15) were PCR amplified from genomic 
DNA and cloned into the backbone using KpnI and HindIII and SacII and BamHI restriction sites, 
respectively. The final vector (Fig. 2.4B) was linearized using the SacII and KpnI restriction sites 
and used for transfection. All primer sequences are listed in chapter 2.1.6.1. 
Figure 2.3 Final plasmid used for generation of gfp::flp parasite line. The plasmid carries the 
ampicillin resistance cassette (ampR, dark blue), the E. coli origin of replication (ORI, dark blue), the 
selection cassette (hDHFR, salmon), gfp (green) and triple HA tag. Fragments corresponding to parts 
of 5’end and 5’UTR of flp (pink) were cloned into the backbone. 
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Figure 2.4 Backbone and final plasmids used for generation of ΔflpC2A parasite line. A) The 
backbone plasmid pBAT-SIL6-MCS carries the ampicillin resistance cassette (ampR, dark blue), 
the E. coli origin of replication (ORI, dark blue), homology arms for integration into a silent 
locus on chromosome 6 (SIL6, yellow) and a recyclable selection cassette (hDHFR, ScFcy, 
salmon). B) Fragments corresponding to parts of 5’UTR of flp and its open reading frame 
starting after the C2A domain (pink) were cloned into the backbone using NaeI and NdeI 
restriction sites.  
 
Figure 2.5 Backbone and final plasmids used for generation of ΔflpTM parasite line. A) The backbone 
plasmid pBAT-SIL6-MCS carries the ampicillin resistance cassette (ampR, dark blue), the E. coli origin 
of replication (ORI, dark blue), homology arms for integration into a silent locus on chromosome 6 
(SIL6, yellow) and a recyclable selection cassette (hDHFR, ScFcy, salmon). B) Fragments 
corresponding to parts of 3’UTR of flp and its open reading frame ending before the TM domain 
(pink) were cloned into the backbone through KpnI, HindIII, SacII and BamHI restriction sites. 
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The AID-GFP vector (Fig. 2.6A, kind gift from Nisha Philip [103]) was used to generate the flp_AID 
vector (for generation of flp::AID parasite line). The vector carries an ampicillin resistance cassette, 
gfp and a hDHFR resistance cassette, which can be used to select for parasites that carry the 
cassette by Pyrimethamine selection. Fragment corresponding to the 3’UTR of flp (624 bp, primers 
#18 and #19) and the 3’end of flp without the stop codon (643 bp, primers #16 and #17) were PCR 
amplified from genomic DNA and cloned into the backbone using the PstI and SapI and SacII and 
XhoI restriction sites, respectively. The final vector (Fig. 2.6B) was linearized using the SacII and 
AhdI restriction sites and used for transfection.  
 
 
The b3D-ama1 vector (Fig. 2.7A), generated by Kirsten Heiss from the b3D.DT^H.^D backbone 
[24], was used to generate the dflp_ook vector (for generation of Δflpook parasite line). Similarly 
to b3D.DT^H.^D, the vector carries an ampicillin resistance cassette, a TgDHFR resistance cassette, 
which can be used to select for parasites that carry the cassette by Pyrimethamine selection and 
ama1 promoter. Fragment corresponding to the 5’end of flp (1205 bp, primers #20 and #21) was 
PCR amplified from genomic DNA and cloned into the open backbone using NotI and SpeI 
restriction sites. The final vector (Fig. 2.7B) was linearized using the BstBI restriction site and used 
for transfection. All primer sequences are listed in chapter 2.1.6.1. 
Figure 2.6 Backbone and final plasmids used for generation of flp::AID parasite line. A) The 
backbone plasmid AID-GFP carries the ampicillin resistance cassette (ampR, dark blue), the E. coli 
origin of replication (ORI, dark blue), gfp (green) and a selection cassette (hDHFR, salmon). B) 
Fragments corresponding to parts of 3’UTR of flp and its 3’end (pink) were cloned into the 
backbone through PstI, SapI, SacII and XhoI restriction sites.  
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The pLIS0185 vector (Fig. 2.8A), generated by Gunnar R. Mair, was used to construct the dflp_spz 
vector (for generation of Δflpspz parasite line). The vector carries an ampicillin resistance cassette, 
a TgDHFR resistance cassette, which can be used to select for parasites that carry the cassette by 
Pyrimethamine selection and ccp promoter. Fragments corresponding to the 5’UTR (1021 bp, 
primers #22 and #23) and 5’end of flp (979 bp, primers #24 and #25) were PCR amplified from 
genomic DNA and cloned into the backbone using KpnI and HindIII and BsmI and SacII restriction 
sites, respectively. The final vector (Fig. 2.8B) was linearized using the KpnI and SacII restriction 
sites and used for transfection. All primer sequences are listed in chapter 2.1.6.1. 
The pBAT-SIL6-MCS vector (Fig. 2.9A, introduced above) was used to generate the dflp_liver 
vector (for generation of Δflpliver parasite line). Fragment corresponding to the 5’UTR of flp (1079 
bp, primers #26 and #27), 5’UTR of PBANKA_062260 (1498 bp, primers #28 and #29) and the 5’end 
of flp (1040 bp, primers #30 and #31) were PCR amplified from genomic DNA and cloned into the 
KpnI/HindIII- and SacII/EcoRV-opened backbone, respectively, using Gibson assembly. The final 
vector (Fig. 2.9B) was linearized using the ScaI restriction site and used for transfection. All primer 
sequences are listed in chapter 2.1.6.1. 
Figure 2.7 Backbone and final plasmids used for generation of Δflpook parasite line. A) The 
backbone plasmid b3D-ama1 carries the ampicillin resistance cassette (ampR, dark blue), the 
E. coli origin of replication (ORI, dark blue), ama1 promoter (green) and a selection cassette 
(TgDHFR, salmon). B) Fragment corresponding to the 5’end of flp (pink) was cloned into the 
backbone using NotI and SpeI restriction sites.  
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The pLIS0209 vector (Fig. 2.10A), generated by Gunnar R. Mair, was used to construct the 
dflp_gam vector (for generation of Δflpgam parasite line). The vector carries an ampicillin resistance 
Figure 2.8 Backbone and final plasmids used for generation of Δflpspz parasite line. A) The 
backbone plasmid pLIS0185 carries the ampicillin resistance cassette (ampR, dark blue), the E. 
coli origin of replication (ORI, dark blue), ccp promoter (red) and a selection cassette (TgDHFR, 
salmon). B) Fragments corresponding to 5’UTR and 5’end of flp (pink) were cloned into the 
backbone through KpnI, HindIII, BsmI and SacII restriction sites. 
Figure 2.9 Backbone and final plasmids used for generation of Δflpliver parasite line. A) The 
backbone plasmid pBAT-SIL6-MCS carries the ampicillin resistance cassette (ampR, dark blue), the 
E. coli origin of replication (ORI, dark blue), homology arms for integration into a silent locus on 
chromosome 6 (SIL6, yellow) and a recyclable selection cassette (hDHFR, ScFcy, salmon). B) 
Fragments corresponding to parts of 5’UTR of flp (pink), 5’UTR of PBANKA_062260 (cyan) and 5’end 
of flp (pink) were cloned into the backbone using KpnI, HindIII, SacII and EcoRV restriction sites.  
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cassette, a hHDFR resistance cassette, which can be used to select for parasites that carry the 
cassette by Pyrimethamine selection and clag promoter. Fragments corresponding to the 5’UTR 
(1021 bp, primers #22 and #23) and 5’end of flp (558 bp, primers #32 and #33) were PCR amplified 
from genomic DNA and cloned into the open backbone using KpnI and HindIII and EcoRV and AatII 
restriction sites, respectively. The final vector (Fig. 2.10B) was linearized using the KpnI and AatII 
restriction sites and used for transfection. All primer sequences are listed in chapter 2.1.6.1. 
 
 
The g377_mCherry vector (used for generation of flp::HA; g377::mCherry parasite line) was 
generated by Gunnar R. Mair. In brief, fragment corresponding to 3’end of g377 without the stop 
codon (1479 bp) was cloned upstream of an mCherry tag (Fig. 2.11A). Vector was linearized using 
the BstZ17I restriction site and used for transfection. 
The pplp2_mCherry vector (used for generation of flp::HA; pplp2::mCherry parasite line) was 
generated by Gunnar R. Mair. In brief, fragment corresponding to 3’end of pplp2 without the stop 
codon (1440 bp) was cloned upstream of an mCherry tag (Fig. 2.11B). Vector was linearized using 
the PmeI restriction site and used for transfection. All primer sequences are listed in chapter 
2.1.6.1.  
Figure 2.10 Backbone and final plasmids used for generation of Δflpgam parasite line. A) The 
backbone plasmid pLIS0185 carries the ampicillin resistance cassette (ampR, dark blue), the E. coli 
origin of replication (ORI, dark blue), clag promoter (red) and a selection cassette (hDHFR, salmon). 
B) Fragments corresponding to 5’UTR and 5’end of flp (pink) were cloned into the backbone using 
KpnI, HindIII, BsmI and SacII restriction sites. 
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2.1.10.2 Linear PlasmoGEM vectors 
The PlasmoGEM project has brought a substantial improvement in the field of Plasmodium 
berghei genetic manipulation. Sanger Institute in London, offers a large library of linear vectors 
(based on pJAZZ vector [170]) that can be used for manipulation of Plasmodium berghei and show 
high transfection efficiencies thanks to very long homology arms [171,172].  
The intermediate tagging vector for flp (PGEM-049911, Fig. 2.12A) was used to generate the 
flp_iLOV vector (for generation of flp::iLOV parasite line). The vector carries ampicillin resistance 
cassette (not shown), long homology arms for the flp locus and an intermediate cassette with 
zeocin resistance cassette surrounded by Gateway attR sites. We generated the final vector using 
a Gateway reaction between the intermediate vector and a circular plasmid carrying the final 
cassette (which carries hDHFR/yFCU recyclable cassette that can be used to select for parasites 
that carry the cassette by Pyrimethamine selection and afterwards for parasites that recycled the 
cassette (via 3’UTR homology regions) by 5’ fluorocytosine selection [169].) surrounded by 
Gateway attL sites (Fig. 2.12B).  The final vector (Fig. 2.12C) was linearized using the NotI 
restriction sites and used for transfection.  
Figure 2.11 Final plasmids used for generation of flp::HA;g377::mCherry and flp::HA;pplp2::mCherry 
parasite lines. A) The plasmid carries the ampicillin resistance cassette (ampR, dark blue), the E.coli 
origin of replication (ORI, dark blue), a selection cassette (hDHFR, salmon) and mCherry (red). Fragment 
corresponding to 3’end of g377 (purple) was cloned into the backbone. B) The plasmid carries the 
ampicillin resistance cassette (ampR, dark blue), the E.coli origin of replication (ORI, dark blue), a 
selection cassette (hDHFR, salmon) and mCherry (red). Fragment corresponding to 3’end of pplp2 
(green) was cloned into the backbone.  
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The final tagging vector for flp (PGEM-049911, Fig. 2.13A) was used for generation of flp::HA 
parasite line. The vector carries ampicillin resistance (not shown), long homology arms for the flp 
locus and a final cassette (which carries triple HA tag and hDHFR/yFCU recyclable cassette that 
can be used to select for parasites that carry the cassette by Pyrimethamine selection and 
afterwards for parasites that recycled the cassette (via 3’UTR homology regions) by 5’ 
fluorocytosine selection [169]).  The vector was linearized using the NotI restriction site and used 
for transfection. 
 
The final knock-out vector for flp (PGEM-120990, Fig. 2.13B) was used for generation of Δflp 
parasite line. The vector carries ampicillin resistance (not shown), long homology arms for the flp 
Figure 2.12 Backbone, cassette and final plasmids used for generation of flp::iLOV parasite 
line. A) The intermediate plasmid for flp tagging carries the zeocin resistance cassette (zeoR, 
dark blue), homology arms for integration into the flp locus (pink and dark grey) and Gateway 
attR sites (yellow). B) The iLOV final cassette plasmid carries tetracycline resistance cassette 
(TetR, dark blue), E. coli origin of replication (ORI, dark blue), a recyclable selection cassette 
(hDHFR, ScFcy, salmon), iLOV (green) and Gateway attL sites (yellow). C) Final plasmid for flp 
iLOV-tagging carries iLOV sequence fused to flp sequence followed by the resistance cassette.  
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locus and a final cassette (which carries triple HA tag and hDHFR/yFCU recyclable cassette that 
can be used to select for parasites that carry the cassette by Pyrimethamine selection and 
afterwards for parasites that recycled the cassette (via 3’UTR homology regions) by 5’ 
fluorocytosine selection [169]).  The vector was linearized using the NotI restriction site and used 
for transfection.  
 
 
Figure 2.13 Final plasmids used for generation of flp::HA and Δflp parasite lines. A) The final plasmid 
for flp tagging carries long homology arms for integration into the flp locus (pink and dark grey) and 
the final cassette (with triple HA tag (green) and a recyclable selection cassette (hDHFR, ScFcy, 
salmon)) and Gateway attL sites (yellow). C) The final plasmid for flp knock-out carries long homology 
arms for integration into the flp locus (pink and dark grey) and the final cassette (with triple HA tag 
(green) and a recyclable selection cassette (hDHFR, ScFcy, salmon)) and Gateway attL sites (yellow). 
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2.2 Methods 
2.2.1 Molecular biology 
2.2.1.1 Isolation of RNA and cDNA preparation 
Parasite material was isolated as described in chapter 2.2.3. RNA was isolated using the RNeasy 
Mini kit and DNA was digested in samples using Turbo DNA free kit. Concentration was measured 
by absorbance at 260 nm (A260) measurement using the Biophotometer. Up to 500 µg of RNA in 
10 µl was used to reverse transcribe cDNA using the First strand cDNA synthesis kit. Each cDNA 
production was performed in duplicates – sample and a control lacking reverse transcriptase (-
RT). Both cDNA samples were tested by Taq PCR (chapter 2.2.1.4) with aldolase primers (a 
housekeeping gene expressed by all parasite stages). Only samples positive for aldolase and with 
negative -RT control were used further. 
2.2.1.2 Quantitative PCR 
Parasite cDNA was added as a template into Power SYBR Green PCR Master mix along with primers 
(final concentration 400nM). Samples were analysed in MicroAmp Optical 96-well reaction plate 
in triplicates, -RT control of the sample with the highest cDNA concentration and H2O were used 
as controls. qPCR was performed using the ABI 7500 Real-Time PCR System and calculated with 
comparative CT method accounting for primer efficiency (chapter 2.2.1.2.1). All primer sequences 
are listed in chapter 2.1.6.2. 
2.2.1.2.1 Primer efficiency 
Serial dilution of parasite gDNA was added as template into Power SYBR Green PCR Master mix 
along with primers (final concentration 400nM). Samples were analysed in MicroAmp Optical 96-
well reaction plate in triplicates, H2O was used as control. qPCR was performed using the ABI 7500 
Real-Time PCR System. CT values were plotted as function of gDNA concentration and five values 
best fitting the linear regression function were used to calculate the slope. Primer efficiency was 
calculated as 10^(-1/slope) and used for comparative CT calculations. All primer sequences are 
listed in chapter 2.1.6.2. 
2.2.1.3 3’ RACE 
RNA was isolated from parasite samples as described in chapter 2.2.1.1. Afterwards, flp specific 
forward primers and polyT and adapter reverse primers (500nM) were used to produce cDNA 
(2mM dNTPS, 20mM Tris, 50mM KCl, 25mM MgCl2, 10 units of SuperScript reverse transcriptase, 
3’RACE System for Rapid Amplification of cDNA ends). The produced cDNA was used as a template 
in a standard Taq PCR reaction (chapter 2.2.1.4) with adapter and nested flp primers. All primer 
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sequences are listed in chapter 2.1.6.2. Both products (cDNA and PCR fragment) were analysed by 
agarose electrophoresis (chapter 2.2.1.9) and cloned into pGEM vectors using a kit from Promega. 
Briefly, purified PCR fragments (50 ng) were added as inserts into ligation mix, incubated for 1 
hour at room temperature and used to transform bacteria. Transformed bacteria were plated 
onto X-gal LB plates and white colonies (in which the lac operon was interrupted by insert) were 
tested for insert presence and used for sequencing. 
2.2.1.4 PCR and RT-PCR 
PCR was performed in 10–50 µl reactions using the Taq polymerase (genotyping, colony PCR, RT-
PCR and plasmid testing) or Phusion polymerase (fragments for cloning and problematic 
genotyping reactions). Taq reaction contained: 750mM Tris, 200mM (NH4)2SO4, 1.5mM MgCl2, 
0.1% Tween 20, 1.5–5 units of Taq polymerase, 2mM dNTPs and 1mM primers. PCR was 
performed in a PCR cycler with initial denaturation (94°C, 3 minutes), 30 cycles of denaturation 
(94°C, 30 seconds), annealing (usually 55°C, 40 seconds) and synthesis (60°C, 0.5-7 minutes) and 
final synthesis phase (60°C, 7-20 minutes). Phusion reaction contained: 1x GC buffer, 0.4–4 units 
of Phusion, 2mM dNTPs and 1mM primers. PCR was performed in a PCR cycler with initial 
denaturation (98°C, 30 seconds), 30 cycles of denaturation (98°C, 10 seconds), annealing (usually 
58°C, 30 seconds) and synthesis (68°C, 0.5-7 minutes) and final synthesis phase (68°C, 7-20 
minutes). Plasmids, gDNA or cDNA were used as templates. All primer sequences are listed in 
chapters 2.1.6.1 and 2.1.6.2. PCR products were analysed by agarose electrophoresis (chapter 
2.2.1.9). For further use, fragments were purified using the QIAquick PCR Purification Kit or cut 
from a gel and purified by the QIAquick Gel Extraction Kit. DNA concentration was measured by 
absorbance at 260 nm (A260) measurement using the Biophotometer.  
2.2.1.4.1 Colony PCR 
Colony PCR was performed in 20 µl reactions using the Taq polymerase. Bacterial colonies were 
reinoculated on fresh LB plates and residual bacteria were transferred directly into PCR reaction 
using a tip. Reaction contained: 750mM Tris, 200mM (NH4)2SO4, 1.5mM MgCl2, 0.1% Tween 20, 
1.5–5 units of Taq polymerase, 2mM dNTPs and 1mM primers. PCR was performed in a PCR cycler 
with initial denaturation (94°C, 10 minutes), 30 cycles of denaturation (94°C, 30 seconds), 
annealing (usually 55°C, 40 seconds) and synthesis (60°C, 0.5-3 minutes) and final synthesis phase 
(60°C, 7-12 minutes). PCR products were analysed by agarose electrophoresis (chapter 2.2.1.9).  
2.2.1.5 Plasmid isolation 
Bacteria grown overnight in a liquid medium (37° C, shaking at 200 rpm) were spun (2879 G, 10 
min) and pellets were frozen down at -20° C or directly used to isolate plasmid DNA with the 
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QIAprep Spin Plasmid Miniprep Kit. Plasmid DNA concentration was measured by absorbance at 
260 nm (A260) measurement using the Biophotometer. 
2.2.1.6 DNA digest 
For cloning steps, 1–3 µg of plasmid DNA or 0.5–2 µg of purified PCR product were mixed with 10–
40 units of restriction enzyme(s) and corresponding buffer and kept overnight at 37° C in an 
incubator or at the recommended temperature in a heating block. To prevent re-ligation of the 
digested plasmid, 10 units of alkaline phosphatase were added for the last hour of digest. Digested 
plasmid DNA was checked by agarose electrophoresis (chapter 2.2.1.9) and purified using the 
QIAquick Gel Extraction Kit. Digested PCR product was purified using the QIAquick PCR Purification 
Kit. DNA concentration was measured by absorbance at 260 nm (A260) measurement using the 
Biophotometer. For digest prior to transfection, >10 µg of plasmid DNA was mixed with 30 units 
of restriction enzyme(s) and kept overnight at 37°C in an incubator or at the recommended 
temperature in a heating block. For plasmid verification, 100 ng of plasmid DNA was mixed 5 - 10 
units of restriction enzyme(s) and corresponding buffer and incubated for 2 – 3 hours at 37°C in 
an incubator or at the recommended temperature in a heating block. Digested plasmid DNA was 
checked by agarose electrophoresis (chapter 2.2.1.9). 
2.2.1.7 Ligation 
Purified DNA fragments (plasmid and PCR product(s)) were mixed in a molar ratio of 1:3 (1:2 for 
long inserts and 1:5 for short inserts), 400 units of T4 DNA ligase and T4 DNA ligase buffer were 
added. Reaction with no insert was used as control. Reactions were incubated overnight in a box 
of slowly melting ice/water mix and used to transform bacteria.  
2.2.1.8 Gibson assembly 
Purified DNA fragments (plasmid and PCR product(s)) were mixed in a molar ratio of 1:3 (1:2 for 
long inserts and 1:5 for short inserts) in a 5 µl sample. DNA was mixed with 5 µl of Gibson assembly 
enzyme mix and incubated in a PCR cycler (2 hours, 40° C). Afterwards, DNA was diluted 1:3 and 
used to transform bacteria. 
2.2.1.9 Agarose electrophoresis 
Solution of 1%-2% agarose in TAE buffer was dissolved while boiling. After cooling down, ethidium 
bromide was added (75 ng/ml) and gel solidified in electrophoresis chamber with combs. DNA 
samples supplemented with loading dye were loaded into pockets and voltage of 100 V was 
applied for 30–60 minutes. Gels were analysed with UV transilluminator and imaged with a 
camera. For further use, DNA was extracted from the gel using the QIAquick Gel Extraction Kit. 
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2.2.1.10 Ethanol DNA precipitation 
Plasmid DNA digested for transfection (chapter 2.2.1.6) was precipitated by adding 2.5 volume of 
100% EtOH and 0.1 volume of 3M NaAc (pH 5.2). The sample was incubated at -80° C for at least 
30 minutes, spun (maximum speed, 4° C, 30 minutes), 500 µl of 70% EtOH was added, sample was 
spun again (maximum speed, 4° C, 5 minutes). Ethanol was removed by pipetting and evaporation, 
DNA was resuspended in 15 µl of ddH2O, DNA concentration was measured by absorbance at 260 
nm (A260) measurement using the Biophotometer. Digested plasmid was analysed by agarose gel 
(chapter 2.2.1.9). 
2.2.1.11 Isolation of genomic DNA 
Mixed asexual blood stages were purified as described in chapter 2.2.3.7.1. Genomic DNA was 
isolated using the QIAamp DNA Blood Kit and concentration was measured by absorbance at 260 
nm (A260) measurement using the Biophotometer. 
2.2.1.12 Gateway reaction 
Intermediate plasmid (90 ng) and a plasmid carrying final cassette (25 ng) were mixed with the LR 
clonase enzyme (1.5 µl) and 1x clonase buffer. Mixture was incubated overnight in a PCR machine 
(25°C), treated with proteinase K (0.5 µl added, 37°C, 10 minutes), dialyzed against ddH2O (RT, 1 
hour) and electroporated into BigEasy-TSA Electrocompetent bacteria. Bacteria were inoculated 
onto YEG-Cl agar plates, incubated overnight (37°C) and colonies were tested by colony PCR 
(chapter 2.2.1.4.1). 
2.2.1.13 Sequencing 
Purified plasmid (2 µg) or PCR fragments (1 µg) in 20µl sample were sent for sequencing by GATC 
along with a 20µl sample of 10 µM primer. 
2.2.1.14 Western blotting 
Proteins were lyzed in RIPA buffer - 20 minutes incubation on ice with vortexing, spinning 
(maximum speed, 4°C, 5 min) and protein lysates were stored at -80°C. In protein expression 
experiments, bacterial lysates were generated as described in chapter 2.2.2.4. Protein lysates 
were mixed with Laemmli buffer and boiled for 5 minutes (10–15 minutes for bacterial pellets). 
Samples were loaded on a BisTris gradient gel (4-12%) and voltage of 150 V was applied until the 
gel front reached the bottom of the gel. Gel was incubated in transfer buffer along with methanol-
activated PVDF membrane. Blotting sandwich was assembled from sponges, Whatman papers, 
PVDF membrane and the gel. Wet transfer was performed in the apparatus filled with transfer 
buffer at 30 V for 3 hours. Membrane was blocked in 5% milk in TBST for (1 hour, room 
temperature, rotator). Afterwards, primary antibody diluted in 5% milk in TBST was added and 
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membrane was incubated overnight at 4° C on a rotator. After three washing steps in TBST (10 
minutes, room temperature, rotator), secondary antibody diluted in 5% milk in TBST was added 
(1 hour, room temperature, rotator). After three washing steps in TBST (10 minutes, room 
temperature, rotator), protein ladder was visualized with WesternSure pen and ECL was added to 
induce peroxidase reaction (5 minutes, room temperature, rotator). Membrane was scanned 
using the LiCor C-DiGit Blot Scanner and figures were processed using Image Studio. All antibodies 
and used concentrations are listed in chapter 2.1.7. 
2.2.1.15 Immunofluorescence assay (IFA) 
2.2.1.15.1 IFA of blood stages 
Blood with mixed blood stages (chapter 2.2.3.7.1) or enriched schizonts (chapter 2.2.3.7.2) were 
fixed in fixing buffer. For activated gametocytes, blood was first incubated in an ookinete medium 
(15 – 20 min, room temperature, rotator) and fixed in fixing buffer. Samples were kept at 4° C or 
directly permeabilized with permeabilization buffer (20 min, room temperature, rotator). Samples 
were blocked in 10% FCS/PBS (1 hour, room temperature, rotator) and stained with primary 
antibody diluted in 10% FCS/PBS (1 hour, room temperature, rotator). Afterwards, samples were 
washed three times in 1% FCS/PBS (15 minutes, room temperature, rotator), stained with 
secondary antibody (1 hour, room temperature, rotator), washed twice in 1% FCS/PBS and once 
in 1% FCS/PBS supplemented with Hoechst (15 minutes, room temperature, rotator). Finally, 
samples were resuspended in PBS and stored at 4° C until imaging. All antibodies and used 
concentrations are listed in chapter 2.1.7. Samples were imaged using Confocal spinning disc 
microscope Nikon Eclipse TI-E or Widefield light miscroscope Axiovert 25, images were processed 
in FIJI and in some cases deconvolved in AutoQuant X3. 
2.2.1.15.2 IFA of liver stages 
Liver stages were cultured as described in chapter 2.2.3.6. At designated time points, cultures 
were fixed with ice cold methanol (20 minutes, room temperature, sterile hood), washed twice 
with 1% FCS/PBS and blocked with 10% FCS/PBS (30 minutes at 37° C or overnight at 4° C). Samples 
were stained with primary antibody diluted in 10% FCS/PBS (1 hour at 37° C), washed three times 
with 1% FCS/PBS, stained with secondary antibody (1 hour at 37° C, for the last 5 minutes Hoechst 
was added) and washed three times with 1% FCS/PBS. Samples were mounted using 30% glycerol, 
sealed with nail polish and kept at 4° C until imaging. All antibodies and used concentrations are 
listed in chapter 2.1.7. For size measurement, fifty images per well were taken using Widefield 
light microscope Axiovert 25 and liver stage size was measured in FIJI. Liver stage numbers were 
counted by hand using Fluorescence microscope.  
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2.2.1.15.3 Gliding assay 
Sporozoites were purified as described in chapter 2.2.3.5. To precoat the surface with BSA (bovine 
serum albumin), 8 well slide was incubated with 3% BSA/RPMI (20 minutes, 37° C). Ten thousand 
isolated sporozoites in 20 µl of 3% BSA/RPMI was pipetted onto the coated wells and incubated 
(20–30 minutes, 37° C). Afterwards, medium was carefully removed, and samples were fixed with 
4% PFA/PBS (15 minutes, room temperature). Samples were washed twice with 1% FCS/PBS and 
blocked with 10% FCS/PBS (30 minutes, 37 ° C). Sporozoites and their trails were stained with anti-
CSP antibody diluted in 10 % FCS/PBS (1 hours, 37° C), washed three times with 1% FCS/PBS, 
stained with secondary antibody diluted in 10% FCS/PBS (1 hours, 37° C) and washed three times 
with 1% FCS/PBS. Afterwards, samples were mounted with 30% glycerol and sealed with nail 
polish and stored at 4° C until analysis. All antibodies and used concentration are listed in chapter 
2.1.7. Samples were analysed by hand using Fluorescence microscope. Gliding capability of sixty 
sporozoites per well was assessed as gliders (one or more circles) or non-gliders (no or less than 
one circle).  
2.2.1.15.4 Invasion assay 
HuH7 cells were infected with sporozoites as described in chapter 2.2.3.6. Sporozoites were 
allowed to invade for two hours and cultures were fixed with 4% PFA/PBS (20 minutes, room 
temperature, sterile hood). Samples were blocked in 10% FCS/PBS (1 hour at 37° C) and stained 
with anti-CSP antibody diluted in 10% FCS/PBS (1 hour at 37° C). Afterwards, samples were washed 
three times with 1% FCS/PBS and stained with secondary antibody (anti-mouse conjugated to 
Alexa 488) diluted in 10% FCS/PBS (1 hour at 37° C) and washed three times with 1% FCS/PBS. 
Next, samples were permeabilized (to allow staining of intracellular sporozoites) with ice cold 
methanol (20 minutes, room temperature). Samples were blocked again in 10% FCS/PBS (1 hour 
at 37° C) and stained with anti-CSP antibody diluted in 10% FCS/PBS (1 hour at 37° C). Afterwards, 
samples were washed three times with 1% FCS/PBS and stained with secondary antibody (anti-
mouse conjugated to Alexa 546) diluted in 10% FCS/PBS (1 hour at 37° C, for 5 last minutes Hoechst 
was added) and washed three times with 1% FCS/PBS. Finally, samples were mounted using 30% 
glycerol, sealed with nail polish and stored at 4° C until imaging. Samples were imaged using the 
Widefield light microscope Axiovert 25. At least fifty sporozoites per well were imaged and their 
invasion status was assessed. Invaded (red staining only) and non-invaded (red and green staining) 
sporozoites were counted. 
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2.2.2 Microbiology 
2.2.2.1 Production and transformation of chemocompetent E. coli 
Chemocompetent XL1 blue bacteria were inoculated from a master stock into 5 ml of LB medium 
supplemented with tetracycline and grew overnight (37° C, shaking at 200 rpm). Bacterial culture 
was diluted into 200 ml of LB medium supplemented with tetracycline to OD600 = 0.1. Culture was 
incubated (37° C, shaking at 200 rpm) until OD600 = 0.48. Bacteria were incubated on ice (15 mins), 
spun (2879 G, 4° C, 7 min) and resuspended in 80 ml of Tbf I buffer. Bacteria were incubated on 
ice (15 mins), spun (2879 G, 4° C, 7 min), resuspended in 8 ml of Tbf II buffer and incubated on ice 
(15 mins). Bacteria were aliquoted into Eppendorf tubes (50 µl) and were either used directly or 
frozen in liquid nitrogen and stored at -80° C. For transformation, bacteria were thawed on ice, 
mixed with DNA (ligation mix, Gibson assembly mix or plasmid) and incubated on ice for 30 mins. 
Bacteria were transformed by heat shock (30 seconds at 42°C followed incubation on ice for 2 
minutes) and diluted in 1 ml LB medium and incubated for 1 hour (37° C, shaking at 200 rpm). 
Bacteria were inoculated onto LB agar plates with corresponding antibiotic and incubated 
overnight at 37° C. Successful transformation was tested by colony PCR (chapter 2.2.1.4.1) or by 
plasmid isolation and control digest (chapter 2.2.1.6). 
2.2.2.2 Production and transformation of electrocompetent E. coli 
Electrocompetent PMC 103 bacteria were inoculated into 10 ml of antibiotic-free SB medium and 
cultivated overnight (37° C, shaking at 200 rpm). Bacteria were diluted 100 times in 600 ml of 
antibiotic free SB medium and grew for 3.5 hours (37° C, shaking at 200 rpm). Bacteria were spun 
(2879 G, 4° C, 10 min), resuspended in 600 ml cold sterile ddH2O, spun again (2879 G, 4° C, 10 
min), resuspended in 600 ml cold sterile ddH2O, spun again (2879 G, 4° C, 10 min) resuspended in 
600 ml cold sterile 10% glycerol, spun again (2879 G, 4° C, 15 min) and resuspended in 1.2ml of 
10% glycerol. Bacteria were aliquoted into cold Eppendorf tubes (50 µl, kept on dry ice/EtOH mix) 
and transferred to -80° C. All manipulations were sterile and on ice. For transformation, bacteria 
were thawed on ice, mixed with DNA (ligation mix, Gibson assembly mix or plasmid) and 100 µl of 
10% glycerol and transferred into an electroporation cuvette. Bacteria were electroporated and 
immediately transferred into 1ml of warm SOC medium and incubated for 1 hour (37° C, shaking 
at 200 rpm). Bacteria were inoculated onto LB agar plates with corresponding antibiotic and 
incubated overnight at 37° C. Successful transformation was tested by colony PCR (chapter 
2.2.1.4.1) or by plasmid isolation and control digest (chapter 2.2.1.6). 
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2.2.2.3 Preparation of bacterial glycerol stocks 
Bacteria were inoculated into a liquid medium with antibiotics and grew overnight (37° C, shaking 
at 200 rpm). 500 µl of the culture was mixed with 500 µl of 30% glycerol in a cryotube and stored 
at -80° C. For inoculation, a small amount of frozen glycerol stock was scraped with a yellow tip 
and inoculated into liquid medium. 
2.2.2.4 Protein expression 
BL21DE3 bacteria transformed with pET28a vectors were inoculated into 5ml of LB medium with 
kanamycin and incubated overnight (37° C, shaking at 200 rpm). Bacterial culture was diluted in 
LB medium supplemented with kanamycin to OD600 = 0.1. Culture was incubated (37° C, shaking 
at 200 rpm) until OD600 = 0.6. At this point, 1 ml of culture was harvested (not induced sample) 
and recombinant expression was induced by addition of IPTG to final concentration of 1µM (or 
0.1µM - 1µM in optimization experiments). Bacteria were cultivated for additional 4 hours (37° C 
or 15° C and 20° C in optimization experiments, shaking at 200 rpm). Bacteria were pelleted by 
centrifugation (2879 G, 4° C, 10 min) and stored at -20° C. For lysis, pellet was thawed on ice and 
resuspended in a lysis buffer. Suspension was sonicated, incubated (magnetic stirrer or rotator, 
20 min, 4° C) and spun (2879 G, 4° C, 10 min). Supernatant was mixed with Laemmli buffer (95° C, 
5 min), pellets were resuspended in Laemmli buffer (95° C, 5 min) and analysed on SDS-PAGE and 
Western blot (chapter 2.2.1.14). 
2.2.3 Parasitology 
2.2.3.1 Parasitaemia and gametocytonemia 
A drop of tail blood from mice infected with parasites was smeared on a glass slide. After the blood 
film dried, the sample was fixed in methanol (30 seconds, room temperature) and stained in 10% 
Giemsa dye (25 minutes, room temperature). Parasitaemia (gametocytonemia) was determined 
using Widefield light microscope Axioskop 40 and counted by hand as number of parasites 
(gametocytes) per field of view (n = 15) divided by total erythrocytes per field of view (n = 3). 
Parasitaemia and gametocytonemia were plotted in percent. 
2.2.3.2 Exflagellation assay 
Drop of tail blood from infected mice was incubated on a glass slide at room temperature for 12 
minutes. For digitonin rescue experiments, 5 µl of ookinete medium with or without 0.002% 
digitonin was added to the sample. Exflagellation was observed using Widefield light microscope 
Axioskop 40 or imaged using Widefield light microscope Axiovert 25.  
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2.2.3.3 Ookinete assay 
Blood with parasites was collected by heart puncture and 20 million infected red blood cells were 
injected intraperitoneally into naïve mouse. Three days later, parasitaemia (chapter 2.2.3.1) and 
exflagellation (2.2.3.2) were analysed. For cross-fertilization assay, mice pairs with similar levels 
of parasites and gametocytes were matched. Blood was collected by heart puncture and 
transferred into 12 ml of ookinete medium (for digitonin rescue, medium was supplemented with 
0.002% digitonin). Cultures were incubated for 20 hours (19° C, shaking at 25 rpm) and afterwards 
ookinetes were analysed by blood smear or directly imaged using Widefield light microscope 
Axiovert 25 or Confocal spinning disc microscope Nikon Eclipse TI-E. Alternatively, ookinetes were 
enriched over 63% Nycodenz/PBS - culture was layered over Nycodenz cushion and spun (1513 G, 
15 min, room temperature). A ring containing ookinetes that established at the 
Nycodenz/medium interface was collected using a Pasteur pipette. Enriched ookinetes were 
resuspended in PBS supplemented with Hoechst and were analysed by blood smear or directly 
imaged using Widefield light microscope Axiovert 25 or Confocal spinning disc microscope Nikon 
Eclipse TI-E. For cross-fertilization assays, fifty random ookinetes were imaged using Widefield 
light microscope Axiovert 25 and red or green fluorescence was assessed using FIJI. For ookinete 
feedings (chapter 2.2.3.4), cultures were spun (404 G, 8 minutes, room temperature) and washed 
with RPMI medium (to remove digitonin). Cultures were resuspended in 800 µl of prewarmed 
blood (collected by heart puncture from naïve mice) and offered to mosquitoes in membrane 
feeder (warmed up to 37° C). 
2.2.3.4 Mosquito feeding 
Anopheles mosquitoes were fed on anaesthetized mice or using a membrane feeder. For feeding 
on mice, drop of tail blood from infected mice was analysed in exflagellation assay (chapter 
2.2.3.2) for gametocyte presence. Mice were anaesthetized (chapter 2.2.4.1.1). After a few 
minutes, lack of reflexes was checked, and fully asleep mice were put on mosquito cages with an 
eye protecting cream. For membrane feeding, ookinete cultures (chapter 2.2.3.3) were 
resuspended in warm blood from naïve mice. This mixture was applied into parafilm-covered 
membrane feeders, which were connected to a constant flow of warm water. Membrane feeders 
were fixed above mosquito cages, so that mosquitoes could feed on the cultures. Mosquitoes 
were starved by removing the sugar and salt solutions 4 hours prior to feeding. The feeding 
proceeded for 20 minutes, with two position changes of the mice/feeders to allow all mosquitoes 
to feed. In case of membrane feeding, unfed mosquitoes were removed one day after feed. 
Mosquitoes were kept in the insectary incubators (21° C, 80% humidity) for up to 21 days.  
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2.2.3.5 Isolation of mosquito stages 
Mosquitoes were dissected using sterile needles and Stereomicroscope Stemi 2000-C. For 
ookinetes, mosquito midguts were isolated 18 – 20 hours post feeding, mashed on one side of a 
glass slide and smeared. For oocyst examination, mosquito midguts were isolated, placed on a 
glass slide, covered with a cover slip and examined for oocyst presence using Widefield light 
microscope Axioskop 40. Midgut sporozoites were isolated from mosquito midguts at day 14 post 
feeding. Midguts were collected in an Eppendorf tube and squished with a micropistill. Mosquito 
tissues were spun (0.1 G, 3 min, 4° C), leaving the purified sporozoites in supernatant. Salivary 
gland sporozoites were isolated from mosquito salivary glands at day 17 - 21 post feeding. Salivary 
glands were collected in an Eppendorf tube and squished with a micropistill. Mosquito tissues 
were spun (0.1 G, 3 min, 4° C), leaving the purified sporozoites in supernatant. 
2.2.3.6 Infection of HuH7 cells 
Isolated salivary gland sporozoites were used to infect human hepatoma cell line (HuH7) in 8-well 
labteks or 24-well plates. HuH7 cells were seeded one day prior to infection (25 000 cells per labtek 
well, 50 000 cells per 24-well plate well). At the time of infection, cells were washed once with 
culture medium to remove dead cells. Sporozoites (10 000 in 100 µl for labtek well or 50 000 in 
200 µl for 24-well plate well) were diluted in culture medium and put onto cells. Invasion 
proceeded for two hours in the cell culture incubator. Afterwards, suspension with uninvaded 
sporozoites was removed and cells were washed twice with culture medium. Cells were cultured 
with daily supplement of fresh medium for the designated times. 
2.2.3.7 Isolation of blood stages 
All blood stage parasite material was isolated from infected mice (chapter 2.2.4.1.2). 
2.2.3.7.1 Mixed asexual stages 
Infected mice were anesthetized and blood with parasites was collected by heart puncture. Blood 
was diluted in PBS (for RNA isolation, blood was filtered over a CF11 column to remove white 
blood cells), spun (404 G, 8 min, RT) and erythrocytes were lyzed in 0.2% saponin in PBS. Parasites 
were spun again (1410 G, 8 min, RT) and used further for gDNA (chapter 2.2.1.11), RNA (chapter 
2.2.1.1) or protein (chapter 2.2.1.14) isolation. 
2.2.3.7.2 Schizonts 
Infected mice were anaesthetized, blood with parasites was collected by heart puncture and 
immediately transferred into 10 ml of warm medium for overnight culture. Blood was spun (404 
G, 8 min, RT), resuspended in 35 ml of warm medium for overnight culture, transferred to a 75 
cm2 culture flask and incubated for 18 hours in a cell culture incubator supplemented with 5% O2. 
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Cultures were underlayered with 55% Nycodenz in a Falcon tube and spun (120 G, 25 min, RT) and 
brown ring at the Nycodenz/medium interface was collected in a fresh tube. Schizonts were spun 
(404 G, 8 min, RT) and further used for IFA staining (chapter 2.2.1.15.1), RNA (chapter 2.2.1.1) or 
protein (chapter 2.2.1.14) isolation, transfection (chapter 2.2.3.8) or purification of rings and 
trophozoites (chapter 2.2.3.7.3).  
2.2.3.7.3 Rings and trophozoites 
Purified schizonts (chapter 2.2.3.7.2) were intravenously injected in naïve mice. Mice were 
anaesthetized, blood with parasites was collected by heart puncture at designated time points (5 
hours post injection for rings and 17 hours post injection for trophozoites). Blood was filtered over 
a CF11 column to remove white blood cells, spun (404 G, 8 min, RT) and erythrocytes were lyzed 
in 0.2% saponin in PBS. Parasites were spun again (1410 G, 8 min, RT) and used for RNA isolation 
(chapter 2.2.1.1). 
2.2.3.7.4 Gametocytes 
Infected mice were treated with sulfadiazine in drinking water for 48 – 72 hours (until asexual 
blood stages were killed as assessed by blood smearing). Mice were anaesthetized, blood with 
gametocytes was collected by heart puncture, diluted in RPMI medium and spun (404 G, 8 min, 
RT). Gametocytes were resuspended in RPMI medium, underlayered by 48% Nycodenz in a Falcon 
tube and spun (1410 G, 15 min, RT) and brown ring at the Nycodenz/medium interface was 
collected in an Eppendorf tube. Gametocytes were spun (404 G, 8 min, RT) and washed in RPMI 
several times and further used for RNA (chapter 2.2.1.1) or protein (chapter 2.2.1.14) isolation.  
2.2.3.8 Transfection of Plasmodium berghei 
Parasites were transfected in the schizonts stage, enriched and purified as described in chapter 
2.2.3.7.2. Parasite transfection was performed using the AMAXA Human T Cell Nucleofector Kit 
according to manufacturer’s instruction and as described [24]. Transfected parasites were 
immediately injected intravenously into naïve mice and after one day of recovery, mice were 
treated with Pyrimethamine in drinking water to select for parasites carrying the dhfr cassette. 
Mice were followed by daily blood smears and after parasitaemia grew over 1 %, mice were 
anaesthetized and blood with parasites was collected by heart puncture (chapter 2.2.3.7.1). 
Parasite material was used to isolate gDNA (chapter 2.2.1.11) and PCR genotyping was performed 
(chapter 2.2.1.4). To obtain a clonal line, transfected parasites were used to infect a mouse and 
kept under Pyrimethamine selection pressure. When mouse reached parasitaemia of 0.1–1 %, it 
was anaesthetized and blood with parasites was collected by heart puncture. Blood was serially 
diluted and aliquots with 1 parasite in 100 µl of RPMI medium were injected into 4 - 10 naïve mice. 
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Mice (with no drug pressure) were followed by daily blood smears and after parasitaemia reached 
1 %, mice were anaesthetized and blood with parasites was collected by heart puncture (chapter 
2.2.3.7.1). Parasite material was used to isolate gDNA (chapter 2.2.1.11) and PCR genotyping was 
performed (chapter 2.2.1.4). 
2.2.3.9 Recycling of selection cassette 
In order to return the transgenic parasite into a Pyrimethamine-sensitive state, in selected cases 
(when dhfr cassette contained yfcu gene for negative selection), the dhfr cassette was recycled. 
For this, mouse was infected with clonal parasite line and after reaching 1% parasitaemia, mice 
were treated with 5’fluorocytosine in drinking water. After parasitaemia recovered and reached 
0.5 %, the mouse was anaesthetized and blood with parasites was collected by heart puncture 
(chapter 2.2.3.7.1). Blood was serially diluted and aliquots with 1 parasite in 100 µl of RPMI 
medium were injected into 4 naïve mice. Mice (with no drug pressure) were followed by daily 
blood smears and after parasitaemia reached 1 %, mice were anaesthetized and blood with 
parasites was collected by heart puncture (chapter 2.2.3.7.1). Parasite material was used to isolate 
gDNA (chapter 2.2.1.11) and PCR genotyping was performed (chapter 2.2.1.4). 
2.2.3.10 Cryopreservation of parasites 
Blood was collected by heart puncture (chapter 2.2.3.7.1) from infected mice with parasitaemia 
of 1–3 %, aliquoted with two volumes of Alsever’s solution with glycerol and immediately 
transferred into and stored in liquid nitrogen tanks. 
2.2.4 Animal experiments 
2.2.4.1 Maintenance of mice 
Eight weeks old mice were kept in Makrolon cages type II in the central animal facility of the 
University of Heidelberg (Interfakultaere Biomedizinische Forschungseinrichtung). Mice were kept 
at constant room temperature of 22°C and 50-60% humidity with a 12/12 hours light/dark cycle. 
Animals were fed with standard dry pellet food. 
2.2.4.1.1 Anaesthesia 
Prior to mosquito feeding, mice were anaesthetized by intraperitoneal injection of 
ketamine/xylazine (100 µl/25 g). Eyes were covered with eye cream to prevent drying and mice 
were covered with paper tissues to reduce heat loss. Anaesthetized mice were offered to pre-
starved mosquitoes (chapter 2.2.3.4). 
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2.2.4.1.2 Parasite infection 
Mice were infected with asexual blood stages or sporozoites. Asexual blood stages were from 
cryopreserved samples (chapter 2.2.3.10) or collected from another mouse by heart puncture 
(2.2.3.7.1). Blood was injected intraperitoneally or intravenously into a naïve mouse. Isolated 
salivary gland sporozoites (chapter 2.2.3.5) were injected intravenously into a naïve mouse. For 
infection by bite, ten infected mosquitoes were transferred one day prior to the experiment into 
a separate cage. Mice were anesthetized (chapter 2.2.4.1.1) and offered to pre-starved 
mosquitoes for 15 minutes. 
2.2.4.2 Mosquito breeding 
All mosquito developmental stages (eggs, larvae, pupae and newly hatched adults) were bred in 
trays filled with salt solution, supplemented with cat pelleted food and covered with nets. Eggs 
were collected into glass dishes with filter paper and salt solution overnight from mosquitoes 3–
7 days post blood meal. Eggs were washed with 70% ethanol and salt solution prior to transferring 
to the trays. All stages developed at 28° C and 80% humidity. Hatched adults were transferred into 
cages and fed with sugar and salt solution soaked into cotton pads. After infectious blood meal 
(chapter 2.2.3.4), mosquitoes were transferred to the insectary incubators (21° C, 80% humidity). 
2.2.3 Cell biology 
2.2.3.1 Cultivation of HuH7 cells 
Human hepatoma cells (HuH7) were cultured in a complete culture medium in a cell culture 
incubator (5% CO2, 37° C) and handled in a sterile cell culture hood. Cells were grown to confluency 
and then washed with serum-free HBSS medium, trypsinized, washed with complete culture 
medium and introduced into a culture flask (10–30% confluency) or counted and seeded in a lab 
tek or 24 well plate (chapter 2.2.3.6).  
2.2.4 Microscopy and image processing 
All imaging was done using Widefield light microscope Axiovert 25 or Confocal spinning disc 
microscope Nikon Eclipse TI-E. All microscopy samples to be compared were analysed with the 
same acquisition conditions. Data were processed in FIJI (contrast and brightness adjustment, 
assigning of artificial colours) and in some cases in AutoQuant X3 (deconvolution). 
2.2.5 Statistical analysis 
Experiments were performed in biological triplicates unless stated otherwise. All statistical 
analysis was performed in GraphPad Prism. T-test was used to compare two data sets with n > 50 
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and normal distribution. Mann-Whitney (a non-parametric t-test) was used to compare two sets 
of data with n < 6. Significance was concluded if p < 0.05. 
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3 Results 
Ferlin-like protein (FLP) is conserved in Plasmodium but also other apicomplexans. Evidence from 
our laboratory shows that P. falciparum FLP might be a promising immune target [161]. 
Transcripts of flp are highly upregulated in irradiated sporozoites used for vaccination (Frank et 
al., unpublished) and antibodies from malaria semi-immune adults bind to FLP (Heiss et al., 
unpublished). 
In this study, we focused on FLP function in the murine malaria parasite 
Plasmodium berghei. Function of ferlins in unicellular organisms is completely unknown. Our 
three main aims were to investigate expression during the life cycle, localization in the parasite 
and depletion phenotype.  
Preliminary data from our laboratory showed that FLP interacted in the yeast-two-hybrid system 
with UIS4, a liver-specific PVM-resident protein (Sabine Fraschka, master thesis). Based on this 
data, we expected to detect flp expression during the liver stage and potentially localizing to the 
PVM.  PVM is a highly dynamic structure [173] and in order to capture the dynamics of FLP 
localization, our main aim was to tag it fluorescently for in vivo imaging. Christina Schulte-Huxel 
(master thesis) and Roland Frank (unpublished) made the first attempts to knock flp out. Their 
attempts were not successful, indicating that FLP might play an essential role during the asexual 
blood stage (the only permissive stage for transgenic manipulations). Based on this evidence, we 
planned several parallel approaches to deplete FLP, namely gene knock-out, protein truncation, 
conditional knock down and promoter swapping. 
3.1 Expression and localization study 
An important question when studying a protein from a parasite with a complex life cycle is the 
identification of stages of interest for the study. We aimed at analysing the expression profile of 
flp during the life cycle on both the transcript (chapter 3.1.1) and protein levels (chapters 3.1.2 
and 3.1.4). Important hints for studying a gene function can be gained from its subcellular 
localization. In order to analyse localization of FLP during the parasite life cycle, we set out two 
aims, preparation of polyclonal antibody targeting the protein directly (chapter 3.1.2) and 
endogenous fusion of the protein to a tag (chapters 3.1.3 and 3.1.4).  
3.1.1 Transcriptional profiling 
To gain an idea about flp expression dynamics during the parasite life cycle, we isolated RNA from 
accessible life cycle stages and used quantitative PCR (qPCR) to assess flp transcript abundance. 
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Ferlin, the second member of the ferlin protein family in P. berghei, is topologically highly similar 
to FLP and might therefore fulfil redundant functions. To gain a full picture about ferlin family 
transcriptional levels, we also analysed ferlin transcript abundance. The profile (Fig. 3.1) revealed 
that both genes are expressed in relatively high levels during the asexual blood stages. 
Interestingly, flp but not ferlin transcription peaks during the gametocyte stage. Mosquito stages 
have rather low flp transcript levels, suggesting that the gene does likely not play a role during 
parasite development in the vector, while ferlin transcripts were present. In contrast, the liver 
stage, especially at later time points of intrahepatic development, shows highly abundant flp and 
ferlin levels. This indicates that both flp and ferlin are functionally involved during the asexual 
blood stages, which is in agreement with our own data (chapter 3.2.1) and a recent screening of 
P. berghei genes [174]. Additionally, the profile identifies the gametocyte and liver stages for 
possible flp functional role. 
 
 
Figure 3.1 Transcriptional profile of flp and ferlin during the parasite life cycle. Transcripts of both 
genes are detected in asexual blood stages and liver stages. Flp transcription peaks in the 
gametocyte stage. Ferlin is additionally detected in mosquito stages. RNA was isolated from 
accessible life cycle stages, retro-transcribed into cDNA and used for qPCR. Liver stages were 
cultured in vitro (HuH7 cells). HOP was used as housekeeping gene for all stages (dashed line). 
Profiles were calculated using comparative Ct method. Pooled results from 3 biological replicates 
are plotted as mean ± SEM. 
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3.1.2 Preparation of antibody 
Although the transcriptional profiling was useful for the identification of stages of interest for the 
flp study, post-transcriptional and translational regulations can lead to discrepancies in transcript 
and protein abundance. Also, assessing localization, which can reveal important hints regarding 
protein function, is dependent on protein visualization. We first aimed at visualizing FLP with a 
polyclonal antibody directed against recombinantly expressed parts of FLP in E. coli. 
Being a large transmembrane protein, the entire FLP sequence is very challenging to be cloned 
and expressed recombinantly. Instead, together with Marcel Deponte, we designed four 
fragments based on structural predictions within the FLP sequence (Fig. 3.2A). The fragments 
Figure 3.2 Recombinant proteins based on FLP parts are not soluble. A) Schematic of FLP topology 
with marked fragments designed for recombinant expression in E. coli. B) His-tag detection of 
recombinant proteins (Ab2 – 38.95 kDa, arrow and Ab4 – 15.4 kDa, arrowhead) in a Western blot of 
bacterial lysates generated with standard lysis buffers. Recombinant proteins can mostly be detected 
in the insoluble (pellet, P) fraction. S = soluble fraction of the lysate, LB = bacteria directly lysed in 
Laemmli buffer, NI = not induced control bacteria. C) His-tag detection of recombinant protein (Ab2 
– 38.95 kDa, arrow) in a Western blot of bacterial lysates generated with a panel of lysis buffers. 
Recombinant protein can only be detected in the insoluble fractions (pellet, P). S = soluble fraction 
of the lysate, LB = bacteria directly lysed in Laemmli buffer.  
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length ranging from 429 to 1236 bp seemed suitable for cloning and expression. Fragments Ab1, 
Ab2 and Ab4 were PCR amplified from genomic DNA and successfully cloned into pET28a vector, 
which allows for fusion to a cleavable N-terminal His tag. Fragment Ab3 corresponds to an flp 
region, which harbours an intron (Fig. 3.2A). Attempts to PCR amplify this fragment from cDNA 
were not successful. The three plasmids were transfected into the BL21DE bacteria, which express 
recombinant proteins upon IPTG induction. Expression of fragments Ab2 and Ab4 was detected 
using the anti-His tag antibody (Fig. 3.2B), while fragment Ab1 expression was not detected (data 
not shown). Using the standard lysis conditions, almost all the recombinant protein was detected 
in the insoluble part of the lysate (Fig. 3.2). We tried to optimize several conditions including the 
IPTG concentration or incubation temperature during expression. We also designed four 
alternative lysis buffers in order to optimize solubilization of the recombinant protein. Neither of 
the optimization, however, led to solubilization of the recombinant protein (Fig. 3.2.C and data 
not shown). 
3.1.3 Fluorescent tagging 
An alternative approach for protein visualization is a fusion of the protein of interest to a tag, 
which can be visualized. In order to minimize the risk of artefacts, we used endogenous tagging of 
FLP and maintained expression of the fusion protein under the endogenous promoter. Other ferlin 
homologues typically act in membrane rearrangements [112,119,123,125,149,151]. To make in 
vivo tracking of FLP in similar highly dynamic processes possible, we used fluorescent tagging in 
our initial approach.  
3.1.3.1 flp::gfp parasite line 
The first method of choice for fluorescent protein tagging is usually C-terminal endogenous fusion 
to a GFP tag. We constructed a vector for double-crossover homologous recombination strategy 
for fusion of gfp to the 3’end of flp (Fig. 3.3A). Two independent transfections did not result in any 
detectable integration of the vector as shown by PCR genotyping (Fig. 3.3B). The lack of integration 
can be explained by interference of the fusion with FLP function during the asexual blood stage 
cycle, by a non-permissible flp locus for genetic manipulation or by technical issues. 
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3.1.3.2 gfp::flp parasite line 
Our next attempt to fluorescently tag FLP targeted the N-terminus of the protein. We prepared a 
vector for single-crossover strategy that introduced the gfp tag at the 5’end of the flp gene along 
with the flp promoter (Fig. 3.4A). Successful integration introduced the gfp tag and an HA tag (not 
depicted in the scheme) in front of the flp gene (Fig 3.4B). Analysis of cDNA from the parasite 
confirmed that the gfp::flp fusion gene was transcribed (Fig. 3.4C).  
   
Figure 3.3 flp is refractory to endogenous C-terminal tagging with gfp. A) Double-crossover 
strategy was used to target the flp locus for homologous recombination. After successful 
integration, flp sequence lacks the stop codon and is fused to gfp sequence (which lacks the 
start codon). Primers used for genotyping bind to sites indicated by arrows. All primer 
sequences are listed in chapter 2.1.6.2.  B) Genotyping with PCR shows that WT locus was 
maintained in two independently-generated parental lines (P1 and P2) and no integration 
was observed. Vector used for transfection (V), wildtype parasites (WT) and water (H
2
O) 
were used as controls.    
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Using the C1 line, we detected the fusion protein at the expected size of 211kDa on Western blot 
of mixed blood stages with anti-HA antibody, although we were not able to detect it in the same 
sample with GFP antibody (Fig. 3.5A). Only background fluorescence was detected live in the 
gfp::flp parasites (data not shown) as well as after fixation and staining with anti -GFP antibody 
(Fig. 3.5B). Interestingly, gfp::flp parasites failed to transmit to Anopheles mosquitoes, with 
extremely limited numbers of midgut sporozoites and no salivary gland sporozoites observed (Fig. 
3.5C). After closer examination, we identified the transmission failure as an impaired gametocyte 
egress phenotype (Fig. 3.5D) with activated gametocyte trapped inside the host red blood cell and 
sterile. This phenotype will be further discussed in chapter 3.3. The protein fusion had a 
detrimental impact on the parasite viability in the host-to-vector transmission with no obvious 
Figure 3.4 Endogenous N-terminal tagging of flp with gfp. A) Single-crossover strategy was used to 
target the flp locus. After successful integration, flp sequence lacks the start codon and is fused to 
gfp sequence (which lacks the stop codon) at the 5’ end. Primers used for genotyping bind to sites 
indicated by arrows. All primer sequences are listed in chapter 2.1.6.2. B) Genotyping with PCR 
shows that four out of five clonal lines (C1 – C3 and C5) completely lack the wildtype locus and 
successfully integrated the vector. Vector used for transfection (V), wildtype parasites (WT) and 
water (H
2
O) were used as controls. C) PCR using cDNA from two clones (C1 and C3) shows that both 
parasite lines synthesize the fusion transcript. cDNA and gDNA from wildtype parasites (WT) and 
water (H
2
O) were used as controls.    
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effect in the asexual stage. However, the high risk that the fusion protein is not properly localized 
and/or expressed made us stop the analysis of this line. 
 
Figure 3.5 gfp::flp parasites arrest at the host-to-vector transmission. A) GFP::FLP fusion protein 
cannot be detected on Western blot with the anti-GFP antibody, but is detected with the anti-HA 
antibody at the expected size (211 kDa) in the clonal gfp::flp line (C1 and C3). Schizonts were lysed in 
RIPA buffer and loaded on a gradient BisTris gel. flp::HA schizonts (PC, 186 kDa, chapter 3.1.4.1) and 
wildtype schizonts (WT) were used as controls. HSP70 was used as a loading control. B) GFP::FLP fusion 
protein cannot be detected with anti-GFP antibody in fixed mixed blood stages. Parasites were fixed 
in 4% PFA/PBS and stained for GFP (green). DNA was stained with Hoechst (blue). Confocal images, 
scale bar 5 µm. C) gfp::flp parasites do not develop after transmission to the mosquito vector. Only 
very limited numbers of sporozoites were observed in the midguts (14 days post feed) and no 
sporozoites were observed in the salivary glands (17-21 days post feed). n represents number of 
mosquitoes analysed. D) gfp::flp gametocytes fail to egress from the red blood cell after gametocyte 
activation, resulting in aberrant exflagellation with bundled flagella. Gametocytes were activated by 
drop in temperature on a glass slides and imaged live. Wide field images, scale bar 5 µm. 
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3.1.3.3 flp::iLOV parasite line 
The flp gene function has proven to be very sensitive for tagging of the gene with gfp from both 
the 5’ and 3’ ends. Given the advantage of fluorescent tagging for in vivo tracking of the protein 
dynamics, we designed a third strategy for FLP fluorescent tagging. We tagged FLP C-terminally 
with a small fluorescent protein iLOV. iLOV is a relatively novel and seldom used fluorescent 
protein of only 10 kDa (less than half of the size of GFP), which outperforms GFP in stability and 
other aspects [167]. We used intermediate tagging vector from PlasmoGEM [171,172] for 
insertion of the iLOV tagging cassette via Gateway cloning. Resulting vector was used to target the 
flp locus via double-crossover strategy homologous recombination and endogenously insert the 
Figure 3.6 Endogenous C-terminal tagging of flp with iLOV. A) Double-crossover strategy 
(PlasmoGEM vector) was used to target the flp locus. After successful integration, flp sequence 
lacks the stop codon and is fused to iLOV sequence (which lacks the start codon) at the 3’ end. 
Primers used for genotyping bind to sites indicated by arrows. All primer sequences are listed in 
chapter 2.1.6.2. B) Genotyping with PCR shows successful integration in the parental line (P). Both 
clonal lines (C1, C2) lack the wildtype locus and successfully integrated the vector. Vector used for 
transfection (V), wildtype parasites (WT) and water (H
2
O) were used as controls. C) PCR using cDNA 
from the clones (C1 and C2) shows that both parasite lines synthesize the fusion transcript 
(transcript is shorter due to the presence of 100bp transcript at the 3’end of the gene). cDNA and 
gDNA from parental line (P) and wildtype parasites (WT), cDNA synthesized without reverse 
transcriptase (RT) and water (H
2
O) were used as controls.    
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iLOV tag (Fig. 3.6A). Successful integration in the parental and two clonal lines was confirmed by 
PCR (Fig. 3.6B) as well as production of flp::iLOV fusion transcript (Fig. 3.6C) by the parasite. 
 
 
Figure 3.7 flp::iLOV parasites arrest at the host-to-vector transmission. A) A band corresponding to 
the FLP::iLOV fusion protein (190 kDa) can be detected on Western blot with the iLOV antibody. 
However, given the low specificity of the antibody, this result should be considered with caution. 
Mixed blood stages were lysed in RIPA buffer and loaded on a gradient BisTris gel. Wildtype parasites 
(WT) were used as a control. HSP70 was used as a loading control. B) flp::iLOV parasites do not develop 
beyond the gametocyte stage in vitro nor in vivo. No ookinetes were observed in three independent 
cultures set up with flp::iLOV parasites. No flp::iLOV ookinetes were observed in midguts 20 hours 
after transmission to the mosquito vector. In agreement with that, no further developmental stages 
were observed either, specifically oocysts (10-14 days post feed) midgut sporozoites (Mid. spz 14 days 
post feed) and salivary gland sporozoites (Sal. gl. spz, 17-21 days post feed). C) flp::iLOV gametocytes 
fail to egress from the red blood cell after gametocyte activation, resulting in aberrant exflagellation 
with bundled flagella. Gametocytes were activated by drop in temperature on a glass slides and 
imaged live. Wide field images, scale bar 5 µm. 
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Using the clonal line, we were not able to detect a fluorescent signal in the flp::iLOV live parasites  
(data not shown). Flavin monophosphate (FMN) is a cofactor of flavin-based fluorescent proteins 
like iLOV [175]. Since the natural FMN concentration in the parasite is not known, we 
supplemented infected mice with riboflavin (a precursor of FMN) in the drinking water. However, 
despite this optimization, no fluorescent signal was detected (data not shown). Analysis of 
flp::iLOV parasite lysates on Western blot revealed a band at the expected size of 190 kDa (Fig. 
3.7A). However, considering the high number of unspecific bands, this result has to be considered 
with caution. Interestingly, similarly to the gfp::flp parasite line, flp::iLOV parasites were not able 
to transmit to the mosquito vector due to an egress impairment during gametogenesis (Fig. 3.7.B 
and C). Unlike the gfp::flp line, flp::iLOV parasites arrested completely at the gametocyte stage 
with no ookinetes, oocysts or sporozoites observed in vitro or in vivo (Fig. 3.7B). This indicates that 
the smaller fluorescent tag at the C-terminus does not interfere with FLP function in the asexual 
blood cycle, but still hampers the function necessary for gamete egress. 
3.1.4 Tagging with a small tag 
Since even one of the smallest fluorescent tags interfered with the protein function, we decided 
to use fusion with a non-fluorescent small tag in order to visualize FLP. 
3.1.4.1 flp::HA parasite line 
We used final tagging vector from PlasmoGEM [171,172] for C-terminal tagging of FLP with a triple 
HA-tag. PlasmoGEM vectors, apart from their high efficiency, offer the possibility to recycle the 
selection cassette via 5’ fluorocytosine selection (Fig. 3.8A) [169]. Vectors have successfully 
integrated via double-crossover strategy and no wildtype locus was observed in the clonal lines 
based both on PbANKA (flp::HA, Fig. 3.8B) and 820cl1m1cl1 (flp::HA820, Fig. 3.8C) backgrounds. 
Using the 5’fluorocytosine selection, we obtained clonal lines that recycled the selection cassette 
(Fig. 3.8B and C) and were therefore available for further modifications. 
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Using the flp::HA recycled clonal line, we detected the fusion protein of expected size on a 
Western blot of the schizont-enriched and gametocyte-enriched samples (Fig. 3.9A). This 
expression matched the transcriptional data from chapter 3.1.1. Using immunofluorescent 
Figure 3.8 Endogenous C-terminal tagging of flp with HA tag. A) Double-crossover strategy 
(PlasmoGEM vector) was used to target the flp locus. After successful integration, flp sequence 
lacks the stop codon and is fused to triple HA tag at the 3’ end. Duplicated 3’UTR of dhfr can be 
used for recycling of the selection cassette using 5’ fluorocytosine selection. Primers used for 
genotyping bind to sites indicated by arrows. All primer sequences are listed in chapter 2.1.6.2.  B) 
Transfection into PbANKA background. Genotyping with PCR shows successful integration of the 
vector and lack of the wildtype locus in the clonal (C) and recycled (R) lines. Recycled line has 
additionally lost the selection cassette. Vector used for transfection (V), wildtype parasites (WT) 
and water (H
2
O) were used as controls. C) Transfection into 820cl1m1cl1 line. Genotyping with PCR 
shows successful integration of the vector and lack of the wildtype locus in the clonal (C) and 
recycled (R) lines. Recycled line has additionally lost the selection cassette. Vector used for 
transfection (V), wildtype parasites (WT, line 820cl1m1cl1) and water (H
2
O) were used as controls. 
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staining, we detected the FLP::HA fusion protein in schizonts and gametocytes. In both cases, the 
signal showed speckled pattern distributed randomly in the cytoplasm (Fig. 3.9B). This pattern is 
typical for localization into vesicles, which is in agreement with localization of other ferlin 
orthologues [123,125,133,153]. In the gametocyte stage, egress vesicles carry proteases and other 
proteins necessary for the gametocyte egress [57–62,64]. A typical feature of egress vesicles is the 
relocalization to the cell periphery after gametocyte activation. Interestingly, after gametocyte 
activation, FLP::HA-labelled vesicles localized to the cell periphery (Fig. 39B), suggesting a role for 
these vesicles in egress.  
 
  
Figure 3.9 FLP::HA is expressed in asexual and sexual blood stages. A) FLP::HA fusion protein 
can be detected by Western blot with the anti-HA antibody at the expected size (186 kDa) in 
the schizont- (SCHI) and gametocyte- (GAM) enriched blood stage samples of the clonal 
recycled flp::HA line (R). Parasites were lysed in RIPA buffer and loaded on a gradient BisTris 
gel. Wildtype parasites (WT) were used as control. HSP70 was used as a loading control. B) 
FLP::HA fusion protein can be detected with HA antibody in fixed schizonts, gametocytes and 
activated gametes. Parasites were fixed in 4% PFA/PBS and stained for HA (green). To obtain 
activated gametes, gametocytes were incubated in ookinete medium at room temperature for 
15 minutes prior to fixation. DNA was stained with Hoechst (blue). Confocal images, scale bar 
5 µm.  
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Figure 3.10 flp::HA parasites progress through life cycle despite minor gametocyte egress and 
liver development impairments. A) Similarly to gfp::flp and flp::iLOV, flp::HA gametocytes 
transiently fail to egress from the RBC after gametocyte activation, resulting in aberrant 
exflagellation with bundled flagella. Observed phenotype was ranging from bundled flagella (upper 
panel, prominent at early time points after activation) to free flagella (lower panel, predominant 
at later time points). Gametocytes were activated by drop in temperature on a glass slides and 
imaged live. Wide field images, scale bar 5 µm. B) flp::HA parasites produce reduced numbers of 
both midgut sporozoites (Mid. spz 14 days post feed) and salivary gland sporozoites (Sal. gl. spz, 
17-21 days post feed). n represents number of mosquitoes analysed. ND = not determined C) 
flp::HA sporozoites show no significant impairment in gliding compared to wildtype sporozoites. 
Isolated sporozoites were allowed to glide on a glass slide for 30 minutes and their trails were 
stained with antibodies and quantified. Data are pooled from 2 biological replicates as mean ± 
SEM. D) Liver stages of flp::HA cultured in vitro (using HuH7 cells) are significantly smaller than 
wildtype and show tendency to slightly lower numbers. Data pooled from 2 independent 
experiments are plotted as mean ± SEM. Statistical analysis: t-test. E) C57BL/6 mice (n = 3) injected 
intravenously with 10 000 flp::HA sporozoites show similar parasitaemia curve as wildtype 
sporozoite-injected mice. Parasitaemia was followed by daily Giemsa smears until day 8 post 
injection (when wildtype controls died of ECM). Data are plotted as mean ± SEM. 
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Given the obvious interference of fluorescent tags fused to the C-terminus with FLP function with 
the asexual development (chapter 3.1.3.1) and gametocyte egress (chapter 3.1.3.3), we were 
wondering if the HA tag had any negative impact on FLP (the triple HA tag adds about 8kDa to the 
protein size, only 2 kDa less than iLOV). We first examined the male exflagellation by microscopy. 
Indeed, exflagellating flp::HA gametes showed an intermediate phenotype (Fig. 3.10A) with some 
gametes with bundled flagella (where egress did not proceed normally, present mainly at early 
timepoints after activation) and some gametes with free flagella (predominant at later time 
points). This moderate egress impairment was mostly transient, as bundling of flagella became 
scarce at later time points (a phenomenon never observed in the case of gfp::flp and flp::iLOV 
lines). This egress delay translated into reduced sporozoite numbers during the mosquito 
development (Fig. 3.10B). The flp::HA sporozoites showed no defect in gliding (Fig. 3.10C). In vitro 
liver stage development revealed a reduction in numbers of flp::HA parasites at 48 hpi (Fig. 3.10D) 
and a moderate reduction in liver stage sizes at both 24 hpi and 48 hpi (3.10D). However, this mild 
phenotype observed in vitro did not correspond to the in vivo situation. C57BL/6 mice injected 
with flp::HA sporozoites showed prepatency and parasite growth in the blood comparable to 
wildtype parasites (Fig. 3.10E). Altogether, tagging of the C-terminus of FLP does interfere with 
FLP function. However, this interference is dependent on the size of the used tag with the 8 kDa 
HA tag leaving only very minor damage to the parasite.  
3.1.4.1.1 flp::HA820 parasite line 
The abundance of FLP in gametocytes on both the transcript (Fig. 3.1) and protein (Fig. 3.9) levels 
made us wonder about sex-specific expression and localization. In order to study the FLP 
specifically in male and female gametocytes, respectively, we generated the flp::HA820 line. This 
line is based on the parental 820cl1m1cl1 line, which expresses fluorescent markers (RFP and GFP) 
under sex-specific promoters, allowing to distinguish the two gametocyte sexes [61]. We obtained 
a clonal line and recycled the selection cassette (Fig. 3.8C). Gametocytes of the flp::HA820 line were 
fixed and stained with anti-HA antibody and a secondary antibody with Alexa 488 or 546 (selected 
not to overlap with the gender-specific marker of the gender analysed). Both male and female 
gametocyte showed similar levels and localization pattern of FLP::HA (Fig. 3.11), indicating that 
the protein plays a gender-independent function in the gametocyte stage. 
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3.1.5 3’ RACE 
The sensitivity of flp to tagging made us wonder about the correct annotation of the gene. The 
sequence of flp contains two introns near the 3’end end of the sequence (Fig. 3.12A). Additionally, 
downstream, very close to the 3’ end of flp, another gene is located on the complementary strand, 
with overlapping 3’UTR with flp. In case flp was spliced in a different manner than had been 
predicted or if alternative splicing was present, we may have altered flp expression by fusing a C-
terminal tag to the incorrect end of the sequence. We used 3’RACE to check the sequence of flp 
transcript, including the splicing of introns. Given the restriction of the flp::iLOV phenotype to the 
gametocyte stage, we analysed both the asexual blood stage and gametocyte-enriched samples 
to account for stage-specific differences. Isolated RNA was used for cDNA synthesis with a polyT 
primer and a gene specific primer annealing upstream of the two introns (Fig. 3.12A). To enhance 
specificity, we performed a nested PCR using a primer annealing to an adapter within the polyT 
primer and a gene specific primer annealing in between the two introns (Fig. 3.12A). The resulting 
Figure 3.11 FLP::HA is expressed and localized equally in male and female gametocytes. FLP::HA 
fusion protein can be detected with anti-HA antibody in fixed male gametocytes (distinguished by 
expression of GFP marker in green) and female gametocytes (distinguished by expression of RFP 
marker in red) of the recycled flp::HA820 line (R). Gametocytes of the line 820cl1m1cl1 (WT) were used 
as negative controls. Gametocytes were fixed in 4% PFA/PBS and stained for HA (red or green). DNA 
was stained with Hoechst (blue). Confocal images, scale bar 5 µm.  
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bands showed similar pattern for both the mixed blood stages and gametocyte-enriched samples 
(Fig. 3.12B) and indicated that the polyA signal was located about 100 bp downstream from the 
stop codon. Four bands were isolated from the gel and cloned into pGEM vector and subsequently 
sequenced. All samples confirmed the correct splicing of both introns in the way the gene is 
annotated in PlasmoDB and the presence of polyA signal at position 118 downstream of the gene 
(data not shown). This indicates that sensitivity of FLP for tagging is likely not originating from 
transcriptional aberrations.  
 
 
3.2 Phenotype analysis of transgenic parasites with altered flp 
expression 
3.2.1 Knock-out 
Knock-out (KO) is the first method of choice for functional studies in Plasmodium. In P. berghei 
about 45 % of genes were shown to be essential (during the asexual blood stage), a very high 
proportion compared to other organisms [174]. Approaches for studying essential genes in 
Plasmodium are still rather scarce but development of new methods is rapidly increasing. 
Figure 3.12 3’RACE shows that flp transcript is spliced as annotated. A) 3’ end of flp contains two 
annotated introns. Primers annealing upstream of the introns and in between them in combination 
with polyT and adapter primers, respectively, were used for 3’RACE. All primer sequences are listed 
in chapter 2.1.6.2. B) PCR products are approximately 100 bp longer than the expected size until 
the stop codon, indicating that the polyA signal is located that far downstream of the stop codon. 
Both mixed blood stages (MBS) and gametocyte (GAM) band patterns look alike.   
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3.2.1.1 Δflp parasite line 
Figure 3.13 The flp locus is refractory to deletion. A) Double-crossover strategy (PlasmoGEM 
vector) was used to target the flp locus. After successful integration, most of the flp sequence is 
deleted. Primers used for genotyping bind to sites indicated by arrows. All primer sequences are 
listed in chapter 2.1.6.2.  B) Genotyping with PCR shows successful integration in parental lines (P1-
P2) and two out of nine clonal lines (C2, C4). None of the parasite population lacks the wildtype 
locus. Vector used for transfection (V), wildtype parasites (WT) and water (H
2
O) were used as 
controls. C) Genotyping with PCR shows that not only the parasites under continuous drug pressure 
(clonal line C2, transfer parasites T and drug-selected parasites D+) but also parasites grown for 
over one week with no drug pressure (D-) kept both the integration and the wildtype loci. Vector 
used for transfection (V), wildtype parasites (WT) and water (H
2
O) were used as controls. D) 
Genotyping with PCR shows that not only the parasites under continuous drug pressure (clonal line 
C2 and drug-selected parasites D+) but also parasites grown for over one week with no drug 
pressure (D-) kept both the integration locus expanding almost 8 kb upstream and 3 kb 
downstream of the selection cassette along with the wildtype locus expanding 8 kb upstream and 
over 3 kb downstream from the flp gene. Vector used for transfection (V), wildtype parasites (WT) 
and water (H
2
O) were used as controls. 
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We used a final KO vector from PlasmoGEM [171,172] to generate Δflp parasites (Fig. 3.13A). 
Although the vector has integrated successfully in two parental lines (P1 and P2) and also in two 
lines obtained after limiting dilution (referred to as clonal lines, C2 and C4), these parasites never 
lost the wildtype locus (Fig. 3.13B). This indicated that disruption of the flp locus was not viable 
for the parasites and that FLP likely played indispensable function during the asexual blood stage 
cycle. This result was recently confirmed by a high-throughput screen of PlasmoGEM knock-out 
vectors, in which flp was classified as an essential gene [174]. 
Interestingly, two clonal lines (C2 and C4) did harbour the integration locus along with the wildtype 
locus (Fig. 3.13B). This might be explained by co-existence of wildtype parasite population along 
with the Δflp parasite population (maintained by the selection pressure of Pyrimethamine) and 
potentially their mutual help in survival. During the limiting dilutions, however, parasites are not 
exposed to the drug pressure and it was therefore unclear how the Δflp population would have 
been maintained. To test whether the integration and wildtype signals originated from different 
parasite populations or rather from parasites harbouring the two loci in a single genome, we first 
tested growth for extended time period (over a week) with and without drug pressure. 
Surprisingly, both populations identically maintained the integration signal along with the 
wildtype one (Fig. 3.13C). This strongly argues against co-existence of two parasite populations 
and suggests a duplication of the flp locus (one remaining intact and the other one integrating the 
vector) in the parasite genome. To get a better idea about the potential duplication, we genotyped 
the integration and wildtype loci with primers annealing further upstream and downstream from 
the flp locus. Both wildtype and integration loci extending further up- and downstream were 
detected by PCR (Fig. 3.13D), indicating that if part of the genome has duplicated, this sequence 
must have covered over 12 kb. 
3.2.2 Truncation of terminal domains 
flp is refractory to gene deletion as well as to tagging with large proteins. From the phenotypes 
caused by the deletion and tagging, it became clear that FLP fulfils functions both in the asexual 
and sexual blood stages. To shed more light on which parts of the protein are indispensable for 
these functions, we deleted N- and C-terminal domains of the protein, respectively. We chose the 
terminal domains for technical reasons as well as for their assumed functional importance.  
3.2.2.1 ΔflpC2A parasite line 
The first C2 domain (C2A) was shown to carry the main functional role in many ferlins [113]. We 
used a single cross-over strategy to delete the C2A domain of FLP, while keeping the partially 
overlapping FerI domain intact, reintroducing the start codon and the flp promoter (Fig. 3.14A). 
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Although the transfected parasites (parental line, P) showed weak positive signal for integration, 
this integration was lost after limiting dilution with all clonal lines (C1 – C6) only containing the 
wildtype flp locus (Fig. 3.14B). An independent second transfection resulted in an identical result 
(data not shown). This indicates that the C2A domain of FLP is necessary for the asexual blood 
stage cycle and probably fulfils an indispensable role. 
 
 
3.2.2.2 ΔflpTM parasite line 
Truncation of the transmembrane domain (TM) might lead to mislocalization of FLP and 
potentially interfere with its function. We used a double-crossover strategy to delete the C-
terminal TM domain, reintroduce the stop codon and 3’UTR of dhfr (3.15A). Despite two 
independent transfections (and two additional ones with b3D.DT^H.^D vector backbone, data not 
shown) we did not observe any integration of the vector into the transfected parasites’ genome 
(3.15B). This indicates that deletion of FLP TM domain is lethal for the parasite. This data, together 
Figure 3.14 flp is refractory to deletion of the N-terminal C2 domain. A) Single-crossover strategy 
was used to target the flp locus. After successful integration, flp sequence lacks the N-terminal C2 
domain and a new start codon is introduced. Primers used for genotyping bind to sites indicated by 
arrows. All primer sequences are listed in chapter 2.1.6.2. B) Genotyping with PCR shows that WT 
locus was maintained in the parental (P) as well as in clonal lines (C1 – C6). Weak integration-
specific bands were observed in the parental line but were lost from all the clonal lines. Vector used 
for transfection (V), wildtype parasites (WT) and water (H
2
O) were used as controls.    
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with no integration yielded for flp::gfp line (chapter 3.1.3.1), suggest that the C-terminal part of 
FLP is especially highly sensitive to genetic manipulations.  
 
 
3.2.3 Auxin-inducible degron system 
About 45 % of genes in Plasmodium berghei are essential for the blood stage [174], leaving them 
inapproachable by knock-out studies. To address function of these proteins, several fast-acting 
inducible systems were developed in the recent years [176]. These systems are typically based on 
the use of small molecules and target the gene expression either at the transcript (glms system 
[177]) or at the protein level (de)stabilization (DD-domain [178] or auxin-inducible degron system, 
AID). The AID system exploits plant proteins, expressing transgenic SCF complex (Skp1, Cullin 1 
Figure 3.15 flp is refractory to deletion of C-terminal transmembrane domain. A) Double-crossover 
strategy was used to target the flp locus. After successful integration, flp sequence lacks the C-
terminal transmembrane domain and a new stop codon is introduced. Primers used for genotyping 
bind to sites indicated by arrows. All primer sequences are listed in chapter 2.1.6.2. B) Genotyping 
with PCR shows that WT locus was maintained in two independently-generated parental lines (P1 
and P2) and no integration was observed. Vector used for transfection (V), wildtype parasites (WT) 
and water (H
2
O) were used as controls.    
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and F box protein ubiquitin ligase) and an F box protein TIR1. In this background, the protein of 
interest is tagged C-terminally with auxin-inducible degron (AID). Upon addition of auxin, TIR1 
recruits the tagged protein for ubiquitination by SCF and subsequent degradation by proteasome 
[179]. The system was recently adapted for P. berghei and showed promising results in depletion 
of calcineurin, an essential gene [103]. 
3.2.3.1 flp::AID parasite line 
We used the AID system to address FLP function by rapid depletion during the asexual blood stage 
and beyond. The PbANKA-based transgenic line expressing SCF and TIR1 as well as the backbone 
plasmid for AID tagging was a kind gift from Nisha Philip and Andrew Waters. We used double-
crossover strategy to tag flp with AID endogenously (Fig. 3.16A). After transfection, no integration 
of the vector, only the wildtype locus and episome were detected (Fig. 3.16B). This was 
Figure 3.16 flp is refractory to endogenous C-terminal tagging with AID tag. A) Double-crossover 
strategy was used to target the flp locus. After successful integration, flp sequence lacks the stop 
codon and is fused to AID sequence (which lacks the start codon). Primers used for genotyping bind 
to sites indicated by arrows. All primer sequences are listed in chapter 2.1.6.2. B) Genotyping with 
PCR shows that wildtype locus along with the episome were maintained in the parental line (P) and 
no integration was observed. Vector used for transfection (V), wildtype parasites (WT) and water 
(H
2
O) were used as controls.    
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reminiscent of the transfection result for C-terminal GFP tagging (chapter 3.1.3.1), where no 
integration was observed either. Given the large size of the tag (27.7 kDa), comparable to the GFP 
size, it seems likely that the AID tag interferes with FLP function. 
3.2.4 Promoter swapping 
Swapping of promoters can be used to study essential genes in other than the asexual blood stage. 
The exact promoter sequence as well as enhancer and silencer sequences are largely unknown in 
Plasmodium. However, using an assumed promoter (around 1.5 kb of 5’UTR) of a gene with a 
known transcription profile has been successfully used to change the transcriptional profile of 
genes of interest [49,60,180–182]. In this chapter, we used 5’ UTR regions of several genes and 
integrated them upstream of the flp gene (with added Kozak sequence in case this was not part 
of the sequence used). These sequences will be referred to as promoters. In all but one case their 
suitability for promoter swapping was reported previously. 
3.2.4.1 Δflpook parasite line 
Based on the transcriptional profile (chapter 3.1.1) the liver stage was of primary importance for 
the functional study of FLP. The promoter of ama1 was the first one used for promoter swapping 
and therefore its sequence suitable for swapping was known. The promoter was previously used 
to shut down expression during the ookinete stage [180]. Based on the transcriptional profile (Fig. 
3.1), depletion in ookinete stage should not have any effect on flp as its transcription is extremely 
low in this stage. ama1 expression is also undetectable during the early liver stage [183], we 
therefore used this promoter to address flp function during the liver stage. We used a single cross-
over strategy to exchange the endogenous flp with the ama1 promoter (Fig. 3.17A). After 
successful integration, flp was under the control of ama1 promoter (Fig. 3.17B) as shown by the 
altered flp transcription profile that resembled the one of ama1 (3.17C). This data set shows that 
the flp locus is suitable for promoter swapping and its transcription profile can be manipulated. 
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We were not able to observe any phenotype of the Δflpook clonal line distinct from the wildtype 
case in either sporozoite numbers, sporozoite gliding, invasion into hepatocytes and liver stage or 
blood stage development (Fig. 3.18). The reason for this might be residual expression of flp in the 
Δflpook early liver stage (Fig. 3.17C), which might be sufficient to maintain FLP function. At the same 
time, the transcription of flp peaks at late time points of the liver development, when ama1 
expression is on again and therefore also the Δflpook line expressed flp (Fig. 3.17C). 
 
Figure 3.17 flp under the control of ama1 promoter changes its transcriptional profile. A) Single-
crossover strategy was used to target the flp locus. After successful integration, flp promoter 
sequence is located further upstream and ama1 promoter is located in front of flp. Primers used for 
genotyping bind to sites indicated by arrows. All primer sequences are listed in chapter 2.1.6.2.  B) 
Genotyping with PCR shows that WT locus was maintained only in the parental lines (P1 - P2) but is 
not present in the clones (C1 – C5). Integration-specific bands were observed in the parental as well 
as clonal lines. Vector used for transfection (V), wildtype parasites (WT) and water (H
2
O) were used 
as controls. C) qPCR profiling shows that after the promoter exchange, flp transcriptional profile 
resembles the one of ama1. HOP was used as housekeeping gene for all stages (dashed line). Data 
were calculated using the comparative CT method. Data are plotted as mean ± SEM. 
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Figure 3.18 Δflpook parasites progress through life cycle with no significant difference compared to 
wildtype. A) Δflpook parasites produce comparable numbers of both midgut sporozoites (Mid. spz, 14 
days post feed) and salivary gland sporozoites (Sal. gl. spz, 17-21 days post feed) to wildtype. n 
represents number of female mosquitoes analysed. B) Sporozoites of the Δflpook line show no 
significant impairment in gliding compared to wildtype sporozoites. Isolated sporozoites were allowed 
to glide on a glass slide for 30 minutes and their trails were stained with antibodies and quantified. 
Data pooled from two experiments are plotted as mean ± SEM. C) Sporozoites of the Δflpook line show 
the same capacity to invade HuH7 cells in vitro as wildtype sporozoites. Sporozoites were allowed to 
invade for 2 hours, fixed, stained and invaded and non-invaded parasites were quantified. Data pooled 
from two experiments are plotted as mean ± SEM. D) Liver stages of Δflpook cultured in vitro (HuH7 
cells) are not different in numbers or sizes compared to wildtype. Data pooled from two experiments 
are plotted as mean ± SEM. E) C57BL/6 mice (n = 6) injected with 10 000 Δflpook sporozoites i.v. show 
similar parasitaemia curve as wildtype sporozoite-injected mice. Parasitaemia was followed by daily 
Giemsa smears. Pooled data are plotted as mean ± SEM. 
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3.2.4.2 Δflpspz parasite line 
Another promoter that had been used previously and had potential to be turned off during the 
liver stage is the ccp promoter. It was used to maintain expression in gametocyte and ookinete 
stages and shut it down during the sporozoite stage [60]. flp transcription seems rather low in the 
sporozoite stage (Fig. 3.1), so no phenotype was expected there. The ccp genes function 
specifically during the transmission to mosquito and their expression is very low in other stages 
[184], which makes them good candidates for liver stage depletion via promoter swapping.  We 
used a double cross-over strategy to exchange the endogenous flp promoter with ccp promoter 
(Fig. 3.19A). Although the integration of the vector was observed in the parental line, all the 
parasites obtained after limiting dilution maintained the wildtype flp locus (Fig. 3.19B). A similar 
result was obtained from another independent transfection (data not shown). After closer 
examination of the published transcriptional profile of ccp, it turned out that its expression during 
Figure 3.19 flp under the control of ccp promoter is lethal for the parasite. A) Double-crossover 
strategy was used to target the flp locus. After successful integration, flp promoter sequence is shifted 
further upstream and flp is under the control of ccp promoter. Primers used for genotyping bind to 
sites indicated by arrows. All primer sequences are listed in chapter 2.1.6.2. B) Genotyping with PCR 
shows that WT locus was maintained in the parental (P) as well as in clonal lines (C1 – C6). Weak 
integration-specific bands were observed in the parental line but were lost from all the clonal lines. 
Vector used for transfection (V), wildtype parasites (WT) and water (H
2
O) were used as controls.    
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asexual blood stages is very low [184]. The pat gene (used previously for the ccp promoter swap) 
[60] is not essential during the asexual blood stage and so the low expression did not affect the 
parasites. The lack of integration of this weak promoter further confirms the essentiality of FLP 
function during the asexual blood stage. 
3.2.4.3 Δflpliver parasite line 
 
 
Figure 3.20 PBANKA_062250 promoter is off in the liver but its activity is likely too low in the blood 
stage. A) qPCR profiling shows that out of four candidates, all are transcribed during blood and 
sporozoite stages. During the liver stage only PBANKA_062260 showed no detectable transcript. HOP 
was used as housekeeping gene for all stages (dashed line). Data were calculated using the 
comparative CT method. All primer sequences are listed in chapter 2.1.6.2.  B) RT-PCR profiling shows 
that out of four candidates, none is detectably transcribed during the liver stage. Three candidates 
show detectable transcription during the blood stage but only PBANKA_062260 showed detectable 
transcript in the mosquito stages. Aldolase was used as housekeeping gene for all stages. All primer 
sequences are listed in chapter 2.1.6.2. C) Double-crossover strategy was used to target the flp locus. 
After successful integration, flp promoter sequence is located further upstream and PBANKA_062260 
promoter is located in front of flp. Primers used for genotyping bind to sites indicated by arrows. All 
primer sequences are listed in chapter 2.1.6.2.  D) Genotyping with PCR shows integration-specific 
bands in both the parental (P) and clonal lines. Although the clonal lines show strong integration 
bands, all the lines maintained residual wildtype locus. Vector used for transfection (V), wildtype 
parasites (WT) and water (H
2
O) were used as controls. 
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After the failure of the two indirect approaches to deplete flp expression in the liver stage, we 
screened potential candidate genes, expression of which is maintained in the blood stage but 
shuts down during the liver stage. This is generally a rare expression profile given that the liver 
stage serves in many aspects as preparation for the blood stage cycle and to our knowledge, there 
are so far no genes with such profile described for P. berghei. We analysed a transcriptional 
screening performed in P. yoellii instead [162]. Searching for genes with the highest ratio between 
blood stage and liver stage transcription, we selected four candidates, which had known 
homologues in P. berghei and their 5’UTR was gene-free. We analysed the transcription profiles 
of the P. berghei homologues using qPCR (Fig. 3.20A) and RT-PCR (Fig. 3.20B). Based on strong 
transcription (detectable by RT-PCR) during the blood and sporozoite stages and lack of 
transcriptional activity in liver stages, we decided to use the promoter of PBANKA_062260.  
We used a double-crossover strategy to introduce the PBANKA_062260 promoter upstream of flp 
(Fig. 3.20C). Although both parental and clonal lines integrated the vector, none of the parasite 
populations was free of the wildtype flp locus (Fig. 3.20D). This is similar to Δflp integration, 
suggesting that the Δflpliver parasites are not viable in the asexual blood stage. This could be 
explained by low promoter activity (similarly to the ccp promoter, chapter 3.2.4.2). Transcription 
of flp and PBANKA_062260 in wildtype parasites were not compared directly but the normalized 
levels indicate about 100 times lower transcription activity for PBANKA_062260 compared to flp 
(Fig. 3.1 and 3.19A). 
3.2.4.4 Δflpgam parasite line 
Two indicators pointed towards functional involvement of FLP in the gametocyte stage. First, flp 
transcript and also the protein were abundant in the gametocyte stage (Fig. 3.1 and 3.9) and the 
protein localization changed during gametogenesis (Fig. 3.9). Second, tagging with GFP at the N-
terminus and iLOV at the C-terminus of FLP interfered with successful continuation of the life 
cycle.  
To study FLP function specifically during the gametocyte stage, we used promoter swapping 
strategy with the clag promoter. This promoter was repeatedly used previously for a similar 
purpose, hence its sequence and transcriptional profile was known [49,182,185]. We used a 
double-crossover strategy to exchange the endogenous flp promoter with the one of clag (Fig. 
3.21A). We have successfully generated a clonal line Δflpgam (Fig. 3.21B) and an independent clonal 
line (Fig. 3.21C) as well as a Δflpgam820 line in the 820cl1m1cl1 background (Fig. 3.21D, further used 
in chapter 3.3.2). We used qPCR to assess changes in flp transcriptional levels. Indeed, flp 
transcriptional profile in the Δflpgam line was altered and resembled the one of clag (Fig. 3.21E). 
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Figure 3.21 flp under the control of clag promoter changes transcriptional profile. A) Double-
crossover strategy was used to target the flp locus. After successful integration, flp promoter 
sequence is located further upstream and clag promoter is located in front of flp. Primers used for 
genotyping bind to sites indicated by arrows. All primer sequences are listed in chapter 2.1.6.2.  B) 
Genotyping with PCR shows that WT locus was maintained only in the parental line (P) and one 
clone (C6) but is not present in seven clones (C1 – C5 and C7 – C8). Integration-specific bands were 
observed in the parental and clonal lines. Vector used for transfection (V), wildtype parasites (WT) 
and water (H
2
O) were used as controls. C) Second independent clone was generated in PbANKA 
background. Genotyping with PCR shows that WT locus was maintained only in the parental line (P) 
but is not present in four clones (C1 – C4). Integration-specific bands were observed in the parental 
as well as clonal lines. Vector used for transfection (V), wildtype parasites (WT) and water (H
2
O) 
were used as controls. D) Third independent clone was generated in the 820cl1m1cl1 background. 
Genotyping with PCR shows that WT locus was maintained only in the parental line (P) but is not 
present in four clones (C1 – C5). Integration-specific bands were observed in the parental as well as 
clonal lines. Vector used for transfection (V), wildtype parasites (WT) and water (H
2
O) were used as 
controls. E) qPCR profiling shows that after the promoter exchange, flp transcriptional profile 
resembles the one of clag. HOP was used as housekeeping gene for all stages (dashed line). Data 
were calculated using the comparative CT method. All primer sequences are listed in chapter 2.1.6.2. 
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Transcript levels do not always correspond to protein levels. In order to see whether FLP was 
depleted in the Δflpgam gametocytes on the protein level, we generated Δflp::HAgam line, in which 
the flp promoter was exchanged with the clag promoter in the background of recycled flp::HA line 
(generated in chapter 3.1.4.1) (Fig. 3.22A). We obtained several clonal lines (Fig. 3.22B), in which 
flp expression was altered – the protein became highly abundant in the schizont stage and was 
absent in the gametocyte stage (Fig. 3.22C). 
 
 
Figure 3.22 flp under the control of clag promoter changes expression profile. A) Double-
crossover strategy was used to target the flp locus. After successful integration, flp promoter 
sequence is located further upstream and clag promoter is located in front of flp. Primers used for 
genotyping bind to sites indicated by arrows. All primer sequences are listed in chapter 2.1.6.2.  B) 
Genotyping with PCR shows that WT locus was maintained only in the parental lines (P1 – P2) but 
is not present in the clones (C1 – C3). Integration-specific bands were observed in the parental as 
well as clonal lines. Wildtype parasites (WT) and water (H
2
O) were used as controls. C) FLP::HA 
fusion protein can be detected with anti-HA antibody in fixed flp::HA schizonts, under the control 
of clag promoter the FLP::HA protein is much more abundant. In flp::HA gametocytes, the fusion 
protein FLP::HA protein can be readily detected but under the control of clag promoter expression 
is not detected. Parasites were fixed in 4% PFA/PBS and stained for HA (green). DNA was stained 
with Hoechst (blue).  Confocal images, scale bar 5 µm.  
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Having established the lines that lacked FLP in the gametocyte stage, the obvious question was 
whether these lines would show similar phenotype to gfp::flp and flp::iLOV. Indeed, a complete 
arrest of life cycle was observed both in vitro and after mosquito feeding (Fig. 3.23A). This 
Figure 3.23 Δflpgam parasites arrest at the host-to-vector transmission. A) Δflpgam parasites do not 
develop beyond the gametocyte stage in vitro nor in vivo. No ookinetes were observed in three 
independent cultures set up with Δflpgam parasites. No Δflpgam ookinetes were observed in midguts 
20 hours after transmission to the mosquito vector. In agreement with that, no further 
developmental stages were observed either, specifically oocysts (10-14 days post feed) midgut 
sporozoites (14 days post feed) and salivary gland sporozoites (17-21 days post feed). Data are 
pooled from three independent experiments and plotted as mean ± SEM. ND = not determined B) 
Similarly to gfp::flp and flp::iLOV, Δflpgam gametocytes fail to egress from the RBC after gametocyte 
activation, resulting in aberrant exflagellation with bundled flagella. Gametocytes were activated 
by drop in temperature on a glass slides and imaged live. Wide field images, scale bar 5 µm. C) 
Parasite growth and gametocytogenesis are comparable between wildtype and Δflpgam line. 
C57BL/6 mice (n = 3) were injected with 106 iRBCs i.v. and parasitaemia and gametocytemia were 
followed by daily Giemsa smears until day 12. Pooled data are plotted as mean ± SEM. 
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phenotype was again underlined by impaired exflagellation with bundled flagella (Fig. 3.23B). The 
highly upregulated expression of flp in the asexual blood stages of the Δflpgam line (Fig. 3.21E and 
3.22C) might affect parasite growth. We injected C57BL/6 mice with infected red blood cells 
(iRBCs) and followed parasitaemia and gametocytemia (Fig. 3.23C) to assess any effects of flp 
overexpression. No difference to wildtype in parasite growth or gametocyte production was 
observed (Fig. 3.23C), neither any obvious changes in parasite morphology (data not shown). 
3.3 Role of FLP in host-to-vector transmission 
Fluorescent FLP tagging and its gametocyte-specific depletion showed that the protein plays an 
indispensable role in gametogenesis, specifically in the egress of microgametes. Microgametes 
lacking FLP remained trapped in the host erythrocyte, beating in the restricted area for long time 
periods (30 mins post activation was latest time point analysed, data not shown). Clearly, FLP was 
critical for the parasite transmission to the mosquito vector as the lack of FLP led to a complete 
arrest of life cycle with no mosquito-specific stages observed in vitro nor in vivo. 
3.3.1 Calcium dependency 
Ferlins, as proteins with multiple C2 domains, typically mediate calcium-dependent functions. FLP 
is a typical ferlin in its topology and it therefore seems plausible that its function is calcium-
mediated. The process of gametogenesis is tightly regulated by calcium. Several pathways are 
regulated simultaneously by a single calcium peak [42], leaving investigation of individual 
pathways very challenging. Egress from surrounding membranes - a part of gametogenesis, is also 
calcium-dependent [53]. A study addressing impact of small molecules on gametocyte egress [53] 
reported a failed egress with bundling flagella, a phenotype similar to that caused by FLP absence, 
as a result of 1,10-phenanthroline treatment. 1,10-phenanthroline is a zinc chelator and its impact 
made authors speculate on the involvement of metalloproteases in the process of egress. 
However, 1,10-phenanthroline at high concentrations (which were needed for the effect) also 
chelates calcium. Although calcium typically peaks in concentration for a very short period of time, 
gametocyte egress consists of a time sequence of events [54]. This made us wonder if we could 
separate the individual pathways in gametogenesis and find conditions in which calcium chelation 
would lead to a similar phenotype as the one caused by FLP absence. 
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We used the membrane-permeable chelator BAPTA-AM used previously to study calcium 
involvement in gametogenesis [57,73]. We collected blood from a mouse with high 
gametocytonemia, incubated it in ookinete medium (mimicking the mosquito environment) for 
15-20 minutes and analysed exflagellation by light microscopy. When blood was added to 
ookinete medium immediately after collecting and BAPTA-AM was added at any time point, all 
samples exflagellated (Table 3.1). This showed that the short manipulation time was long enough 
to trigger calcium-dependent pathways before BAPTA-AM was added. We optimized the assay 
with a pre-incubation step at 37° C in RPMI medium (mimicking the mammalian host environment) 
before mixing the blood with ookinete medium and BAPTA-AM to achieve more precise regulation 
of activation. In this approach, addition of BAPTA-AM at later time points (5 mins and later) as 
well as addition of DMSO (the BAPTA-AM solute) did not hinder exflagellation. In contrast, 
addition of BAPTA-AM at 0, 1 and 2 minutes after activation by ookinete medium, respectively, 
Table 3.1 Exflagellation of wildtype gametocytes is abolished by BAPTA-AM at early time points 
after gametocyte activation. Blood with high gametocytonemia was collected and incubated in 
ookinete medium (no preincubation) or first pre-incubated in RPMI medium at 37⁰C. Addition of 
BAPTA-AM without preincubation had no negative effect on exflagellation. After pre-incubation, 
addition of BAPTA-AM at later time points did not interfere with exflagellation, addition at early 
time points interfered with exflagellation. However, no intermediate phenotype was observed. 
Addition of DMSO (vehicle) and no treatment were used as controls. ND = not determined. 
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led to a complete abolishment of exflagellation (Table 3.1). Addition of BAPTA-AM between 2 and 
5 mins after activation led to inconsistent outcomes. However, the outcome was always either a 
population of exflagellating or not exflagellating parasites with no intermediate phenotype 
observed. This indicates that impairment of pathways leading to the flagella bundling cannot be 
mimicked by calcium chelation in vitro. 
Another possibility to address calcium dependency of FLP would be interfering with calcium 
binding to the protein by mutation of involved residues. Calcium binds into negatively charged 
pockets in the C2 domains, which consist of several aspartates [91,114]. However, with no 
structural information on the C2 domains of Plasmodial ferlins, finding these pockets based on 
relatively low evolutionary sequence conservation is almost impossible. The first C2 domains (C2A) 
generally carry the main functional activity in ferlins [113]. Our attempts to delete the first C2 
domain were unsuccessful (chapter 3.2.2.1), indicating that this domain is necessary for FLP 
function during the asexual blood stage and its function therefore cannot be easily addressed in 
the parasite.  
3.3.2 Female fertility status 
While the Δflpgam male gametes were clearly impaired with all observed flagella trapped inside the 
RBC during exflagellation (Fig. 3.23B), female fertility status in the absence of FLP remained 
unclear. Similar phenotypes underlined by impaired egress were previously linked both to 
processes common for both gametocyte sexes [59,61,64] and specific for male gametocytes [62]. 
To address the female fertility status in the absence of FLP, we made use of the Δflpgam820 line 
(generated in chapter 3.2.4.4), which expresses red fluorescent protein in female gametocytes, 
gametes, zygotes and ookinetes [61]. We used this line for a cross-fertilization assay (Fig. 3.24A) 
with GFPcon [163], a line that expresses cytosolic GFP in all stages. Briefly, equal amounts of 
gametocytes from both lines were mixed in an ookinete culture. In case that the Δflpgam820 
macrogametes were fertile, they would get fertilized by GFPcon microgametes and red ookinetes 
would be produced (Fig. 3.24A). While mixing of the two parental lines (820cl1m1cl1 and GFPcon) 
led to production of both red and green ookinetes in a ratio of about 1:1 (Fig. 3.24B), mixing of 
Δflpgam820 with GFP con led to production of significantly reduced amount of red ookinetes, 
indicating that Δflpgam820 female macrogametes are impaired in their fertilization capacity, likely 
due to an egress impairment. 
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3.3.3 Egress failure 
By comparing the gametocyte impairment caused by the absence of FLP with similar published 
phenotypes, we speculated that the parasites remained trapped inside the host RBC. The 
gametocyte needs to disrupt two surrounding membranes in order to egress – red blood cell 
membrane (RBCM) and parasitophorous vacuole membrane (PVM). The previously published 
phenotypes underlined by impaired egress were linked to defects of rupture of both these 
membranes – PVM rupture impairment underlies most of these defects [59–61,64], but also 
RBCM rupture defect can result in an aberrant exflagellation [62]. 
Figure 3.24 Female Δflpgam820 gametocytes are impaired in fertility. A) Schematic of the cross-
fertilization experiment between Δflpgam820 and GFPcon. While GFPcon expresses GFP in all stages, 
Δflpgam820 expresses RFP in female gametocytes, gametes, zygotes and ookinetes. In case the 
Δflpgam820 macrogametes were fertile, the product of cross-fertilization between Δflpgam820 
macrogamete and GFPcon microgamete would be a red ookinete. B) Ookinete cultures with equal 
amounts of gametocytes from each line were set up and 50 random ookinetes per experiment were 
analysed for fluorescent marker (GFP or RFP) presence, ratios were plotted in a bar chart. While 
cross-fertilization of parental lines produces both red and green ookinetes, cross-fertilization of 
FLP-lacking gametocytes (Δflpgam820) with fully fertile green gametocytes (GFPcon) produces 
significantly less red ookinetes. DNA was stained with Hoechst (blue). Confocal images, scale bar 5 
µm. Data pooled from five experiments are plotted as mean ± SEM. Statistical analysis: Mann-
Whitney test. 
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In order to address the status of membrane rupture in activated gametocytes lacking FLP, we used 
antibodies against markers of the two membranes, i.e. TER-119 (RBCM marker) and SEP1 (PVM 
marker, [166]). Activated gametes were fixed and stained for the membrane marker and for 
tubulin (staining flagella) to distinguish microgametes that had triggered the process of 
gametogenesis (Fig. 3.25). While in the wildtype case, over half of the tubulin-positive 
microgametes were free of RBCM, gametes lacking FLP were all trapped inside an intact RBCM, 
which was often expanded along the flagella (Fig. 3.25A). The PVM was lyzed in over 80 % of 
tubulin-positive wildtype microgametes, while about two thirds of gametes lacking FLP were still 
inside an intact PVM and the rest was surrounded by a damaged PVM (Fig. 3.25B).  
 
 
Figure 3.25 Δflpgam microgametes fail to disrupt the RBCM and PVM. A) While wildtype flagellated 
gametes mostly egress from the RBCM, Δflpgam flagellated microgametes remain trapped inside the 
RBCM. Gametocytes were activated in ookinete medium for 20 minutes, fixed in 4% PFA/PBS and 
stained for TER-119 (RBCM marker, green) and tubulin (flagella, red). DNA was stained with Hoechst 
(blue).  Confocal images, scale bar 5 µm. 50 images of random tubulin-positive microgametes per 
experiment (n = 3) were used to quantify the membrane condition and plotted in bar plot. Pooled 
data are plotted as mean ± SEM. B) While wildtype flagellated gametes egress from the PVM, Δflpgam 
flagellated microgametes remain trapped inside. Gametocytes were activated in ookinete medium for 
20 minutes, fixed in 4% PFA/PBS and stained for SEP1 (PVM marker, green) and tubulin (flagella, red). 
DNA was stained with Hoechst (blue).  Confocal images, scale bar 5 µm. 50 images of random tubulin-
positive microgametes per experiment (n = 3) were used to quantify the membrane condition and 
plotted in bar plot. Pooled data are plotted as mean ± SEM. 
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3.3.4 Rescue of the egress defect with detergent lysis 
Gametocytes that lacked FLP were clearly trapped inside the RBCM and PVM, which likely caused 
the transmission failure. In order to study whether this was the only impairment caused by FLP 
absence, we used mild detergent lysis to release gametes from the surrounding membranes 
(similarly to a published assay [62]). Δflpgam gametocytes treated with 0.002% digitonin at the time 
of activation showed normal-looking exflagellation with free flagella (Fig. 3.26A), which got 
released from the residual body. This effect was not observed if digitonin was added at later time 
points, when exflagellation has already started (data not shown), a similar observation was made 
before [62]. In ookinete cultures with 0.002% digitonin in the medium the Δflpgam line produced 
ookinetes with normal morphology (in contrast to untreated cultures where no ookinetes but 
large number of unfertilized female gametes was observed, Fig. 3.26B).  
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Ookinetes from digitonin-treated cultures were used for feeding of Anopheles mosquitoes and 
oocyst as well as both sporozoite populations developed (Fig. 3.26C). We repeated cross-
fertilization of Δflpgam820 and GFPcon line (used in chapter 3.3.2). After digitonin treatment, this 
cross-fertilization produced comparable numbers of red and green ookinetes (Fig.3.26D). Isolated 
sporozoites (from ookinete-fed Anopheli, Fig. 3.26C) were used to infect HuH7 cells. Analysis of in 
vitro liver stages did not show significant differences to wildtype in sizes or numbers (Fig. 3.26E). 
Isolated sporozoites were also injected into C57BL/6 mice and all mice developed parasitaemia, 
although Δflpgam sporozoite-injected mice showed a delay in prepatency compared to wildtype 
sporozoite-injected mice (Fig. 3.26C). The growth of parasites in the mice did not show any 
Figure 3.26 Δflpgam parasites rescued by detergent lysis in vitro progress through life cycle. A) 
While Δflpgam gametocytes show exflagellation impairment with bundled flagella, after digitonin 
treatment, free flagella are recovered. Gametocytes were activated by drop in temperature and 
5 µl of ookinete medium (with or without 0.002% digitonin) on a glass slides and imaged live. Wide 
field images, scale bar 5 µm. B) Δflpgam820 do not produce ookinetes and many unfertilized female 
gametes can be observed in ookinete cultures. After digitonin is added, Δflpgam820 ookinetes with 
normal morphology are observed. C) Δflpgam ookinetes can develop into subsequent stages after 
transmission to Anopheles mosquitoes. Digitonin-treated parasites produce reduced numbers of 
both midgut sporozoites (14 days post feed) and salivary gland sporozoites (17-21 days post feed), 
probably due to toxic effects of the detergent. Isolated sporozoites were used to inject C57BL/6 
mice (n = 3) and all mice developed blood stage parasitaemia. Prepatency is depicted in days. D) 
Ookinete cultures with equal amounts of gametocytes from each line were set up as in fig. 3.24. 
While in cross-fertilization of FLP-lacking gametocytes with fully fertile green gametocytes 
produces significantly less red ookinetes (Fig. 3.24B), after digitonin treatment, red ookinetes are 
produced again. DNA was stained with Hoechst (blue). Confocal images, scale bar 5 µm. Pooled 
data from 5 experiments are plotted as mean ± SEM. Statistical analysis: Mann-Whitney test. E) 
Liver stages of Δflpgam cultured in vitro (using HuH7 cells) are comparable to wildtype in both sizes 
and numbers. Data are plotted as mean ± SEM. F) C57BL/6 mice (n = 3) injected with 10 000 Δflpgam 
sporozoites i.v. show similar parasitaemia curve as wildtype sporozoite-injected mice. 
Parasitaemia was followed by daily Giemsa smears until day 8 post infection (when wildtype 
controls died by ECM). Data are plotted as mean ± SEM. F) qPCR profiling shows that flp 
transcriptional profile resembles the one of clag during the liver stage. HOP was used as 
housekeeping gene for all stages (dashed line). Data were calculated using the comparative CT 
method. Data are plotted as mean ± SEM. All primer sequences are listed in chapter 2.1.6.2. 
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difference to wildtype (Fig. 3.26F). The lack of phenotype during the liver stage was a bit surprising, 
but transcriptional profiling of clag and flp showed that the profiles of the two genes are 
somewhat comparable during the liver stage (Fig. 3.16G). This indicates that flp expression in the 
Δflpgam line is probably comparable to wildtype levels during the liver stages and no phenotypes 
are to be expected. 
3.3.5 Colocalization of FLP and known egress factors 
FLP plays a specific role in egress of male and female gametocytes and localizes to vesicles. 
Vesicles carrying egress molecules play a fundamental role in gametocyte egress. The marker of 
osmiophilic bodies, the first reported egress vesicles, is the protein G377, which also takes part in 
their biogenesis [57,58]. We investigated colocalization between G377::mCherry and FLP::HA 
using a double mutant transgenic line, an approach employed previously to colocalize G377 and 
PAT, another egress molecule [60]. We used the recycled flp::HA line (chapter 3.1.4.1) and a single-
crossover strategy to insert an endogenous mCherry tag at the 3’end of g377 (Fig.3.27A). 
Successful integration was verified by PCR genotyping (Fig. 3.27B). We fixed gametocytes of the 
double mutant and checked for localization of the mCherry and HA-tag. Although both fusion 
proteins localized to speckles indicating vesicular localization, these speckles clearly did not 
colocalize (Fig. 3.27C). The G377 protein expression is restricted to female gametocytes 
[36,57,58]. FLP is expressed in both male and female gametocytes (Fig. 3.11), which suggests that 
vesicles occupied by FLP should be different to the female-specific G377-positive OBs. Another 
protein known to occupy egress vesicles but not colocalizing with G377-positive OBs is PPLP2 [62]. 
We again investigated a double mutant line for colocalization between PPLP2::mCherry and 
FLP::HA. We used a single-crossover strategy to insert an endogenous mCherry tag at the 3’end of 
pplp2 in the flp::HA background (Fig.3.27D). Successful integration was verified by PCR genotyping 
(Fig. 3.27E). In fixed gametocytes, both fusion proteins localized to speckles indicating vesicular 
localization, but clearly did not colocalize (Fig. 3.27F). This indicates that although FLP is an 
indispensable player in gametocyte egress, it occupies a distinct subset of vesicles than do G377 
and PPLP2. 
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Figure 3.27 Colocalization of FLP::HA with egress molecules G377 and PPLP2. A) Single-crossover 
strategy was used to target the g377 locus. After successful integration, g377 sequence lacks the stop 
codon and is fused to mCherry sequence at the 3’ end. Primers used for genotyping bind to sites 
indicated by arrows. All primer sequences are listed in chapter 2.1.6.2.  B) Genotyping with PCR shows 
successful integration in the parental line (P). Both clonal lines (C1, C2) completely lack the wildtype 
locus and successfully integrated the vector. Vector used for transfection (V), wildtype parasites (WT) 
and water (H
2
O) were used as controls. C) FLP::HA fusion protein detected with HA antibody (green) 
does not colocalize with G377::mCherry (red). Gametocytes were fixed in 4% PFA/PBS. DNA was 
stained with Hoechst (blue).  Confocal images, scale bar 5 µm. D) Single-crossover strategy was used 
to target the pplp2 locus. After successful integration, pplp2 sequence lacks the stop codon and is fused 
to mCherry sequence at the 3’ end. Primers used for genotyping bind to sites indicated by arrows. All 
primer sequences are listed in chapter 2.1.6.2.  E) Genotyping with PCR shows successful integration 
in the parental line (P). Both clonal lines (C1, C2) completely lack the wildtype locus and successfully 
integrated the vector. Vector used for transfection (V), wildtype parasites (WT) and water (H
2
O) were 
used as controls. F) FLP::HA fusion protein detected with HA antibody (green) does not colocalize with 
PPLP2::mCherry (red). Gametocytes were fixed in 4% PFA/PBS. DNA was stained with Hoechst (blue).  
Confocal images, scale bar 5 µm. 
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4 Discussion 
Ferlins are well established important players in several secretory pathways, not very different 
from SNAREs [119,125,127,131,133,186]. Their function is dependent on calcium and takes part 
in regulation of vesicle fusion [112,116–119], although other roles were assigned to ferlins as well 
[118,120,126,148,154]. The molecular pathways, including interaction partners, were only 
deciphered for mammalian ferlins [127,129,135,136,141,154]. Especially human ferlins have been 
in the focus of active research as their mutation causes severe conditions (such as deafness and 
muscular dystrophy) [121,132,187]. Human ferlins, due to their involvement in growth factors 
signalling [143–145,147,148,155], have also become the focus of cancer research. Much less data 
was reported about invertebrate ferlins. However, two ferlins from invertabrates (Fer 1 from C. 
elegans and Misfire from D. melanogaster), play a critical role in fertility [112,153,157,188]. This 
originally named the whole family of proteins – fertility factors or ferlins. Mammalian ferlins have 
not been linked to fertility to date. However, also in mammals, ferlin transcripts were found in 
testis [188].  
4.1 flp expression peaks in the gametocyte stage and late liver 
stage 
To identify stages in which FLP function can be anticipated, we first analysed flp expression levels 
during the life cycle. We used qPCR to determine expression of flp and ferlin in all accessible stages 
of the parasite (Fig. 3.1). Based on the interaction between FLP and a liver-specific protein UIS4, 
which was previously identified in our laboratory (Sabine Fraschka, master thesis), we expected 
flp expression during the liver stage. Indeed, the highest abundance of flp transcript was detected 
at the late liver stage, with a gradual rise throughout liver development.  
Both flp and ferlin transcripts were abundant in the asexual blood stage (Fig. 3.1), which matched 
the essential role proposed for both genes (chapter 3.2.1, preliminary data from our laboratory 
and [174]). Similarly, during the liver stage, both gene transcripts were detected in high levels. We 
identified two stages, in which flp and ferlin pattern differed – the gametocyte stage and mosquito 
stages. Purification of the gametocyte stage is challenging and asexual blood stage contamination 
cannot be avoided [189]. Therefore, each result has to be considered biased towards the mixed 
asexual stages. Despite that, both genes show significantly different level compared to the asexual 
blood stage (Fig. 3.1). flp expression on the transcript level peaks in the gametocyte, while ferlin 
transcript is not abundant. During the mosquito stages, ferlin expression is detected while flp 
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transcript is not abundant. This suggests that only one ferlin gene is active in both the gametocyte 
and sporozoite stages. 
4.2 flp is highly sensitive to genetic manipulations 
The Plasmodium life cycle consist of a number of stages that subsequently develop in the 
mammalian host and the mosquito vector during the period of several weeks (Fig. 1.1). Only one 
exception in the cycle allows for cultivation and multiplication of parasite material - the asexual 
blood stage cycle (Fig. 1.1). The blood stage cycle lasts 48 hours and produces over 20 merozoites 
in each iRBC, which allows for selection methods. This is the reason why, to date, only the asexual 
blood stage is permissive for transgenesis followed by selection of transfected parasites [24]. This 
leaves genetic manipulations that are lethal for the parasite during the asexual blood stage 
challenging or even impossible to study. Interestingly, this is the case for a large number of gene 
manipulations [174] and flp is one of the sensitive genes. Given the restriction of transgenic 
manipulations, the lethality of given gene manipulation will translate into failure to generate 
transfected parasites. The transfection itself as well as the homologous recombination and 
subsequent selection process are a multistep and complex procedure. The simple lack of 
transfected parasites can therefore be assigned to the failure of any of the steps and lethality of 
the manipulation cannot be reliably concluded. However, failure of multiple attempts (typically 
three), complemented with an independent approach (different vector background etc.) are 
usually considered as a strong argument against the viability of the given manipulation for the 
parasite in the malaria field. To confirm that the genetic locus is permissive to manipulation per 
se, a knock-in strategy, in which the wildtype locus is inserted should serve as control. 
FLP deletion by knock-out is not viable for the parasite as shown by several independent 
approaches by us (chapter 3.2.1, Christina Schulte-Huxel, Roland Frank) and an independent 
screening [174]. Interestingly, integration of the flp KO vector was detected in some parasite 
populations, but wildtype population was always present as well (Fig. 3.12). By further analysis, 
we showed that both the wildtype and flp-KO loci are maintained in the population even without 
drug pressure. At the same time, no clear duplication of genomic regions could be detected (Fig. 
3.12). This shows that the presence of flp-KO locus is conditioned by the presence of the wildtype 
flp locus in the same parasite population or, more likely, in the very same parasite. However, more 
detailed analysis including the detection of duplicated regions with FISH probes is needed to 
address the molecular basis. FLP function during asexual blood stage development remains 
unknown and its investigation would require an inducible system. Inducible systems for 
Plasmodium are still rather scarce and mostly require tagging of the protein of interest [176]. Since 
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endogenous tagging has proven to be detrimental in the case of FLP (discussed below), the 
recently developed inducible systems will probably not be applicable to study its function. 
All the other manipulations performed in this study need to be considered with caution as 
independent approaches performed at other times or other laboratories are missing. However, 
most of the results originate from several biological replicates. The number of independent non-
viable lines collectively represents a strong argument supporting flp as a very sensitive gene for 
genetic manipulations (Fig. 4.1). The conclusion of five transgenic manipulations (chapters 3.1.3.1, 
3.1.3.2, 3.1.3.3 and 3.2.3.1) is that FLP cannot be endogenously tagged with large proteins and its 
terminal domains cannot be deleted (chapters 3.2.2.1 and 3.2.2.2). Especially the C-terminus of 
the protein seems to be very sensitive, as no integration was detected for vectors truncating the 
C-terminal transmembrane domain (two vector backbones were used in four transfections, 
chapter 3.2.2.2) and for tagging of FLP with a large tag (GFP and AID, chapters 3.1.3.1 and 3.2.3.1, 
respectively). Small fluorescent protein iLOV was fused successfully to FLP (chapter 3.1.3.3) but 
interfered with its function in host-to-vector transmission. FLP tagged with HA tag was viable 
throughout the life cycle, although a minor phenotype at host-to-vector transmission was 
observed (chapter 3.1.4.1). The N-terminus of FLP was sensitive to the truncation of the first C2 
domain (chapter 3.2.2.1). Similarly to Δflp, ΔflpC2A parasites were detected in the population but 
the wildtype locus was never lost. N-terminal fusion of FLP to a GFP tag (chapter 3.1.3.2) interfered 
with host-to-vector transmission. Interestingly, both FLP::iLOV and GFP::FLP interfered with FLP 
function in the gametocyte stage and showed similar phenotype to depletion of FLP – impaired 
egress with disrupted transmission (Fig. 3.5, 3.7 and 3.23). While flp::iLOV (and the FLP-depleted 
Δflpgam line) underwent a complete arrest of life cycle, gfp::flp parasites could transmit an 
extremely reduced number of parasites, as detected by the presence of a few sporozoites in the 
midgut (Fig. 3.5). Likely due to the highly limited numbers, these parasites did not overcome the 
upcoming bottleneck of midgut-to-salivary gland migration and no sporozoites were observed in 
the salivary glands. Phenotypes underlined by impaired egress that result in partial block of 
transmission were observed before [59,61,62]. These phenotypes were reported in KO studies, 
indicating that the deleted genes played important but not crucial roles in the process of egress. 
We have shown that FLP plays and indispensable role in egress (Fig. 3.23). Therefore, the only 
likely explanation of the development of several gfp::flp midgut sporozoites is only partial 
interference of the tag with FLP function. 
Surprisingly, neither GFP nor iLOV fluorescence was detected in either of the lines. FLP protein 
levels in the asexual blood stage are likely very low (Fig. 3.9) and that may prevent the detection 
of the fusion proteins live. Using Western blot, we successfully detected the GFP::FLP fusion 
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protein with anti-HA antibody (HA tag was used as a linker between GFP and FLP) but not with 
anti-GFP antibody. This suggests that GFP antibody did not efficiently detect the fusion protein 
and it explains why IFA on fixed parasites was not successful with this antibody (Fig. 3.4). Anti-
iLOV antibody detected a band corresponding to FLP::iLOV on a Western blot (Fig. 3.6), although 
many unspecific bands were present. The anti-iLOV antibody does not detect native protein and 
so it could not be used for IFA [167]. In conclusion, low FLP levels together with suboptimal 
antibodies prevented the detection of fluorescently tagged FLP during the asexual blood stage. A 
set of antibodies and proper controls with similar (low) levels of iLOV and GFP proteins, 
respectively, would be needed for optimization of detection procedures. 
The only tag, fusion of which to FLP did not abolish transmission of the parasite, was the small HA 
tag (Fig. 4.1). However, flp::HA line showed a transient egress impairment and slower liver stage 
development in vitro (Fig. 3.10). This indicates that FLP::HA cannot fulfil its function completely 
due to the very small tag. The localization determined using the tagged line (Fig. 3.9) has to be, 
therefore, considered with caution. Three main points argue against mislocalization of tagged FLP 
– first, mislocalized proteins do usually not localize to distinct speckles (the case of FLP::HA) but 
are degraded, localize to uneven aggregates or show no particular localization in the cell. Second, 
FLP::HA localizes to vesicles, which matches very well with ferlin orthologues from a number of 
organisms [112,117,123,125,133]. Third, although the HA tagging caused a delay in egress, the 
flp::HA parasites were viable throughout the life cycle (Fig. 3.10). This, in contrast to gfp::flp and 
flp::iLOV parasites, which completely fail to transmit (Fig. 3.5 and 3.7), indicates that FLP::HA must 
be functional and likely largely properly localized. However, cases in which mislocalized tagged 
protein was functionally completely intact were reported [190]. The biggest risk of mislocalization 
is represented by dimerizing fluorescent proteins from the GFP family. Dimerization of YFP 
underlined the mislocalization mentioned above [190]. Dimerization of GFP might contribute to 
the interference with FLP::GFP and GFP::FLP functions. No dimerization or oligomerization was 
reported for the HA tag and iLOV was shown to stay monomeric in solution [191]. This suggests 
that it is rather direct interference with FLP function than the mislocalization that causes egress 
impairment observed in flp::iLOV and transiently in flp::HA. Although we were not able to address 
FLP role during the liver stage in this study, based on the high transcript abundance (Fig. 3.1), its 
function can be anticipated. Also, flp::HA line was impaired during the liver stage in vitro, 
indicating that HA tag  (and potentially other tags) might interfere with FLP function in the liver 
stage.  
Interestingly, gfp::flp and flp::iLOV lines showed no effect on the asexual blood stage development 
but interfered with FLP function in the gametocyte stage. These two stages differ in the 
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surrounding environment – mammalian host and mosquito vector differ by almost 15° C in 
temperature. Temperature sensitive mutations are known from yeast and they were observed in 
the case of ferlins as well. C. elegans Fer1 mutations are temperature sensitive [112] and also four 
mutation of human otoferlin are temperature dependent, leading to a more severe phenotype at 
elevated temperature [124]. However, proving that the change in temperature causes defects to 
the tagged FLP would require thorough biochemical analysis. 
Using transfection of additional copies of the genes, C-terminal tagging of five human ferlins led 
to no obvious phenotype in ferlin behaviour or the viability of the cells in cell culture [123]. 
However, to our knowledge, no endogenous tagging was reported for any ferlin member to date. 
This may indicate that the detrimental effects of endogenous tagging are a common feature of 
the protein family. 
FLP depletion by KO was not possible (Fig. 3.13) and its sensitivity to tagging prevented conditional 
depletion with the AID system (Fig. 3.16). As an alternative approach, we used promoter 
swapping. The first generated line, Δflpook, proved that the 5’UTR of flp was genetically accessible 
and, more importantly, that flp transcriptional profile can be manipulated (Fig. 3.17). However, 
no difference to wildtype was detected in the Δflpook line (Fig. 3.18), which indicates that FLP does 
not play a role in the ookinete stage, as was expected from the transcriptional profile (Fig. 3.1). 
What remains unclear is the role of FLP in the early liver stage. Ama1 expression is very low in this 
stage [183], but residual expression of flp under the ama1 promoter was detected (Fig. 3.17). The 
lack of phenotype can hence be explained by the lack of FLP function in the early liver stage or by 
a function that can be fulfilled by very low amount of the protein.  
Generation of two other lines with promoter swapping was not feasible, namely Δflpspz (ccp 
promoter) and Δflpliver (PBANKA_062260 promoter). In the case of ccp promoter, transcriptional 
data point towards very low expression during the asexual blood stage, during which FLP plays an 
essential function. The fact that integration of the ccp promoter was observed but wildtype 
population was never lost (Fig. 3.19) reproduces the phenotype observed for the Δflp line (Fig. 
3.13). This further argues for the too low expression of FLP in the asexual blood stage as the reason 
why Δflpspz could not be generated. A similar story is the generation of the Δflpliver line. Based on 
similarities with the Δflpspz line mentioned above, the suboptimal expression levels during the 
asexual blood cycle seem to be the most likely explanation for the failure of generation of this line. 
However, since the promoter of PBANKA_062260 was never used before, its sequence is not 
known and it is possible that the 1.5 kb of its 5’UTR is not acting as a promoter. In such case, this 
line would resemble the Δflp line and in either case would not be viable.  
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The promoter swap approach was not successful for FLP depletion during the liver stage. This is 
underlined by the fact that expression profile covering all stages but the liver stage is very rare. 
The liver stage fulfils a preparation role for the blood stage and finding a gene that is off in that 
stage but abundantly expressed during the asexual blood cycle is very unlikely. An alternative 
approach with the use of more than one promoter, specific for individual stages, might support 
Figure 4.1 FLP is sensitive to genetic manipulations. All parasite transgenesis is taking place during 
the asexual blood stage, leaving manipulations lethal for this stage impossible to establish. flp is 
refractory to gene knock-out (Δflp). Truncations of both N-terminal C2A domain (ΔflpC2A) and C- 
terminal TM domain (ΔflpTM) are not viable for the parasite. Tagging of FLP shows different degree 
of interference depending on the size and location of the tag. C-terminus is more sensitive, with 
GFP tag (flp::gfp) and AID tag (flp::AID) lethal and iLOV (flp::iLOV) interfering with FLP function in 
gametogenesis leading to arrest at host-to-vector transmission. Promoter swapping using a weak 
asexual blood stage promoter (ccp. Δflpspz) was lethal for the parasite. Promoter inactive in the 
gametocyte stage (clag. Δflpgam) abolished host-to-vector transmission. Promoter inactive in the 
ookinete stage (ama1. Δflpook) had no effect on the viability. The flp gene locus is permissive for 
genetic manipulations as shown by successful transgenesis at both the 5’end (Δflpook) and the 3’end 
(flp::HA). Tagging might interfere with functions of the terminal domains – the first C2 domain and 
the transmembrane domain. 
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parasite development through the blood and mosquito stages and shut flp expression down in the 
liver stage. However, this approach would require cloning of the whole gene, which is almost 
impossible due to its size. Alternatively, a conditional KO with FLP/FRT system [192] could be used 
to excise the flp locus from the genome in the beginning of the liver stage.   
Depletion of FLP in the gametocyte stage by promoter swapping worked very well as shown by 
the reduction in transcript and protein levels (Fig 3.21 and 3.22). Clag expression is much higher 
than flp expression during the asexual blood stage, which led to overexpression of flp about 
hundred-fold in the Δflpgam line (Fig. 3.21 and 3.22). Surprisingly, this overexpression did not 
translate into a phenotype, as both parasite growth and gametocyte development remained 
comparable to wildtype in the Δflpgam line (Fig. 3.22). This indicates that FLP fulfils functions, which 
are not hampered by high abundance of the protein. Depletion study should be complemented 
by a genetic rescue to exclude possible artefacts. Similarity with the role and the evolutionary 
conservation between FLP and Fer-1 from C. elegans made us additionally consider 
complementation with that gene. In both cases, cloning was not successful despite many 
attempts, likely due to the extremely large size of the genes and the AT-rich genome of 
Plasmodium. 
The failure of transgenesis in Plasmodium can be underlined by the resistance of the genetic locus 
to manipulations. However, this option cannot be considered in the case of FLP. First, both the 
5’end and the 3’end were successfully modified without impact on parasite viability. The 5’UTR of 
flp was replaced by ama1 promoter with no harm to the parasite (Fig. 3.18). At the 3’end, HA tag 
was fused to FLP, which resulted in a viable line (Fig. 3.10). An explanation for the failure of C-
terminal tagging could be an alternative splicing or alternative end of the gene. Our 3’RACE 
analysis showed that during both the asexual blood stage and the gametocyte stage, flp transcript 
is spliced and terminated exactly as annotated (Fig. 3.12). This overall suggests that it is indeed an 
interference with FLP function that prevents fusion to tags or truncation of the gene. The 
explanation for that is suggested by the domain assignment (Fig. 4.1). The C-terminus is occupied 
by the TM domain (with a single C-terminal amino acid outside of the membrane). This structure 
and topology is reminiscent of SNARE proteins, which rely on the very short C-terminus during co-
translational insertion into membranes and C-terminal tagging is not possible. Similarly to SNARE, 
C-terminal tagging of FLP might interfere with insertion of the protein into membranes. The N-
terminus of FLP is occupied by the first C2 domain, which was shown to carry the most important 
functions in many ferlin homologues [113] and a tag might compromise its function. Usually, 
interference of tags with protein functions can be prevented by a linker of several amino acids 
between the tag and the protein. We used a linker of at least 10 amino acids for all the tagged 
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lines. However, the function of FLP was still compromised. Overall it is very difficult to conclude 
what underlies the failure to generate tagged line. The impact of tagging cannot be reliably 
predicted even for proteins with clear domain topology and known functions. With no function 
assigned to FLP domains, the design and troubleshooting of tagging strategies is more a guessing.  
Given the tendency that smaller tags translated into better viability of the parasite, other small 
tags could be fused to the less sensitive N-terminus of FLP to confirm its localization pattern 
determined using the flp::HA line (Fig. 3.9). The ideal option would be to use a fluorescent tag, to 
capture dynamics of the protein. One option might be the tetra-cysteine tags FlAsH and ReAsh, 
one of the smallest available tags that can react with fluorescent dyes in vivo [193]. However, this 
tagging approach is generally prone to high background as all cysteine-rich proteins (which are 
common in Plasmodium) coordinate the dye. The tag was used once in Plasmodium so far and 
although the visualization of the protein of interest was successful it was not perfect and 
complementary approaches had to be used to confirm the data [194]. 
The usual approach to confirm protein subcellular localization is antibody staining. We tried to 
express recombinant parts of the FLP protein and use it for immunization of rodents and 
generation of polyclonal antibody (chapter 3.1.2). Although two out of four recombinant proteins 
were successfully expressed, they were not soluble and extensive optimizations did not help. The 
insoluble recombinant protein could be purified under denaturing conditions and used for 
immunization. However, this approach fundamentally increases the risk of future off-targeting of 
the polyclonal antibody. Another alternative is the commercial generation of anti-peptide 
antibodies offered by several companies. Apart from the high cost of the procedure, experience 
with these antibodies in the malaria field is generally not good. 
4.3 FLP is necessary for host-to-vector transmission 
Ferlins are established mediators of calcium-induced membrane fusion and regulated exocytosis 
in higher eukaryotes. We showed for the first time that an evolutionarily ancient member of the 
ferlin protein family is critical for fertility in a protozoan. Specifically FLP is necessary for egress of 
both male and female gametes from the host RBC (3.24 and 3.25) and life cycle progression in the 
mosquito vector (Fig. 3.23).  
Vesicular localization is typical for the ferlin protein family [117,125,132,153]. Using the flp::HA 
line, we detected FLP in speckles, indicating vesicular localization, in both asexual and sexual blood 
stages (Fig. 3.9). These vesicles relocalized to the cell surface in the process of gametogenesis (Fig. 
3.9), suggesting localization to egress vesicles, e.g. osmiophilic bodies [56,58] or egress vesicles 
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containing PPLP2 [62,63], GEST [59], PAT [60] or MTRAP [64,66]. Indeed, we observed an egress 
defect after gametocyte-specific depletion of FLP - gametes lacking FLP failed to egress from the 
host RBC (Fig. 3.24).  
While the RBCM was clearly intact around activated Δflpgam microgametes (Fig. 3.24), the rupture 
of the PVM could not be completely excluded or confirmed from our data. The FLP-lacking 
gametes were still decorated by the PVM marker SEP1 after activation (Fig. 3.24), but the signal 
was less prominent than in non-activated gametocytes and the PVM often appeared damaged. 
This is reminiscent of starting PVM vacuolisation, an early step of gamete egress defined in a 
recent study [54]. The explanation for this membrane appearance could be an incomplete lysis or 
a blocked release of PVM remnants due to the presence of the RBCM (these remnants readily 
dissolve in the activated wildtype gametes, Fig. 3.24). However, the appearance of a completely 
lysed PVM trapped inside the intact RBCM (as reported for PPLP2 knock-out [62]) appears 
substantially different to our observation [54], suggesting that PVM egress is indeed impaired in 
the Δflpgam parasites. Partially successful PVM lysis in the activated gametes lacking FLP could be 
explained by the reported observation that the PVM can rupture in the absence of calcium [53]. 
As discussed in chapter 4.4, FLP likely functions downstream of the calcium signalling and 
therefore an additional pathway that is FLP- and calcium-independent might initiate PVM rupture.  
Similar egress impairment phenotypes were reported in a number of studies [53,59–62,64,66]. All 
of the proteins underlying these phenotypes localize to vesicular structures, similarly to FLP (Fig. 
3.9). In several cases, these vesicles were identified as OBs by co-localization with the marker 
proteins G377 or MDV1/PEG3 [59–61]. While we detected FLP expression in both male and female 
gametocytes (Fig. 3.11) with similar abundance and localization of the protein, we could not 
observe obvious co-localization with G377- or PPLP2-containing vesicles (Fig. 3.27). Interestingly, 
while depletion of GEST and MDV1/PEG3 (egress factors localizing to G377-positive OBs) only 
leads to partial arrest of the life cycle at host-to-vector transmission [59,61], FLP-depleted 
parasites failed to transmit completely (Fig. 3.23), demonstrating the essential role of the protein 
in this process. This is reminiscent of PAT and MTRAP, two recently described egress factors, 
depletion of which leads to a complete life-cycle arrest during transmission [60,64,64,66,66]. 
MTRAP localizes to egress vesicles but does not colocalize with G377 in P. falciparum [64] nor with 
MDV1/PEG3 in P. berghei [64,66]. This indicates that gametocyte egress molecules cluster into 
different combinations and occupy different subsets of vesicles. From published data it appears 
that some subsets have a smaller impact on gametocyte egress than others with partial 
redundancy. While MDV1/PEG3, PPLP2, G377 and GEST KO show severe but incomplete block of 
transmission [57–59,61–63], respectively, PAT [60], MTRAP [64,66] and FLP are critical for 
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transmission. PAT was previously shown to occupy vesicles together with female-specific G377 
and male-specific PPLP2 [60]. This indicates that PAT is present in several subsets of vesicles, likely 
underlying its necessary role (Fig. 4.2). MTRAP and FLP do not colocalize with G377, respectively 
(Fig. 3.27, [64]), MTRAP does not colocalize with MDV1/PEG3 [64] and FLP with PPLP2 (Fig. 3.27). 
Both proteins localize to vesicles that are essential for gametocyte egress and their colocalization 
was not analysed, so we speculate that FLP and MTRAP might occupy the same or similar subset 
of vesicles (Fig. 4.2).  
Due to the lack of a marker protein defining the FLP-containing vesicles, we were not able to 
address the precise time and localization of the egress defect caused by FLP absence. Based on 
data from other ferlin orthologues, a function in vesicular exocytosis seems most likely, with 
impaired fusion of egress vesicles in Δflpgam parasites possibly causing the observed phenotype. 
Alternatively, FLP could play a role in the trafficking of egress vesicles to the cell periphery, as 
mediating of vesicular trafficking via interaction within protein complexes was reported to be an 
additional function of dysferlin [152]. 
In vitro, Δflpgam female gametocytes were strongly impaired in fertility as shown by cross 
fertilization experiments. Some of the Δflpgam macrogametes got fertilized by fertile microgametes 
as shown by the presence of a few red ookinetes (Fig. 3.24). This could be explained by physical 
forces exerted by the motile microgametes, leading to fertilization of non-egressed 
macrogametes. An alternative explanation of the dramatically reduced fertilization capacity in 
macrogametes, other than an egress defect, seems highly unlikely as the Δflpgam life cycle 
progression as well as macrogamete fertilization can be rescued by chemical membrane lysis (Fig. 
3.26). 
Although the transmission of FLP-depleted parasites was completely abolished, the trapped 
gametes were fully fertile as transmission could be rescued by chemical membrane lysis (Fig. 3.26). 
This is in agreement with the function of other ferlins important for fertility since ferlin-lacking 
sperm cells were unable to fuse vesicles or lyse a surrounding membrane, but otherwise 
developed normally [153,157]. While C. elegans, D. melanogaster and P. berghei ferlins are 
critically needed for fertility, no mammalian ferlin was reported to play similar roles to date. 
However, ferlin transcripts were detected in testis and male germ line of mice and colts [195,196]. 
Otoferlin-specific antibody also detected the protein in murine testis [125]. This might indicate 
that the ancient role of ferlins was to some degree maintained in evolution, although more 
specialized roles for ferlins developed.  
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4.4 FLP as a candidate for calcium-dependent mediator of 
egress 
While we were not able to answer whether FLP function is calcium-dependent in this study, many 
ferlins were shown to be critically dependent on calcium signalling [112,117,118,125,132]. The C2 
domain, the most characteristic feature of ferlins, is a well described calcium- and phospholipid-
binding unit of about 130 amino acids, which typically confers calcium-dependent functions to 
proteins that harbour it, e.g. synaptotagmins [91]. Egress in the related apicomplexan parasite 
Toxoplasma gondii is dependent on a C2 domain-containing protein DOC2, which mediates 
exocytosis in a calcium-dependent fashion [82]. In Plasmodium, the only egress factor with 
calcium binding domain suggested to date is CDPK1, a calcium-dependent protein kinase. CDPK1 
plays multiple roles in transmission and subsequent ookinete development. However, its role in 
egress was suggested based on the delayed egress of CDPK1-depleted gametocytes [49]. Although 
the reason for the delay is not clear, it is unlikely that CDPK1 mediates egress of the essential 
egress vesicles, as CDPK1-KO gametes eventually egress [49]. Given the dependence of 
Plasmodium gamete egress on calcium signalling and the presence of six C2 domains in the FLP 
sequence, it seems likely that its functions during this process is indeed regulated by calcium. FLP 
may even represent the missing link between calcium signalling and gamete egress (Fig. 4.2). 
However, more experiments are needed to confirm or disprove this hypothetical link. This remains 
a major challenge due to the essentiality of FLP during the asexual blood stage on the one hand, 
and several pathways being simultaneously triggered by calcium during gametogenesis on the 
other.  
Several pathways are regulated by a single transient peak in calcium in the beginning of 
gametogenesis (Fig. 4.2) [73]. It is therefore challenging to track the dependency of individual 
pathways on calcium. Chelation is known to inhibit exflagellation [73]. We chelated calcium at 
different time points after induction of gametogenesis with the aim to trigger CDPK pathways but 
prevent FLP functions. However, no intermediate outcomes resembling the absence of FLP were 
observed (Table 3.1), indicating that the whole pathway is regulated simultaneously and/or is 
irreversible by chelation once calcium has bound its targets. 
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Egress of asexual and sexual blood stages of Plasmodium differs in many points. For example, 
gamete egress is triggered in response to the sudden and profound changes in the extracellular 
environment, while asexual parasites emerge when they reach maturity. While many of the 
described gamete egress factors can be knocked-out and have therefore no critical function during 
the asexual development [58–64,66], flp is refractory to gene deletion (Fig. 3.13). Its localization 
Figure 4.2 Revised model of gametogenesis regulated by calcium. In response to the drop in 
temperature and presence of the xanthurenic acid, signal transduction is triggered that results 
in calcium release from the endoplasmic reticulum. Calcium mediates several pathways. 
Activation of CDPK4 and CDPK1 lead to flagella assembly and mitosis in microgametocytes and 
to changes in gene expression, respectively. Calcium mediates egress of gametocytes via 
exocytosis of egress vesicles. These vesicles carry different sets of cargo proteins (shown is a 
suggestion of individual subsets based on published data) and have different importance for 
the gametocyte egress. The molecular player necessary for translation of the calcium signal 
into the exocytosis of vesicle is currently not known and we propose FLP as a potential 
candidate. 
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in the schizont stage (Fig. 3.9) appears similar to the staining of exonemes, vesicles carrying the 
egress protease SUB1 in the asexual blood stage [69,74]. It is therefore tempting to speculate that 
FLP plays a role in egress of blood stage merozoites, perhaps even extending its role to the egress 
of liver stage merozoites as suggested by the high flp transcript abundance in the late liver stage 
(Fig 3.1). Host cell egress of intraerythrocytic sexual and blood-stage parasites, as well as intra-
hepatic liver-stage merozoites do share common features [26]; for example the inside-out model 
is currently accepted for the egress of all three parasite stages with PVM rupture preceding that 
of the RBCM [21,53,70]. Furthermore, a sharp increase of calcium levels has been reported in all 
three cases [72–74] and some common players such as proteases from the SERA family, SUB1, 
falcipain-1/berghepain-1, plasmepsins IX and X can be found [52,53,66,69,74–81]). 
4.5 Conclusion 
In conclusion, we present the first characterization of an apicomplexan ferlin protein that 
functions in fertility. Progression of life cycle is critically dependent on FLP with both male and 
female gametes remaining trapped inside the host RBC and sterile when FLP is depleted. FLP 
localization to vesicles is in very good agreement with data from other ferlin orthologues, which 
allows speculating on calcium-dependency of FLP function and its potential role in exocytosis of 
its resident vesicles. Our data establish FLP as a critical factor for Plasmodium gamete egress with 
a potential hypothetical function in the egress of other parasite stages.  
Further experiments shall address the dependency of FLP function on calcium as well as its 
functions in the asexual blood and liver stages. Given the restrictions in flp manipulations, novel 
techniques able to overcome the essentiality during asexual blood stage, allowing for tracking of 
individual pathways in a complex signalling transduction and visualizing of proteins live with 
minimal impact on their function will likely be needed to answer the questions. Although flp 
sensitivity to manipulations is extraordinary, many other essential genes can be found in the 
Plasmodium genome. There is a strong request for novel techniques and many people work on 
the development. After detailed analysis, FLP might be established not only as a promising 
immune target but also as a multi-stage essential (egress) factor. 
5 References 
 1.  Laveran A (1881) The pathology of malaria. Lancet 2: 840–841. 
 
2.  Ross R (1897) Observations on a condition necessary to the transformation of the 
malaria crescent. British Medical Journal 1: 251. 
 
124 
 
3.  Han YS, Thompson J, Kafatos FC, Barillas-Mury C (2000) Molecular interactions 
between Anopheles stephensi midgut cells and Plasmodium berghei: the time 
bomb theory of ookinete invasion of mosquitoes. The EMBO journal 19: 6030–
6040. 
 
4.  Sinden RE, Dawes EJ, Alavi Y, Waldock J, Finney O, Mendoza J, Butcher GA, 
Andrews L, Hill AV, Gilbert SC, et al. (2007) Progression of Plasmodium berghei 
through Anopheles stephensi is density-dependent. PLoS Pathog 3: e195. 
 
5.  Kariu T, Yuda M, Yano K, Chinzei Y (2002) MAEBL is essential for malarial 
sporozoite infection of the mosquito salivary gland. J Exp Med 195: 1317–1323. 
 
6.  Al-Olayan EM, Beetsma AL, Butcher GA, Sinden RE, Hurd H (2002) Complete 
development of mosquito phases of the malaria parasite in vitro. Science 295: 677–
679. 
 
7.  Ménard R, Sultan AA, Cortes C, Altszuler R, Van Dijk MR, Janse CJ, Waters AP, 
Nussenzweig RS, Nussenzweig V (1997) Circumsporozoite protein is required for 
development of malaria sporozoites in mosquitoes. Nature 385: 336. 
 
8.  Vanderberg J, Rhodin J (1967) Differentiation of nuclear and cytoplasmic fine 
structure during sporogonic development of Plasmodium berghei. The Journal of 
cell biology 32: C7. 
 
9.  Sinden R, Garnham P (1973) A comparative study on the ultrastructure of 
Plasmodium sporozoites within the oocyst and salivary glands, with particular 
reference to the incidence of the micropore. Transactions of the Royal Society of 
Tropical Medicine and Hygiene 67: 631–634. 
 
10.  Klug D, Frischknecht F (2017) Motility precedes egress of malaria parasites from 
oocysts. Elife 6: 
 
11.  Aly AS, Matuschewski K (2005) A malarial cysteine protease is necessary for 
Plasmodium sporozoite egress from oocysts. Journal of Experimental Medicine 
202: 225–230. 
 
12.  Wang Q, Fujioka H, Nussenzweig V (2005) Exit of Plasmodium sporozoites from 
oocysts is an active process that involves the circumsporozoite protein. PLoS 
Pathog 1: e9. 
 
13.  Sinden R, Matuschewski K (2005) The sporozoite. In, Molecular Approaches to 
Malaria pp 169–190. American Society of Microbiology. 
 
14.  Hillyer JF, Barreau C, Vernick KD (2007) Efficiency of salivary gland invasion by 
malaria sporozoites is controlled by rapid sporozoite destruction in the mosquito 
haemocoel. Int J Parasitol 37: 673–681. 
 
15.  Pimenta PF, Touray M, Miller L (1994) The journey of malaria sporozoites in the 
mosquito salivary gland. Journal of Eukaryotic Microbiology 41: 608–624. 
 
125 
 
16.  Matsuoka H, Yoshida S, Hirai M, Ishii A (2002) A rodent malaria, Plasmodium 
berghei, is experimentally transmitted to mice by merely probing of infective 
mosquito, Anopheles stephensi. Parasitology international 51: 17–23. 
 
17.  Amino R, Thiberge S, Martin B, Celli S, Shorte S, Frischknecht F, Ménard R 
(2006) Quantitative imaging of Plasmodium transmission from mosquito to 
mammal. Nat Med 12: 220–224. 
 
18.  Frevert U, Engelmann S, Zougbédé S, Stange J, Ng B, Matuschewski K, Liebes L, 
Yee H (2005) Intravital observation of Plasmodium berghei sporozoite infection of 
the liver. PLoS Biol 3: e192. 
 
19.  Lingelbach K, Joiner KA (1998) The parasitophorous vacuole membrane 
surrounding Plasmodium and Toxoplasma: an unusual compartment in infected 
cells. Journal of cell science 111: 1467–1475. 
 
20.  Gonzalez V, Combe A, David V, Malmquist NA, Delorme V, Leroy C, Blazquez 
S, Ménard R, Tardieux I (2009) Host cell entry by apicomplexa parasites requires 
actin polymerization in the host cell. Cell Host Microbe 5: 259–272. 
 
21.  Graewe S, Rankin KE, Lehmann C, Deschermeier C, Hecht L, Froehlke U, 
Stanway RR, Heussler V (2011) Hostile takeover by Plasmodium: reorganization 
of parasite and host cell membranes during liver stage egress. PLoS pathogens 7: 
e1002224. 
 
22.  Baer K, Klotz C, Kappe SH, Schnieder T, Frevert U (2007) Release of hepatic 
Plasmodium yoelii merozoites into the pulmonary microvasculature. PLoS 
pathogens 3: e171. 
 
23.  Sturm A, Amino R, van de Sand C, Regen T, Retzlaff S, Rennenberg A, Krueger 
A, Pollok J-M, Menard R, Heussler VT (2006) Manipulation of host hepatocytes 
by the malaria parasite for delivery into liver sinusoids. Science 313: 1287–1290. 
 
24.  Janse CJ, Franke-Fayard B, Mair GR, Ramesar J, Thiel C, Engelmann S, 
Matuschewski K, van Gemert GJ, Sauerwein RW, Waters AP (2006) High 
efficiency transfection of Plasmodium berghei facilitates novel selection 
procedures. Molecular and biochemical parasitology 145: 60–70. 
 
25.  Arnot DE, Ronander E, Bengtsson DC (2011) The progression of the intra-
erythrocytic cell cycle of Plasmodium falciparum and the role of the centriolar 
plaques in asynchronous mitotic division during schizogony. International journal 
for parasitology 41: 71–80. 
 
26.  Kuehn A, Pradel G (2010) The coming-out of malaria gametocytes. J Biomed 
Biotechnol 2010: 976827. 
 
27.  Sinha A, Hughes KR, Modrzynska KK, Otto TD, Pfander C, Dickens NJ, Religa 
AA, Bushell E, Graham AL, Cameron R, et al. (2014) A cascade of DNA-binding 
proteins for sexual commitment and development in Plasmodium. Nature 507: 
126 
 
253. 
 
28.  Lopez-Rubio J-J, Mancio-Silva L, Scherf A (2009) Genome-wide analysis of 
heterochromatin associates clonally variant gene regulation with perinuclear 
repressive centers in malaria parasites. Cell host \& microbe 5: 179–190. 
 
29.  Kafsack BFC, Rovira-Graells N, Clark TG, Bancells C, Crowley VM, Campino 
SG, Williams AE, Drought LG, Kwiatkowski DP, Baker DA, et al. (2014) A 
transcriptional switch underlies commitment to sexual development in malaria 
parasites. Nature 507: 248–252. 
 
30.  Brancucci NM, Bertschi NL, Zhu L, Niederwieser I, Chin WH, Wampfler R, 
Freymond C, Rottmann M, Felger I, Bozdech Z, et al. (2014) Heterochromatin 
protein 1 secures survival and transmission of malaria parasites. Cell host \& 
microbe 16: 165–176. 
 
31.  Coleman BI, Skillman KM, Jiang RH, Childs LM, Altenhofen LM, Ganter M, 
Leung Y, Goldowitz I, Kafsack BF, Marti M, et al. (2014) A Plasmodium 
falciparum histone deacetylase regulates antigenic variation and gametocyte 
conversion. Cell host \& microbe 16: 177–186. 
 
32.  Alano P (2007) Plasmodium falciparum gametocytes: still many secrets of a 
hidden life. Mol Microbiol 66: 291–302. 
 
33.  Silvestrini F, Alano P, Williams J (2000) Commitment to the production of male 
and female gametocytes in the human malaria parasite Plasmodium falciparum. 
Parasitology 121: 465–471. 
 
34.  Smith T, Lourenco P, Carter R, Walliker D, Ranford-Cartwright L (2000) 
Commitment to sexual differentiation in the human malaria parasite, Plasmodium 
falciparum. Parasitology 121: 127–133. 
 
35.  Robert V, Read A, Essong J, Tchuinkam T, Mulder B, Verhave J-P, Carnevale P 
(1996) Effect of gametocyte sex ratio on infectivity of Plasmodium falciparum to 
Anopheles gambiae. Transactions of the Royal Society of Tropical Medicine and 
Hygiene 90: 621–624. 
 
36.  Khan SM, Franke-Fayard B, Mair GR, Lasonder E, Janse CJ, Mann M, Waters AP 
(2005) Proteome analysis of separated male and female gametocytes reveals novel 
sex-specific Plasmodium biology. Cell 121: 675–687. 
 
37.  Guttery DS, Roques M, Holder AA, Tewari R (2015) Commit and Transmit: 
Molecular Players in Plasmodium Sexual Development and Zygote 
Differentiation. Trends in parasitology 31: 676–685. 
 
38.  Sinden R, Croll N (1975) Cytology and kinetics of microgametogenesis and 
fertilization in Plasmodium yoelii nigeriensis. Parasitology 70: 53–65. 
 
39.  Billker O, Lindo V, Panico M, Etienne A, Paxton T, Dell A, Rogers M, Sinden R, 
Morris H (1998) Identification of xanthurenic acid as the putative inducer of 
127 
 
malaria development in the mosquito. Nature 392: 289. 
 
40.  Mair GR, Lasonder E, Garver LS, Franke-Fayard BMD, Carret CK, Wiegant 
JCAG, Dirks RW, Dimopoulos G, Janse CJ, Waters AP (2010) Universal features 
of post-transcriptional gene regulation are critical for Plasmodium zygote 
development. PLoS Pathog 6: e1000767. 
 
41.  Mair GR, Braks JA, Garver LS, Dimopoulos G, Hall N, Wiegant JC, Dirks RW, 
Khan SM, Janse CJ, Waters AP (2006) Translational Repression is essential for 
Plasmodium sexual development and mediated by a DDX6-type RNA helicase. 
Science (New York, NY) 313: 667. 
 
42.  Brochet M, Billker O (2016) Calcium signalling in malaria parasites. Molecular 
microbiology 100: 397–408. 
 
43.  Straschil U, Talman AM, Ferguson DJP, Bunting KA, Xu Z, Bailes E, Sinden RE, 
Holder AA, Smith EF, Coates JC, et al. (2010) The Armadillo repeat protein PF16 
is essential for flagellar structure and function in Plasmodium male gametes. PLoS 
ONE 5: e12901. 
 
44.  Tewari R, Dorin D, Moon R, Doerig C, Billker O (2005) An atypical mitogen-
activated protein kinase controls cytokinesis and flagellar motility during male 
gamete formation in a malaria parasite. Molecular microbiology 58: 1253–1263. 
 
45.  Marques SR, Ramakrishnan C, Carzaniga R, Blagborough AM, Delves MJ, 
Talman AM, Sinden RE (2015) An essential role of the basal body protein SAS-6 
in Plasmodium male gamete development and malaria transmission. Cellular 
microbiology 17: 191–206. 
 
46.  Rangarajan R, Bei AK, Jethwaney D, Maldonado P, Dorin D, Sultan AA, Doerig C 
(2005) A mitogen-activated protein kinase regulates male gametogenesis and 
transmission of the malaria parasite Plasmodium berghei. EMBO Rep 6: 464–469. 
 
47.  Deligianni E, Morgan RN, Bertuccini L, Kooij TW, Laforge A, Nahar C, 
Poulakakis N, Schüler H, Louis C, Matuschewski K, et al. (2011) Critical role for a 
stage-specific actin in male exflagellation of the malaria parasite. Cellular 
microbiology 13: 1714–1730. 
 
48.  Sinden R, Talman A, Marques S, Wass MN, Sternberg MJ (2010) The flagellum in 
malarial parasites. Current opinion in microbiology 13: 491–500. 
 
49.  Sebastian S, Brochet M, Collins MO, Schwach F, Jones ML, Goulding D, Rayner 
JC, Choudhary JS, Billker O (2012) A Plasmodium calcium-dependent protein 
kinase controls zygote development and transmission by translationally activating 
repressed mRNAs. Cell host \& microbe 12: 9–19. 
 
50.  Janse C, Van der Klooster P, Van der Kaay H, Van der Ploeg M, Overdulve J 
(1986) Rapid repeated DNA replication during microgametogenesis and DNA 
synthesis in young zygotes of Plasmodium berghei. Transactions of the Royal 
128 
 
Society of Tropical Medicine and Hygiene 80: 154–157. 
 
51.  Ukaegbu UE, Zhang X, Heinberg AR, Wele M, Chen Q, Deitsch KW (2015) A 
unique virulence gene occupies a principal position in immune evasion by the 
malaria parasite plasmodium falciparum. PLoS Genet 11: e1005234. 
 
52.  Blackman MJ (2008) Malarial proteases and host cell egress: an 
“emerging”cascade. Cellular microbiology 10: 1925–1934. 
 
53.  Sologub L, Kuehn A, Kern S, Przyborski J, Schillig R, Pradel G (2011) Malaria 
proteases mediate inside-out egress of gametocytes from red blood cells following 
parasite transmission to the mosquito. Cellular microbiology 13: 897–912. 
 
54.  Andreadaki M, Hanssen E, Deligianni E, Claudet C, Wengelnik K, Mollard V, 
McFadden GI, Abkarian M, Braun-Breton C, Siden-Kiamos I (2018) Sequential 
Membrane Rupture and Vesiculation during Plasmodium berghei Gametocyte 
Egress from the Red Blood Cell. Scientific Reports 8: 3543. 
 
55.  Hale VL, Watermeyer JM, Hackett F, Vizcay-Barrena G, van Ooij C, Thomas JA, 
Spink MC, Harkiolaki M, Duke E, Fleck RA, et al. (2017) Parasitophorous vacuole 
poration precedes its rupture and rapid host erythrocyte cytoskeleton collapse in 
Plasmodium falciparum egress. Proceedings of the National Academy of Sciences 
114: 3439–3444. 
 
56.  Sinden R (1982) Gametocytogenesis of Plasmodium falciparum in vitro: an 
electron microscopic study. Parasitology 84: 1–11. 
 
57.  Olivieri A, Bertuccini L, Deligianni E, Franke-Fayard B, Currà C, Siden-Kiamos I, 
Hanssen E, Grasso F, Superti F, Pace T, et al. (2015) Distinct properties of the 
egress-related osmiophilic bodies in male and female gametocytes of the rodent 
malaria parasite Plasmodium berghei. Cellular microbiology 17: 355–368. 
 
58.  Koning-Ward D, Tania F, Olivieri A, Bertuccini L, Hood A, Silvestrini F, 
Charvalias K, Berzosa D’\iaz P, Camarda G, McElwain TF, et al. (2008) The role 
of osmiophilic bodies and Pfg377 expression in female gametocyte emergence and 
mosquito infectivity in the human malaria parasite Plasmodium falciparum. 
Molecular microbiology 67: 278–290. 
 
59.  Talman AM, Lacroix C, Marques SR, Blagborough AM, Carzaniga R, Ménard R, 
Sinden RE (2011) PbGEST mediates malaria transmission to both mosquito and 
vertebrate host. Molecular microbiology 82: 462–474. 
 
60.  Kehrer J, Singer M, Lemgruber L, Silva PA, Frischknecht F, Mair GR (2016) A 
Putative Small Solute Transporter Is Responsible for the Secretion of G377 and 
TRAP-Containing Secretory Vesicles during Plasmodium Gamete Egress and 
Sporozoite Motility. PLoS Pathog 12: e1005734. 
 
61.  Ponzi M, Sidén-Kiamos I, Bertuccini L, Currà C, Kroeze H, Camarda G, Pace T, 
Franke-Fayard B, Laurentino EC, Louis C, et al. (2009) Egress of Plasmodium 
berghei gametes from their host erythrocyte is mediated by the MDV-1/PEG3 
129 
 
protein. Cellular microbiology 11: 1272–1288. 
 
62.  Deligianni E, Morgan RN, Bertuccini L, Wirth CC, Silmon de Monerri NC, 
Spanos L, Blackman MJ, Louis C, Pradel G, Siden-Kiamos I (2013) A perforin-
like protein mediates disruption of the erythrocyte membrane during egress of 
Plasmodium berghei male gametocytes. Cellular microbiology 15: 1438–1455. 
 
63.  Wirth CC, Glushakova S, Scheuermayer M, Repnik U, Garg S, Schaack D, 
Kachman MM, Weißbach T, Zimmerberg J, Dandekar T, et al. (2014) Perforin-like 
protein PPLP2 permeabilizes the red blood cell membrane during egress of 
Plasmodium falciparum gametocytes. Cellular microbiology 16: 709–733. 
 
64.  Bargieri DY, Thiberge S, Tay CL, Carey AF, Rantz A, Hischen F, Lorthiois A, 
Straschil U, Singh P, Singh S, et al. (2016) Plasmodium Merozoite TRAP Family 
Protein Is Essential for Vacuole Membrane Disruption and Gamete Egress from 
Erythrocytes. Cell Host \& Microbe 20: 618–630. 
 
65.  Lal K, Delves MJ, Bromley E, Wastling JM, Tomley FM, Sinden RE (2009) 
Plasmodium male development gene-1 (mdv-1) is important for female sexual 
development and identifies a polarised plasma membrane during zygote 
development. International journal for parasitology 39: 755–761. 
 
66.  Kehrer J, Frischknecht F, Mair GR (2016) Proteomic analysis of the Plasmodium 
berghei gametocyte egressome and vesicular bioID of osmiophilic body proteins 
identifies merozoite TRAP-like Protein (MTRAP) as an essential factor for 
parasite transmission. Molecular \& Cellular Proteomics 15: 2852–2862. 
 
67.  Blackman MJ, Carruthers VB (2013) Recent insights into apicomplexan parasite 
egress provide new views to a kill. Curr Opin Microbiol 16: 459–464. 
 
68.  Baum J, Gilberger T-W, Frischknecht F, Meissner M (2008) Host-cell invasion by 
malaria parasites: insights from Plasmodium and Toxoplasma. Trends Parasitol 
24: 557–563. 
 
69.  Yeoh S, O’Donnell RA, Koussis K, Dluzewski AR, Ansell KH, Osborne SA, 
Hackett F, Withers-Martinez C, Mitchell GH, Bannister LH, et al. (2007) 
Subcellular discharge of a serine protease mediates release of invasive malaria 
parasites from host erythrocytes. Cell 131: 1072–1083. 
 
70.  Wickham ME, Culvenor JG, Cowman AF (2003) Selective inhibition of a two-step 
egress of malaria parasites from the host erythrocyte. Journal of Biological 
Chemistry 278: 37658–37663. 
 
71.  Sturm A, Graewe S, Franke-Fayard B, Retzlaff S, Bolte S, Roppenser B, 
Aepfelbacher M, Janse C, Heussler V (2009) Alteration of the parasite plasma 
membrane and the parasitophorous vacuole membrane during exo-erythrocytic 
development of malaria parasites. Protist 160: 51–63. 
 
72.  Sturm A, Amino R, Van de Sand C, Regen T, Retzlaff S, Rennenberg A, Krueger 
A, Pollok J-M, Menard R, Heussler VT (2006) Manipulation of host hepatocytes 
130 
 
by the malaria parasite for delivery into liver sinusoids. Science 313: 1287–1290. 
 
73.  Billker O, Dechamps S, Tewari R, Wenig G, Franke-Fayard B, Brinkmann V 
(2004) Calcium and a calcium-dependent protein kinase regulate gamete formation 
and mosquito transmission in a malaria parasite. Cell 117: 503–514. 
 
74.  Agarwal S, Singh MK, Garg S, Chitnis CE, Singh S (2013) Ca(2+) -mediated 
exocytosis of subtilisin-like protease 1: a key step in egress of Plasmodium 
falciparum merozoites. Cell Microbiol 15: 910–921. 
 
75.  Pino P, Caldelari R, Mukherjee B, Vahokoski J, Klages N, Maco B, Collins CR, 
Blackman MJ, Kursula I, Heussler V, et al. (2017) A multistage antimalarial 
targets the plasmepsins IX and X essential for invasion and egress. Science 358: 
522–528. 
 
76.  Hopp CS, Bennett BL, Mishra S, Lehmann C, Hanson KK, Lin J, Rousseau K, 
Carvalho FA, van der Linden WA, Santos NC, et al. (2017) Deletion of the rodent 
malaria ortholog for falcipain-1 highlights differences between hepatic and blood 
stage merozoites. PLoS pathogens 13: e1006586. 
 
77.  Nasamu AS, Glushakova S, Russo I, Vaupel B, Oksman A, Kim AS, Fremont DH, 
Tolia N, Beck JR, Meyers MJ, et al. (2017) Plasmepsins IX and X are essential and 
druggable mediators of malaria parasite egress and invasion. Science 358: 518–
522. 
 
78.  Schmidt-Christensen A, Sturm A, Horstmann S, Heussler VT (2008) Expression 
and processing of Plasmodium berghei SERA3 during liver stages. Cellular 
microbiology 10: 1723–1734. 
 
79.  Withers-Martinez C, Strath M, Hackett F, Haire LF, Howell SA, Walker PA, 
Christodoulou E, Dodson GG, Blackman MJ (2014) The malaria parasite egress 
protease SUB1 is a calcium-dependent redox switch subtilisin. Nature 
communications 5: 3726. 
 
80.  Tawk L, Lacroix C, Gueirard P, Kent R, Gorgette O, Thiberge S, Mercereau-
Puijalon O, Ménard R, Barale J-C (2013) A key role for Plasmodium subtilisin-like 
SUB1 protease in egress of malaria parasites from host hepatocytes. Journal of 
Biological Chemistry 288: 33336–33346. 
 
81.  Collins CR, Hackett F, Atid J, Tan MSY, Blackman MJ (2017) The Plasmodium 
falciparum pseudoprotease SERA5 regulates the kinetics and efficiency of malaria 
parasite egress from host erythrocytes. PLoS pathogens 13: e1006453. 
 
82.  Farrell A, Thirugnanam S, Lorestani A, Dvorin JD, Eidell KP, Ferguson DJ, 
Anderson-White BR, Duraisingh MT, Marth GT, Gubbels M-J (2012) A DOC2 
protein identified by mutational profiling is essential for apicomplexan parasite 
exocytosis. Science 335: 218–221. 
 
83.  Kafsack BF, Pena JD, Coppens I, Ravindran S, Boothroyd JC, Carruthers VB 
(2009) Rapid membrane disruption by a perforin-like protein facilitates parasite 
131 
 
exit from host cells. Science 323: 530–533. 
 
84.  Koussis K, Withers-Martinez C, Yeoh S, Child M, Hackett F, Knuepfer E, Juliano 
L, Woehlbier U, Bujard H, Blackman MJ (2009) A multifunctional serine protease 
primes the malaria parasite for red blood cell invasion. EMBO J 28: 725–735. 
 
85.  Berridge MJ, Lipp P, Bootman MD (2000) The versatility and universality of 
calcium signalling. Nature reviews Molecular cell biology 1: 11. 
 
86.  Rohrbach P, Friedrich O, Hentschel J, Plattner H, Fink RHA, Lanzer M (2005) 
Quantitative calcium measurements in subcellular compartments of Plasmodium 
falciparum-infected erythrocytes. J Biol Chem 280: 27960–27969. 
 
87.  Gazarini ML, Garcia CR (2004) The malaria parasite mitochondrion senses 
cytosolic Ca 2+ fluctuations. Biochemical and biophysical research 
communications 321: 138–144. 
 
88.  Rotmann A, Sanchez C, Guiguemde A, Rohrbach P, Dave A, Bakouh N, Planelles 
G, Lanzer M (2010) PfCHA is a mitochondrial divalent cation/H+ antiporter in 
Plasmodium falciparum. Molecular microbiology 76: 1591–1606. 
 
89.  Docampo R, Moreno SN (2011) Acidocalcisomes. Cell calcium 50: 113–119. 
 
90.  Harper JF, Breton G, Harmon A (2004) Decoding Ca2+ signals through plant 
protein kinases. Annu Rev Plant Biol 55: 263–288. 
 
91.  Nalefski EA, Falke JJ (1996) The C2 domain calcium-binding motif: structural and 
functional diversity. Protein Science 5: 2375–2390. 
 
92.  Raabe A, Berry L, Sollelis L, Cerdan R, Tawk L, Vial HJ, Billker O, Wengelnik K 
(2011) Genetic and transcriptional analysis of phosphoinositide-specific 
phospholipase C in Plasmodium. Exp Parasitol 129: 75–80. 
 
93.  Martin SK, Jett M, Schneider I (1994) Correlation of phosphoinositide hydrolysis 
with exflagellation in the malaria microgametocyte. The Journal of parasitology 
371–378. 
 
94.  Ward P, Equinet L, Packer J, Doerig C (2004) Protein kinases of the human 
malaria parasite Plasmodium falciparum: the kinome of a divergent eukaryote. 
BMC genomics 5: 79. 
 
95.  Weiss GE, Gilson PR, Taechalertpaisarn T, Tham W-H, de Jong NW, Harvey KL, 
Fowkes FJ, Barlow PN, Rayner JC, Wright GJ, et al. (2015) Revealing the 
sequence and resulting cellular morphology of receptor-ligand interactions during 
Plasmodium falciparum invasion of erythrocytes. PLoS pathogens 11: e1004670. 
 
96.  Wasserman M, Alarcón C, Mendoza PM (1982) Effects of Ca++ depletion on the 
asexual cell cycle of Plasmodium falciparum. The American journal of tropical 
medicine and hygiene 31: 711–717. 
 
132 
 
97.  Glushakova S, Lizunov V, Blank PS, Melikov K, Humphrey G, Zimmerberg J 
(2013) Cytoplasmic free Ca2+ is essential for multiple steps in malaria parasite 
egress from infected erythrocytes. Malar J 12: 41. 
 
98.  Hotta CT, Gazarini ML, Beraldo FH, Varotti FP, Lopes C, Markus RP, Pozzan T, 
Garcia CR (2000) Calcium-dependent modulation by melatonin of the circadian 
rhythm in malarial parasites. Nat Cell Biol 2: 466–468. 
 
99.  Brochet M, Collins MO, Smith TK, Thompson E, Sebastian S, Volkmann K, 
Schwach F, Chappell L, Gomes AR, Berriman M, et al. (2014) Phosphoinositide 
metabolism links cGMP-dependent protein kinase G to essential Ca2+ signals at 
key decision points in the life cycle of malaria parasites. PLoS biology 12: 
e1001806. 
 
100.  Collins CR, Hackett F, Strath M, Penzo M, Withers-Martinez C, Baker DA, 
Blackman MJ (2013) Malaria parasite cGMP-dependent protein kinase regulates 
blood stage merozoite secretory organelle discharge and egress. PLoS pathogens 9: 
e1003344. 
 
101.  Dvorin JD, Martyn DC, Patel SD, Grimley JS, Collins CR, Hopp CS, Bright AT, 
Westenberger S, Winzeler E, Blackman MJ, et al. (2010) A plant-like kinase in 
Plasmodium falciparum regulates parasite egress from erythrocytes. Science 328: 
910–912. 
 
102.  Giganti D, Bouillon A, Tawk L, Robert F, Martinez M, Crublet E, Weber P, 
Girard-Blanc C, Petres S, Haouz A, et al. (2014) A novel Plasmodium-specific 
prodomain fold regulates the malaria drug target SUB1 subtilase. Nature 
communications 5: 
 
103.  Philip N, Waters AP (2015) Conditional degradation of Plasmodium calcineurin 
reveals functions in parasite colonization of both host and vector. Cell host \& 
microbe 18: 122–131. 
 
104.  Siden-Kiamos I, Ecker A, Nybäck S, Louis C, Sinden RE, Billker O (2006) 
Plasmodium berghei calcium-dependent protein kinase 3 is required for ookinete 
gliding motility and mosquito midgut invasion. Mol Microbiol 60: 1355–1363. 
 
105.  Ishino T, Orito Y, Chinzei Y, Yuda M (2006) A calcium-dependent protein kinase 
regulates Plasmodium ookinete access to the midgut epithelial cell. Mol Microbiol 
59: 1175–1184. 
 
106.  Carey AF, Singer M, Bargieri D, Thiberge S, Frischknecht F, Ménard R, Amino R 
(2014) Calcium dynamics of Plasmodium berghei sporozoite motility. Cellular 
microbiology 16: 768–783. 
 
107.  Doi Y, Shinzawa N, Fukumoto S, Okano H, Kanuka H (2011) Calcium signal 
regulates temperature-dependent transformation of sporozoites in malaria parasite 
development. Experimental parasitology 128: 176–180. 
 
133 
 
108.  Suarez C, Volkmann K, Gomes AR, Billker O, Blackman MJ (2013) The malarial 
serine protease SUB1 plays an essential role in parasite liver stage development. 
PLoS pathogens 9: e1003811. 
 
109.  McRobert L, Taylor CJ, Deng W, Fivelman QL, Cummings RM, Polley SD, 
Billker O, Baker DA (2008) Gametogenesis in malaria parasites is mediated by the 
cGMP-dependent protein kinase. PLoS biology 6: e139. 
 
110.  Muhia DK, Swales CA, Deng W, Kelly JM, Baker DA (2001) The gametocyte-
activating factor xanthurenic acid stimulates an increase in membrane-associated 
guanylyl cyclase activity in the human malaria parasite Plasmodium falciparum. 
Molecular microbiology 42: 553–560. 
 
111.  Kawamoto F, Alejo-Blanco R, Fleck SL, Kawamoto Y, Sinden RE (1990) Possible 
roles of Ca2+ and cGMP as mediators of the exflagellation of Plasmodium berghei 
and Plasmodium falciparum. Molecular and biochemical parasitology 42: 101–
108. 
 
112.  Washington NL, Ward S (2006) FER-1 regulates Ca2+-mediated membrane fusion 
during C. elegans spermatogenesis. Journal of cell science 119: 2552–2562. 
 
113.  Lek A, Lek M, North KN, Cooper ST (2010) Phylogenetic analysis of ferlin genes 
reveals ancient eukaryotic origins. BMC evolutionary biology 10: 231. 
 
114.  Helfmann S, Neumann P, Tittmann K, Moser T, Ficner R, Reisinger E (2011) The 
crystal structure of the C 2 A domain of otoferlin reveals an unconventional top 
loop region. Journal of molecular biology 406: 479–490. 
 
115.  Staub E, Fiziev P, Rosenthal A, Hinzmann B (2004) Insights into the evolution of 
the nucleolus by an analysis of its protein domain repertoire. Bioessays 26: 567–
581. 
 
116.  Jiménez JL, Bashir R (2007) In silico functional and structural characterisation of 
ferlin proteins by mapping disease-causing mutations and evolutionary information 
onto three-dimensional models of their C2 domains. Journal of the neurological 
sciences 260: 114–123. 
 
117.  Covian-Nares JF, Koushik SV, Puhl HL, Vogel SS (2010) Membrane wounding 
triggers ATP release and dysferlin-mediated intercellular calcium signaling. J Cell 
Sci 123: 1884–1893. 
 
118.  Davis DB, Doherty KR, Delmonte AJ, McNally EM (2002) Calcium-sensitive 
phospholipid binding properties of normal and mutant ferlin C2 domains. Journal 
of Biological Chemistry 277: 22883–22888. 
 
119.  Ramakrishnan NA, Drescher MJ, Morley BJ, Kelley PM, Drescher DG (2014) 
Calcium regulates molecular interactions of otoferlin with soluble NSF attachment 
protein receptor (SNARE) proteins required for hair cell exocytosis. Journal of 
Biological Chemistry 289: 8750–8766. 
 
134 
 
120.  Johnson CP (2017) Emerging Functional Differences between the Synaptotagmin 
and Ferlin Calcium Sensor Families. Biochemistry 56: 6413–6417. 
 
121.  Yasunaga S, Grati M, Cohen-Salmon M, El-Amraoui A, Mustapha M, Salem N, 
El-Zir E, Loiselet J, Petit C (1999) A mutation in OTOF, encoding otoferlin, a 
FER-1-like protein, causes DFNB9, a nonsyndromic form of deafness. Nature 
genetics 21: 363. 
 
122.  Liu J, Aoki M, Illa I, Wu C, Fardeau M, Angelini C, Serrano C, Urtizberea JA, 
Hentati F, Hamida MB, et al. (1998) Dysferlin, a novel skeletal muscle gene, is 
mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nature 
genetics 20: 31. 
 
123.  Redpath GM, Sophocleous RA, Turnbull L, Whitchurch CB, Cooper ST (2016) 
Ferlins Show Tissue-Specific Expression and Segregate as Plasma Membrane/Late 
Endosomal or Trans-Golgi/Recycling Ferlins. Traffic 17: 245–266. 
 
124.  Pangr\vsi\vc T, Reisinger E, Moser T (2012) Otoferlin: a multi-C2 domain protein 
essential for hearing. Trends in neurosciences 35: 671–680. 
 
125.  Roux I, Safieddine S, Nouvian R, Grati M, Simmler M-C, Bahloul A, Perfettini I, 
Le Gall M, Rostaing P, Hamard G, et al. (2006) Otoferlin, defective in a human 
deafness form, is essential for exocytosis at the auditory ribbon synapse. Cell 127: 
277–289. 
 
126.  Pangrsic T, Lasarow L, Reuter K, Takago H, Schwander M, Riedel D, Frank T, 
Tarantino LM, Bailey JS, Strenzke N, et al. (2010) Hearing requires otoferlin-
dependent efficient replenishment of synaptic vesicles in hair cells. Nat Neurosci 
13: 869–876. 
 
127.  Johnson CP, Chapman ER (2010) Otoferlin is a calcium sensor that directly 
regulates SNARE-mediated membrane fusion. The Journal of cell biology 191: 
187–197. 
 
128.  Heidrych P, Zimmermann U, Kuhn S, Franz C, Engel J, Duncker SV, Hirt B, 
Pusch CM, Ruth P, Pfister M, et al. (2009) Otoferlin interacts with myosin VI: 
implications for maintenance of the basolateral synaptic structure of the inner hair 
cell. Human molecular genetics 18: 2779–2790. 
 
129.  Heidrych P, Zimmermann U, Breß A, Pusch CM, Ruth P, Pfister M, Knipper M, 
Blin N (2008) Rab8b GTPase, a protein transport regulator, is an interacting 
partner of otoferlin, defective in a human autosomal recessive deafness form. 
Human molecular genetics 17: 3814–3821. 
 
130.  Davis DB, Delmonte AJ, Ly CT, McNally EM (2000) Myoferlin, a candidate gene 
and potential modifier of muscular dystrophy. Hum Mol Genet 9: 217–226. 
 
131.  Doherty KR, Cave A, Davis DB, Delmonte AJ, Posey A, Earley JU, Hadhazy M, 
McNally EM (2005) Normal myoblast fusion requires myoferlin. Development 
135 
 
132: 5565–5575. 
 
132.  Bansal D, Campbell KP (2004) Dysferlin and the plasma membrane repair in 
muscular dystrophy. Trends Cell Biol 14: 206–213. 
 
133.  Bernatchez PN, Sharma A, Kodaman P, Sessa WC (2009) Myoferlin is critical for 
endocytosis in endothelial cells. American Journal of Physiology-Cell Physiology 
297: C484–C492. 
 
134.  Robinson JM, Ackerman IV WE, Behrendt NJ, Vandre DD (2009) While dysferlin 
and myoferlin are coexpressed in the human placenta, only dysferlin expression is 
responsive to trophoblast fusion in model systems. Biology of reproduction 81: 33–
39. 
 
135.  Matsuda C, Hayashi YK, Ogawa M, Aoki M, Murayama K, Nishino I, Nonaka I, 
Arahata K, Brown RH (2001) The sarcolemmal proteins dysferlin and caveolin-3 
interact in skeletal muscle. Hum Mol Genet 10: 1761–1766. 
 
136.  Huang Y, de Morrée A, van Remoortere A, Bushby K, Frants RR, den Dunnen JT, 
van der Maarel SM (2008) Calpain 3 is a modulator of the dysferlin protein 
complex in skeletal muscle. Hum Mol Genet 17: 1855–1866. 
 
137.  Ho M, Post CM, Donahue LR, Lidov HG, Bronson RT, Goolsby H, Watkins SC, 
Cox GA, Brown Jr RH (2004) Disruption of muscle membrane and phenotype 
divergence in two novel mouse models of dysferlin deficiency. Human molecular 
genetics 13: 1999–2010. 
 
138.  Therrien C, Dodig D, Karpati G, Sinnreich M (2006) Mutation impact on dysferlin 
inferred from database analysis and computer-based structural predictions. Journal 
of the neurological sciences 250: 71–78. 
 
139.  Cenacchi G, Fanin M, De Giorgi L, Angelini C (2005) Ultrastructural changes in 
dysferlinopathy support defective membrane repair mechanism. Journal of clinical 
pathology 58: 190–195. 
 
140.  Inoue M, Wakayama Y, Kojima H, Shibuya S, Jimi T, Oniki H, Nishino I, Nonaka 
I (2006) Expression of myoferlin in skeletal muscles of patients with 
dysferlinopathy. The Tohoku journal of experimental medicine 209: 109–116. 
 
141.  Doherty KR, Demonbreun AR, Wallace GQ, Cave A, Posey AD, Heretis K, Pytel 
P, McNally EM (2008) The endocytic recycling protein EHD2 interacts with 
myoferlin to regulate myoblast fusion. Journal of Biological Chemistry 283: 
20252–20260. 
 
142.  Bernatchez PN, Sharma A, Kodaman P, Sessa WC (2009) Myoferlin is critical for 
endocytosis in endothelial cells. Am J Physiol, Cell Physiol 297: C484–92. 
 
143.  Bernatchez PN, Acevedo L, Fernandez-Hernando C, Murata T, Chalouni C, Kim J, 
Erdjument-Bromage H, Shah V, Gratton J-P, McNally EM, et al. (2007) Myoferlin 
regulates vascular endothelial growth factor receptor-2 stability and function. 
136 
 
Journal of Biological Chemistry 282: 30745–30753. 
 
144.  Demonbreun AR, Posey AD, Heretis K, Swaggart KA, Earley JU, Pytel P, 
McNally EM (2010) Myoferlin is required for insulin-like growth factor response 
and muscle growth. The FASEB Journal 24: 1284–1295. 
 
145.  Turtoi A, Blomme A, Bellahcène A, Gilles C, Hennequière V, Peixoto P, Bianchi 
E, Noel A, De Pauw E, Lifrange E, et al. (2013) Myoferlin is a key regulator of 
EGFR activity in breast cancer. Cancer Res 73: 5438–5448. 
 
146.  Amatschek S, Koenig U, Auer H, Steinlein P, Pacher M, Gruenfelder A, Dekan G, 
Vogl S, Kubista E, Heider K-H, et al. (2004) Tissue-wide expression profiling 
using cDNA subtraction and microarrays to identify tumor-specific genes. Cancer 
Res 64: 844–856. 
 
147.  Volakis LI, Li R, Ackerman IV WE, Mihai C, Bechel M, Summerfield TL, Ahn 
CS, Powell HM, Zielinski R, Rosol TJ, et al. (2014) Loss of myoferlin redirects 
breast cancer cell motility towards collective migration. PloS one 9: e86110. 
 
148.  Leung C, Yu C, Lin MI, Tognon C, Bernatchez P (2013) Expression of myoferlin 
in human and murine carcinoma tumors: role in membrane repair, cell 
proliferation, and tumorigenesis. The American journal of pathology 182: 1900–
1909. 
 
149.  Posey Jr AD, Demonbreun A, McNally EM (2011) Ferlin proteins in myoblast 
fusion and muscle growth. Current topics in developmental biology 96: 203. 
 
150.  Reisinger E, Bresee C, Neef J, Nair R, Reuter K, Bulankina A, Nouvian R, Koch 
M, Bückers J, Kastrup L, et al. (2011) Probing the functional equivalence of 
otoferlin and synaptotagmin 1 in exocytosis. Journal of Neuroscience 31: 4886–
4895. 
 
151.  Lek A, Evesson FJ, Sutton RB, North KN, Cooper ST (2012) Ferlins: regulators of 
vesicle fusion for auditory neurotransmission, receptor trafficking and membrane 
repair. Traffic 13: 185–194. 
 
152.  Leung C, Utokaparch S, Sharma A, Yu C, Abraham T, Borchers C, Bernatchez P 
(2011) Proteomic identification of dysferlin-interacting protein complexes in 
human vascular endothelium. Biochemical and biophysical research 
communications 415: 263–269. 
 
153.  Achanzar WE, Ward S (1997) A nematode gene required for sperm vesicle fusion. 
Journal of cell science 110: 1073–1081. 
 
154.  Defour A, Van der Meulen JH, Bhat R, Bigot A, Bashir R, Nagaraju K, Jaiswal JK 
(2014) Dysferlin regulates cell membrane repair by facilitating injury-triggered 
acid sphingomyelinase secretion. Cell death \& disease 5: e1306. 
 
155.  Demonbreun AR, Fahrenbach JP, Deveaux K, Earley JU, Pytel P, McNally EM 
(2010) Impaired muscle growth and response to insulin-like growth factor 1 in 
137 
 
dysferlin-mediated muscular dystrophy. Human molecular genetics 20: 779–789. 
 
156.  Krajacic P, Pistilli EE, Tanis JE, Khurana TS, Lamitina ST (2013) FER-
1/Dysferlin promotes cholinergic signaling at the neuromuscular junction in C. 
elegans and mice. Biology open 2: 1245–1252. 
 
157.  Ohsako T, Hirai K, Yamamoto M-T (2003) The Drosophila misfire gene has an 
essential role in sperm activation during fertilization. Genes \& genetic systems 78: 
253–266. 
 
158.  Sun X, Zhu Y, Wang L, Liu H, Ling Y, Li Z, Sun L (2017) The Catsper channel 
and its roles in male fertility: a systematic review. Reproductive Biology and 
Endocrinology 15: 65. 
 
159.  Sodergren E, Weinstock GM, Davidson EH, Cameron RA, Gibbs RA, Angerer 
RC, Angerer LM, Arnone MI, Burgess DR, Burke RD, et al. (2006) The genome 
of the sea urchin Strongylocentrotus purpuratus. Science 314: 941–952. 
 
160.  Xiong Y, Zhang M, Hong Y, Wei M, Ai D, Meng P, Han Y, Fu Z, Shi Y, Yang J, 
et al. (2013) Characterization analysis of Schistosoma japonicum plasma 
membrane repair relative gene myoferlin. PloS one 8: e66396. 
 
161.  Mueller A-K, Morath E (2015) Malaria vaccines based on apicomplexan ferlins, 
ferlin-like proteins and other C2-domain containing proteins. 
 
162.  Hall N, Karras M, Raine JD, Carlton JM, Kooij TW, Berriman M, Florens L, 
Janssen CS, Pain A, Christophides GK, et al. (2005) A comprehensive survey of 
the Plasmodium life cycle by genomic, transcriptomic, and proteomic analyses. 
Science 307: 82–86. 
 
163.  Franke-Fayard B, Trueman H, Ramesar J, Mendoza J, van der Keur M, van der 
Linden R, Sinden RE, Waters AP, Janse CJ (2004) A Plasmodium berghei 
reference line that constitutively expresses GFP at a high level throughout the 
complete life cycle. Molecular and biochemical parasitology 137: 23–33. 
 
164.  Nussenzweig R, Nussenzweig V (1989) Antisporozoite vaccine for malaria: 
experimental basis and current status. Clinical Infectious Diseases 11: S579–S585. 
 
165.  Tsuji M, Mattei D, Nussenzweig RS, Eichinger D, Zavala F (1994) Demonstration 
of heat-shock protein 70 in the sporozoite stage of malaria parasites. Parasitol Res 
80: 16–21. 
 
166.  Birago C, Albanesi V, Silvestrini F, Picci L, Pizzi E, Alano P, Pace T, Ponzi M 
(2003) A gene-family encoding small exported proteins is conserved across 
Plasmodium genus. Molecular and biochemical parasitology 126: 209–218. 
 
167.  Chapman S, Faulkner C, Kaiserli E, Garcia-Mata C, Savenkov EI, Roberts AG, 
Oparka KJ, Christie JM (2008) The photoreversible fluorescent protein iLOV 
outperforms GFP as a reporter of plant virus infection. Proceedings of the National 
138 
 
Academy of Sciences 105: 20038–20043. 
 
168.  Kooij TW, Rauch MM, Matuschewski K (2012) Expansion of experimental 
genetics approaches for Plasmodium berghei with versatile transfection vectors. 
Molecular and biochemical parasitology 185: 19–26. 
 
169.  Braks JA, Franke-Fayard B, Kroeze H, Janse CJ, Waters AP (2006) Development 
and application of a positive-negative selectable marker system for use in reverse 
genetics in Plasmodium. Nucleic Acids Research 34: e39–e39. 
 
170.  Godiska R, Mead D, Dhodda V, Wu C, Hochstein R, Karsi A, Usdin K, Entezam 
A, Ravin N (2009) Linear plasmid vector for cloning of repetitive or unstable 
sequences in Escherichia coli. Nucleic acids research 38: e88–e88. 
 
171.  Gomes AR, Bushell E, Schwach F, Girling G, Anar B, Quail MA, Herd C, Pfander 
C, Modrzynska K, Rayner JC, et al. (2015) A genome-scale vector resource 
enables high-throughput reverse genetic screening in a malaria parasite. Cell host 
\& microbe 17: 404–413. 
 
172.  Schwach F, Bushell E, Gomes AR, Anar B, Girling G, Herd C, Rayner JC, Billker 
O (2015) PlasmoGEM, a database supporting a community resource for large-scale 
experimental genetics in malaria parasites. Nucleic Acids Res 43: D1176–82. 
 
173.  Grützke J, Rindte K, Goosmann C, Silvie O, Rauch C, Heuer D, Lehmann MJ, 
Mueller A-K, Brinkmann V, Matuschewski K, et al. (2014) The spatiotemporal 
dynamics and membranous features of the Plasmodium liver stage tubovesicular 
network. Traffic 15: 362–382. 
 
174.  Bushell E, Gomes AR, Sanderson T, Anar B, Girling G, Herd C, Metcalf T, 
Modrzynska K, Schwach F, Martin RE, et al. (2017) Functional profiling of a 
Plasmodium genome reveals an abundance of essential genes. Cell 170: 260–272. 
 
175.  Mukherjee A, Walker J, Weyant KB, Schroeder CM (2013) Characterization of 
flavin-based fluorescent proteins: an emerging class of fluorescent reporters. PloS 
one 8: e64753. 
 
176.  De Koning-Ward TF, Gilson PR, Crabb BS (2015) Advances in molecular genetic 
systems in malaria. Nature Reviews Microbiology 13: 373–387. 
 
177.  Ferré-D’Amaré AR (2010) The glmS ribozyme: use of a small molecule coenzyme 
by a gene-regulatory RNA. Quarterly reviews of biophysics 43: 423–447. 
 
178.  Armstrong CM, Goldberg DE (2007) An FKBP destabilization domain modulates 
protein levels in Plasmodium falciparum. Nature methods 4: 1007. 
 
179.  Nishimura K, Fukagawa T, Takisawa H, Kakimoto T, Kanemaki M (2009) An 
auxin-based degron system for the rapid depletion of proteins in nonplant cells. 
Nature methods 6: 917. 
 
139 
 
180.  Siden-Kiamos I, Ganter M, Kunze A, Hliscs M, Steinbüchel M, Mendoza J, Sinden 
RE, Louis C, Matuschewski K (2011) Stage-specific depletion of myosin A 
supports an essential role in motility of malarial ookinetes. Cellular microbiology 
13: 1996–2006. 
 
181.  De Niz M, Helm S, Horstmann S, Annoura T, del Portillo HA, Khan SM, Heussler 
VT (2015) In Vivo and In Vitro Characterization of a Plasmodium Liver Stage-
Specific Promoter. PloS one 10: 
 
182.  Laurentino EC, Taylor S, Mair GR, Lasonder E, Bartfai R, Stunnenberg HG, 
Kroeze H, Ramesar J, Franke-Fayard B, Khan SM, et al. (2011) Experimentally 
controlled downregulation of the histone chaperone FACT in Plasmodium berghei 
reveals that it is critical to male gamete fertility. Cellular microbiology 13: 1956–
1974. 
 
183.  Silvie O, Franetich J-F, Charrin S, Mueller MS, Siau A, Bodescot M, Rubinstein E, 
Hannoun L, Charoenvit Y, Kocken CH, et al. (2004) A role for apical membrane 
antigen 1 during invasion of hepatocytes by Plasmodium falciparum sporozoites. 
Journal of Biological Chemistry 279: 9490–9496. 
 
184.  Lavazec C, Moreira CK, Mair GR, Waters AP, Janse CJ, Templeton TJ (2009) 
Analysis of mutant Plasmodium berghei parasites lacking expression of multiple 
PbCCp genes. Molecular and biochemical parasitology 163: 1–7. 
 
185.  Santos JM, Kehrer J, Franke-Fayard B, Frischknecht F, Janse CJ, Mair GR (2015) 
The Plasmodium palmitoyl-S-acyl-transferase DHHC2 is essential for ookinete 
morphogenesis and malaria transmission. Scientific reports 5: 16034. 
 
186.  Vogl C, Panou I, Yamanbaeva G, Wichmann C, Mangosing SJ, Vilardi F, 
Indzhykulian AA, Pangr\vsi\vc T, Santarelli R, Rodriguez-Ballesteros M, et al. 
(2016) Tryptophan-rich basic protein (WRB) mediates insertion of the tail-
anchored protein otoferlin and is required for hair cell exocytosis and hearing. The 
EMBO Journal 35: 2536–2552. 
 
187.  Kobayashi K, Izawa T, Kuwamura M, Yamate J (2012) Dysferlin and animal 
models for dysferlinopathy. J Toxicol Pathol 25: 135–147. 
 
188.  Smith MK, Wakimoto BT (2007) Complex regulation and multiple developmental 
functions of misfire, the Drosophila melanogaster ferlin gene. BMC developmental 
biology 7: 1. 
 
189.  Beetsma A, van de Wiel TJ, Sauerwein R, Eling W (1998) Plasmodium 
bergheiANKA: Purification of Large Numbers of Infectious Gametocytes. 
Experimental parasitology 88: 69–72. 
 
190.  Swulius MT, Jensen GJ (2012) The helical MreB cytoskeleton in Escherichia coli 
MC1000/pLE7 is an artifact of the N-Terminal yellow fluorescent protein tag. 
Journal of bacteriology 194: 6382–6386. 
 
140 
 
191.  Buckley AM, Petersen J, Roe AJ, Douce GR, Christie JM (2015) LOV-based 
reporters for fluorescence imaging. Current opinion in chemical biology 27: 39–
45. 
 
192.  Lacroix C, Giovannini D, Combe A, Bargieri DY, Späth S, Panchal D, Tawk L, 
Thiberge S, Carvalho TG, Barale J-C, et al. (2011) FLP/FRT-mediated conditional 
mutagenesis in pre-erythrocytic stages of Plasmodium berghei. Nature protocols 6: 
1412. 
 
193.  Estévez JM, Somerville C (2006) FlAsH-based live-cell fluorescent imaging of 
synthetic peptides expressed in Arabidopsis and tobacco. Biotechniques 41: 572–
564. 
 
194.  Crivat G, Tokumasu F, Sa JM, Hwang J, Wellems TE (2011) Tetracysteine-based 
fluorescent tags to study protein localization and trafficking in Plasmodium 
falciparum-infected erythrocytes. PloS one 6: e22975. 
 
195.  Nancy H, Laughlin AM, Varner DD, Welsh TH, Forrest DW, Blanchard TL, 
Johnson L (2004) Gene expression in the spermatogenically inactive “dark” and 
maturing “light” testicular tissues of the prepubertal colt. Journal of andrology 25: 
535–544. 
 
196.  Carninci P, Hayashizaki Y (1999) [2] High-efficiency full-length cDNA cloning. 
In, Methods in enzymology pp 19–44. Elsevier. 
 
197.  Smith RC, Barillas-Mury C (2016) Plasmodium oocysts: overlooked targets of 
mosquito immunity. Trends in parasitology 32: 979–990. 
 
198.  Janse CJ, Waters AP (2007) The exoneme helps malaria parasites to break out of 
blood cells. Cell 131: 1036–1038. 
 
199.  Wirth CC, Pradel G (2012) Molecular mechanisms of host cell egress by malaria 
parasites. International Journal of Medical Microbiology 302: 172–178. 
 
  
